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An important eld in plastic and reconstructive surgery is the reconstruction of tissue 
defects. Large defects can be reconstructed by transferring autologous tissue using local or 
free aps, for instance in reconstruction of breasts or for coverage of traumatic lower limb 
defects. In case of limb amputation, the only functional reconstructive option used to be 
replantation. However, a new option emerged into the eld of plastic and reconstructive 
surgery in the nineties: Vascularised Composite Allotransplantation (VCA; allogenic 
composite tissue transplantation). In reconstructive procedures involving VCAs, the 
a¡ected body part is procured from a donor and transplanted to the patient. This highly 
complex procedure enables functional reconstruction when no other reconstructive options 
are possible or desirable. Since the rst hand transplantation in 1998, other body parts have 
been successfully transplanted as well, such as abdominal wall, uterus, penis and face.1-5 
The rst Dutch bilateral hand-arm transplantation has been successfully performed in the 
Radboud University Medical Center in 2019, pushing the boundaries for reconstructive 
surgery in the Netherlands.6 
Flaps are generally composed of one or two tissue types (e.g. skin, fat and/or muscle). In 
contrast, VCAs comprise multiple tissues that together form a functional unit, such as skin, 
fat, nerves, blood vessels, skeletal muscle or bone. Of these tissues, muscle is most sensitive 
to ischemia, resulting from its active metabolism. The maximum ischemia time for skeletal 
muscle at body temperature is 4 hours, compared to 8 hours for nerve, 13 hours for fat, 24 
hours for skin and 4 days for bone.7 Survival of skeletal muscle is vital since it is the main 
component in most free aps and VCAs, provides volume and is essential for functionality 
of the gra® by generation of movement though contraction. Therefore, VCAs that contain 
large volumes of muscle need to be revascularized within four hours or need to be safely 
preserved to prevent irreversible tissue damage.7, 8 The di°culty of preservation of muscle 
tissue includes the maintenance of the delicate electrolyte equilibrium in the cells, the 
inability of muscle tissue to process lactate (the end product of anaerobic metabolism) and 
its susceptibility to weight gain (oedema).9-1
Considering these unique features of skeletal muscle, concepts derived from solid organ 
preservation cannot directly be extrapolated to the preservation of composite tissues or 
VCAs. In clinical practise this translates to the fact that VCA preservation is more time-
sensitive than solid organ preservation. Replantation or VCA procedures have longer 
ischemia times and more easily exceed the maximum ischemia tolerance. This is caused 
by the higher complexity of these procedures, since not only blood vessels, but also nerves, 
tendons and bones need to be cautiously reconnected.12 Furthermore, in the Netherlands, 
organs and tissues are procured in the donor hospital, requiring additional time to transport 
tissues from donor to recipient hospital during VCA procedures. 
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Ischemia-reperfusion injury
Irreversible tissue damage occurs when the critical ischemia time is overridden. The 
process responsible for cell damage during replantation or transplantation is called 
‘ischemia-reperfusion injury’ (IRI). During ischemia, tissue damage progressively develops 
due to a lack of oxygen and nutrients and will be greatly irreversible a®er exceeding the 
maximum tolerable ischemia time. Depletion of ATP during ischemia results in a switch 
to anaerobic metabolism and consequently in lactate acidosis. Also, the activity of the 
ATP dependent Na+/K+-ATPase and Ca2+-ATPase pumps is reduced, leading to increased 
intracellular Na+ and Ca2+ concentrations. This ultimately leads to cellular swelling due to 
increased osmolality.13 However, it is not the ischemic response but the response to tissue 
reperfusion (restoration of blood ow) that causes the most signicant tissue damage. 
Following reperfusion, the oxygen supply exceeds the demand in cells that are still making 
the switch from anaerobic to aerobic metabolism. As a result, the production of reactive 
oxygen species is increased, while the natural cellular scavenger processes are depressed or 
depleted.14 These oxygen radicals are responsible for cell membrane damage and increased 
microvasculature permeability by introducing large leakage sites in vessels.15 At the end 
of the IRI process, a cascade of pro-inammatory reactions is initiated, activating the 
complement (e.g. caspase-3) and cytokine system (e.g. TNF-α and IL-1), ultimately leading 
to cell death or even to multiple organ failure.16 Tissue preservation techniques therefore 
aim to reduce both ischemia and reperfusion injury.
Static cold storage (SCS)
Currently, tissue preservation in composite tissues and VCA is achieved by decreasing the 
metabolism of the cells, by lowering their temperature. The aim of hypothermia (storage 
on melting ice at a temperature of approximately 4°C) is to reduce the tissue’s temperature, 
without freezing it. All energy consuming processes are slowed down, with a 1.5 to 2-fold 
decrease of cellular metabolism for every 10°C drop in temperature.14, 17 Hypothermia still 
is the standard preservation method for amputated limbs or VCAs.18 Static cold storage 
(SCS) is preceded by a ush with cooled heparin-saline solution or preservation uid. 
This ush initiates the cooling of the tissue and is important for removing blood from the 
vascular bed, preventing stasis of proinammatory and prothrombotic blood mediators 
during preservation.19, 20 Hypothermia only enables an extension of the maximum allowable 
ischemia time from 4 to approximately 6 hours for skeletal muscle.21-23 Therefore, early 
revascularisation remains the mainstay in this approach to minimise ischemic tissue 
damage.
Since it is not always possible to reduce ischemia time below the maximum of six hours, 
there is a need for preservation techniques that can safely prolong this maximum tissue 
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Chapter 1
ischemia time. The ability to better and longer preserve these tissues will improve 
postoperative outcomes, such as muscle function or nerve ingrowth. Furthermore, it is 
thought that improved tissue preservation is associated with a decreased risk of acute 
rejection a®er VCA.8, 24 
Extracorporeal perfusion (ECP)
Extracorporeal perfusion (ECP) has been proposed as a technique for prolonged composite 
tissue preservation outside the body.25 Tissue is connected to the perfusion machine 
during ECP while a solution is articially pumped through it, diluting and ushing away 
toxic metabolites and providing oxygen and nutrients to the tissue to maintain aerobic 
cell metabolism.26, 27 Optionally, the preservation solution can be cooled, reducing cell 
metabolism and following similar principles to hypothermic preservation. 
The precursor of the extracorporeal perfusion machine as we now know it, is the heart-lung 
machine which has been used since 1953 to bypass the heart during cardiac surgery.28 Since 
the principles of the heart-lung machine (bypassing the heart from the blood circulation) 
are opposite to those in organ perfusion (perfusing an isolated organ outside the body), 
the setup was not yet compatible for organ preservation. Driven by the shortage of donor-
organs, the machine was adjusted and improved for use during solid organ preservation 
in the 1960’s.29 The technique attracted the interest of reconstructive surgeons and the rst 
experiments using ECP for limb preservation were performed in the 1980’s.30, 31 
The technique kept on evolving and now is increasingly used clinically for solid organ 
preservation, for instance during liver or kidney transplantation.15, 32 Nowadays, ECP can 
also be utilized for quality assessment and preconditioning of marginal organs (donor 
organs in a lesser condition) with the goal to further increase the organ donor-pool.33 In 
contrast, ECP is not yet clinically implemented for composite tissue or VCA preservation. 
Despite of the growing interest in ECP for preservation of these tissues as well, the 
evidence is still limited and the technique has not yet found its way into clinical practice 
for this indication.19 Therefore, there is need for further investigation of ECP for prolonged 
composite tissue preservation. 
The rst perfusion machine that was used by our research group was assembled in 2016 by 
Slater et al. and consisted of parts of a heart-lung machine.34 Since then the machine was 
further rened and reduced in size to t onto a trolley car. 
The ECP-machine consists of three essential elements (Figure 1): 
1) A pump to generate a pulsatile or continuous perfusion ow
2) An oxygenator to provide the preservation uid with oxygen
3) A heater-cooler machine to regulate uid temperature 
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Perfusion settings
The di°culty in ECP is to determine the correct settings in a vast number of parameters 
inuencing clinical outcomes. Amongst these settings are perfusion temperature, perfusion 
pressure and preservation solution. 
A large variety of temperature settings has been described in literature, where normothermic 
perfusion (between 35-37°C) and hypothermic perfusion (between 5-20°C) form the two ends 
of the spectrum. Normothermic perfusion usually uses blood or blood-based perfusion 
uids. These uids are only suitable for use at body temperature and generally require a low 
oxygen tension due to presence of oxygen-carriers in the uid (e.g. haemoglobin vesicles). 
Normothermic perfusion is thought to minimize peripheral vasoconstriction and shunting, 
while maintaining intracellular mechanisms including cell adaptation and repair.35, 36 
However, these uids need to be replenished frequently to remove excess waste products. 
Also, whole blood needs to be matched and contains clotting factors that make the set-up 
prone to thrombosis.14 Hypothermic perfusion has the advantage of reducing the tissue’s 
metabolic activity and decreasing the oxygen needs, requiring less complex solutions.35 
Hypothermic perfusion uses acellular uids of which most are commercially available. 
Important protective elements in these uids are bu¡ers and antioxidants, allowing to 
neutralise the e¡ects of metabolic waste products.15 Therefore, hypothermic perfusion 
uids have a lower need for replenishment compared to the normothermic uids, making 
them easy and cheaper in use. 
Figure 1. A systematic illustration of the extracorporeal perfusion set-up as used in this thesis
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Our research group assessed di¡erent techniques of ECP on porcine musculocutaneous 
aps in a pilot study in 2016.34 Normothermic heparinised blood perfusion was compared 
to acellular perfusion. Superior results were found on histological examination in aps 
that were preserved by hypothermic perfusion with acellular solutions in contrast to the 
blood-perfused aps. Following these results, the experiments in this thesis continued to 
use hypothermic ECP with acellular preservation solutions. 
Acellular preservation solutions
A large number of acellular preservation solutions have become available over the last 
decades, driven by the di¡erent requirements of each transplantable tissue. The main 
function of any preservation solution is to maintain a physiological cell milieu while 
preventing tissue oedema and cellular electrolyte imbalance.14, 37 Two of the most common 
preservation solutions in solid organ perfusion are Histidine-Tryptophan-Ketoglutarate 
(HTK) and University of Wisconsin (UW) solution.32 Both are commercially available and 
possess qualities that could also make them suitable for hypothermic skeletal muscle and 
VCA preservation.38 
University of Wisconsin solution
UW solution was developed in 1980’s by Belzer and Southard and was successfully 
introduced in 1987 as cold storage solution for liver preservation.39 Following positive 
results in pancreas and kidney preservation as well, its clinical use expanded rapidly. 32 
UW solution has a high potassium and low sodium content (Table 1). The high potassium 
concentration aims to prevent the e¸ux of cellular potassium that is induced during 
ischemia by Na+/K+-ATPase dysfunction. The oncotic ingredients hydroxyethyl starch 
(HES), lactobionate and ra°nose in UW solution prevent extravasation of the solution 
and reduce tissue oedema. ATP production is supported by adenosine and phosphate 
and the antioxidants glutathione and allopurinol serve as radical oxygen scavengers.40 
A disadvantage of UW solution is its high viscosity, which makes is less attractive 
for low-ow perfusion. The solution can potentially obstruct small vessels during 
ush or perfusion.41 Additionally, the high potassium rate in UW solution can induce 
hyperkalaemia upon reperfusion, introducing the risk of cardiac arrythmia or vascular 
contraction.32 Following to the growing interest in organ perfusion, Belzer and colleagues 
introduced a modied version of their UW solution for application during ECP, known 
as UW-machine perfusion solution or Belzer-MPS.42 Two modications in UW-MPS were 
the altered potassium-sodium ratio (low potassium, high sodium concentration) and the 
choice for gluconate as impermeant instead of lactobionate, since the latter appeared to 
be ine¡ective during ECP. 
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Histidine-tryptophan-ketoglutarate solution
HTK, or Custodiol, was originally developed by H.J. Brettschneider as cardioplegic solution 
in open heart-surgery43 and was introduced for liver perfusion in 1989.32 The uid is 
characterized by a low sodium and low potassium concentration and by its strong bu¡er 
capacity which is created by histidine (Table 1). Tryptophan acts as membrane stabilizer 
and ketoglutarate is the ATP precursor in the uid. Mannitol is the only impermeant that 
is added to the solution.44 HTK therefore has a low viscosity (slightly higher than water), 
which is thought to increase the e¡ectivity of the pre-storage ush to washout blood.45 Also, 
the risk of capillary obstruction during continuous low-ow tissue perfusion is theoretically 
lower.46 A disadvantages of HTK is the absence of colloids in the solution, which are 
important to prevent the development of oedema during preservation.25 
HTK and UW solution both have been extensively assessed for their application in organ 
preservation. Overall results seem to be comparable, with small di¡erences that have led 
to preferences for either solution per organ.32 Although the type of preservation solution 
is a hot topic in organ transplantation research, similar knowledge is not available in 
extracorporeal perfusion of skeletal muscle or VCAs.
Table 1. Composition of preservation solutions used in this thesis
UW cold storage UW-MPS HTK
Potassium  (mmol/L) 125 25 15
Sodium  (mmol/L) 29 100 9
Impermeants Lactobionate, Ranose Gluconate, Ranose Mannitol
Colloids HES HES -
Buers Phosphate Phosphate Histidine
Antioxidants Glutathione, Allopurinol Glutathione, Allopurinol -
ATP precursors Adenosine, Phosphate Adenosine, Phosphate Ketoglutarate
Viscosity High High Low
UW = University of Wisconsin solution, MPS = Machine Perfusion Solution, HTK = Histidine-
Tryptophan-Ketoglutarate solution, HES = hydroxyethyl starch, ATP = adenosine triphosphate.
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Aim and outline of this thesis
To summarize, a complex procedure such as limb replantation or VCA transplantation 
will benet from a technique that enables prolonged tissue preservation, maintaining the 
quality and vitality of tissues and improving postoperative outcomes. Multiple biological 
and technical factors are associated with tissue survival, as described earlier.
The aim of this thesis was to evaluate hypothermic extracorporeal perfusion as a 
strategy for prolonged preservation of free muscle 
aps and limbs, with the ultimate 
goal to safely prolong preservation of these tissues beyond their maximum cold ischemia 
time. Measurements included the assessment of muscle viability and function, evaluation 
of perfusion settings and comparison of acellular preservation solutions. A porcine model 
was used in all experiments. All experiments were approved by the local and national 
animal ethical committee. 
Chapter 1 contains the general introduction of this thesis and elaborates on tissue 
preservation and extracorporeal perfusion.
Chapter 2 provides an overview of the available literature on ECP for free ap and VCA 
preservation. The systematic review in this chapter had the goal to generate hypotheses and 
to identify areas for further research. 
Chapter 3, 4 and 5 collected evidence on di¡erent levels to evaluate the overall e¡ect of 
ECP for prolonged skeletal muscle preservation. The experiments in these chapters were 
all conducted on free musculocutaneous rectus abdominis aps. The goal was to assess 
the feasibility of long-term ECP and gain insight into the cellular processes during muscle 
preservation. 
Chapter 3 described the onset and severity of muscle damage during preservation on 
a cellular level. Mitochondrial, myobrillar and capillary changes were assessed using 
transmission electron microscopy. Preservation by ECP with UW solution was compared to 
SCS.  
Chapter 4 assessed the feasibility of 36-hour ECP. Two preservation solutions for continuous 
ECP were used: UW-MPS solution and HTK solution. Gene expression, ap perfusion patterns 
and weight increase were compared between the groups. Biochemical markers were measured 
in preservation solution samples that were collected during ECP.
Chapter 5 further studied gene expression with the goal to gain more insight into the processes 
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during ischemia-reperfusion injury in skeletal muscle tissue. This experiment evaluated gene 
expression patterns aer ap preservation and replantation. The expression of genes related 
to hypoxia, inammation, apoptosis and muscle regeneration were measured and compared 
between the current gold standard of 4-hour SCS and 18-hour ECP with either UW-MPS or 
HTK.
Chapters 6 and 7 focused on the evaluation of clinical outcomes a®er autologous 
replantation of composite tissues that were preserved by ECP. 
Chapter 6 assessed muscle histology aer preservation and replantation of free rectus 
abdominis aps and compared 4-hour SCS to 18-hour ECP with UW-MPS or HTK solution. 
Additionally, HTK and UW-MPS solution were compared. Outcomes were collected during a 
12-hour follow-up period aer replantation. 
Chapter 7 followed a similar set-up on porcine forelimbs and compared results aer 4-hour 
SCS to 18-hour ECP with UW-MPS. This experiment focused on the additive value of in-vivo 
muscle contraction testing and compared these functional results to histological outcomes 
aer replantation.
Chapter 8 described the preparations that were necessary to launch the platform for the rst 
hand-arm transplantation in the Netherlands and provided an overview of current knowledge. 
Chapter 9 presents the rst Dutch hand-arm transplantation case and describes the 
procedure and results at 1-year follow-up. Since an upper-limb transplantation is one of the 
indications for the use of ECP, the technique might be applied in similar procedures in the 
future.
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Current insights in extracorporeal perfusion 
of free tissue 
aps and extremities 
A systematic review and data-synthesis














Extracorporeal perfusion is a promising new technique for prolonged preservation of 
free aps and extremities; however, uncertainties on perfusion settings and e°cacy still 
exist. No overview of literature is currently available. This review systematically appraised 
available evidence comparing extracorporeal perfusion to static storage.
Materials and methods 
An electronic systematic search was performed on June 12, 2016, in MEDLINE and EMBASE. 
Articles were included when evaluating the e¡ect of extracorporeal perfusion of free aps 
or extremities compared to that of a control group. Two independent researchers conducted 
the selection process, critical appraisal, and data extraction.
Results
Of 3485 articles screened, 18 articles were included for further analyzation. One article 
studied discarded human tissue; others were studies conducted on rats, pigs, or dogs. 
Perfusion periods varied from 1 hour to 10 days; eight articles also described replantation. 
Risk of bias was generally scored high; none of the articles was excluded based on 
these scores. Tissue vitality showed overall better results in the perfused groups, more 
pronounced when perfusing over 6 hours. The development of oedema was a broadly 
described side e¡ect of perfusion.
Conclusions
Although tissue vitality outcomes seem to favour extracorporeal perfusion, this is di°cult to 
objectify because of large heterogeneity and poor quality of the available evidence. Future 
research should focus on validating outcome measures, oedema prevention, perfusion 
settings, and maximum perfusion time for safe replantation and be preferably performed 
on large animals to increase translation to clinical settings.
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Introduction
Numerous advantages have been made over the last decades in the eld of transplant 
medicine. A new technique for solid organ preservation was introduced by means of 
machine perfusion, with superior results compared to cold storage (CS).1,2 This trend was 
followed in the domain of free ap and extremity transplantation since the 1980’s, when 
experiments on extracorporeal perfusion techniques commenced in these tissues.3,4 
Muscle is the tissue most sensitive to ischemia and reperfusion injury, with a maximum 
ischemia tolerance of 4 to 6 hours, followed by nerves with a tolerance of approximately 
8 hours.5 The current standard of preservation of free aps or extremities is cold storage 
(±4°C), preferably a®er a heparin-solution ush to washout blood and prevent intravasal 
clotting. It is hypothesized that preservation of free aps and extremities can be enhanced 
by extracorporeal perfusion, either by using acellular preservation uids or blood products. 
Proposed mechanisms are protection of the endothelial cell lining of blood vessels, dilution 
and prolonged washout of toxic metabolites and bu¡ering capacities of the perfusion 
solutions for toxic metabolites.6,7 Optionally, the perfusion solution is cooled, thereby 
slowing cell metabolism and reducing oxygen needs of the tissue. Also, oxygen can be 
added to the perfusion solution to maintain aerobic cell metabolism.8,9 The ultimate goal of 
extracorporeal perfusion is to lengthen the ischemic period of free aps or extremities with 
hours or even days. This enables vascularized composite allotransplantation to come into 
closer reach, for instance of extremities or the face. In addition, unexpected intraoperative 
complications can be treated and time becomes available for stabilization or transportation 
of patients with traumatic amputations (e.g. war victims).10-12 Some authors even foresee the 
use of extracorporeal perfusion for transplantation of tissue to areas depleted of acceptor 
vessels (e.g. radiated tissue), maintaining ap viability for days until neovascularization 
of the transplanted tissue has occurred.13 Despite of these exciting applications of 
extracorporeal perfusion and on-going preclinical trials, many uncertainties on its e°cacy 
and use still exist and an overview of currently available literature is missing. The aim of 
this review therefore is to systematically appraise the available evidence comparing tissue 
vitality in extracorporeal perfused free aps and extremities to non-perfused control groups. 
Previous preclinical systematic reviews have proven to be useful in hypothesis generation 
and in optimizing the design of both preclinical and clinical studies. Therefore, the second 
aim of this article was to provide directions for further research, aiming to improve the 
quality of research in the eld of extracorporeal perfusion.14
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Records after duplicates removed 
(n = 3485) 
 
Title/abstract screening 
(n = 3485) 
 
Records excluded (n=3438): 
Article type: n=6 
Domain/intervention*: n= 3432 
 
Full-text articles assessed for 
eligibility 
(n = 47) 
Articles excluded (n=28): 
Article type: n= 5 
No control group: n= 2 
Intervention*: n= 15 
Domain*: n= 1 
Outcome*: n= 4 
Duplicate: n= 1 (Japanese version) 
Studies for inclusion in 
systematic review 
(n = 19) 
Studies included in 
quantitative synthesis 
(n = 11) 
Additional records identified 
through other sources 
Cross reference screening: n = 2 
 
*Domain: free tissue flaps or extremities 
*Intervention: extracorporeal perfusion 
*Outcome: hypoxic injury and/or tissue function 
 
Articles excluded (n=1): 
Unclear definition of  
study groups: 1 
 
Articles excluded (n=7): 
Incomplete data: 5 
Non-numeric outcomes:  2 
Records identified through 
database searching (n= 3959):  
MEDLINE: n = 1535 
EMBASE: n= 2429 
 
Figure 1. Flow chart summarizing the number of included articles in the screening and selection 
process. Search conducted on July 12, 2016.
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Materials and methods
The protocol for this review was registered on the website of the SYstematic Review Centre 
for Laboratory animal Experimentation (SYRCLE, Nijmegen) before starting data extraction.15 
An electronic systematic search was performed in MEDLINE (1946-present) and EMBASE 
(1947-present) using a combination of ‘free aps’/’extremities’ and ‘extracorporeal perfusion’ 
with synonyms (Appendix A). The rst author (ASK) designed the search strategy with 
support from a librarian. No publication date or language restrictions were applied. All 
articles were collected into a single reference library (Endnote X7.7.1, Thomson Reuters, New 
York) and duplicates were removed. Two independent reviewers (ASK and HW) rst screened 
the articles on title and abstract, followed by a full-text screening resulting in a selection of 
relevant articles. Final consensus was reached by deliberation between both reviewers. Cross-
reference search and citation check were performed to identify additional articles. 
Original articles evaluating the e¡ect of extracorporeal perfusion of free aps or extremities 
of both animals and humans were included in the review. Extracorporeal perfusion was 
dened as a (semi-)closed circuit containing a uid for continuous tissue preservation 
with regulated pressure or ow, with or without oxygen supply. Subjects receiving a single 
ush with preservation solution rather than continuous perfusion were not included in this 
review, nor were articles without a control group. The primary outcome was tissue vitality, 
further divided in the following three categories: histology, serum markers and tissue 
function. The secondary outcome was oedema/weight gain. Oedema is a known side e¡ect 
of machine perfusion, which might impede the replantation procedure and inuence results 
a®er replantation when present at a high degree. Weight gain was extracted from the data 
as percentage of weight increase based on the tissue’s original weight. The two independent 
reviewers critically appraised and extracted data from all included articles. Short deliberation 
between the reviewers followed on ve articles until consensus was reached. The SYRCLE’s 
risk of bias tool16 was used for risk of bias assessment at study level, expanded with the 
following criteria: statement on compliance with animal welfare regulations, sample size 
calculation/post-hoc power analysis performed, statement on conicts of interests. Each 
criterion was scored with Yes (Y), No (N), Unknown (?) or Not Applicable (N/A). Extracted 
data included: study characteristics and design, animal/patient characteristics, intervention 
characteristics, outcomes for tissue viability, tissue function and oedema, dropouts and 
presence of a sample size calculation. Data were extracted directly from text or tables or were 
derived from graphs using a digital screen ruler. In case of incomplete or unclear outcomes 
in the included articles, corresponding authors were contacted by email twice with a two-
week interval. For data synthesis, articles were imported and analysed in Review Manager 
(Version 5.3, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). 
There was an intention to conduct a meta-analysis, however, this appeared to be impossible 
based on predened criteria15 due to the large heterogeneity in study group characteristics, 
study design and follow-up. Instead, two summarizing Forest plots were composed to provide 
a cumulative overview of data for histology and oedema.
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Literature searches identied 3,485 non-duplicate articles from both databases. Two 
additional articles were found by cross-reference screening, due to nonspecic titles and 
keywords.17,18 One duplicate article was found in the full-text screening, it appeared to be a 
duplicate article in Japanese writing.4,19 One article was excluded a®er the screening process 
during the quality assessment phase, based on poorly dened and irreproducible study 
groups.3 Eventually, a total of 18 articles published between 1985 and 2016 were included 
in the systematic review. Six authors were contacted to obtain additional information or 
missing data. One author replied not to have the data available anymore7, the other ve 
authors did not respond.6,20-23 These data were eventually marked as missing. Of all articles, 
11 presented comparable and complete data (mean, SD) and could be used for quantitative 
synthesis. 4,7,8,17,18,21,22,24-27 An overview of the screening and selection process is given in 
the ow chart in Figure 1. Experiments were performed on rats3,7,12,17,18,23, pigs 6,9,11,21,22,24-28 
and dogs.4,8,20 One experiment used human waste tissue.29 The perfused tissue concerned 
extremities in 11 articles, muscle aps in ve articles and adipofascial aps in two articles. 
In ve articles blood products were used as perfusion uid, 11 articles used acellular 
preservation solutions; two articles studied both. The perfusion period varied from one 
hour to 24 hours, eight articles also described the replantation phase. An overview of 
baseline characteristics of the articles included is given in Table 1. For more detail see also 
Appendix B. Risk of bias scores of the included articles were generally poor, with the vast 
majority of variables being unknown (Table 2). Only six experiments blinded their analysts 
during outcome assessment. None of the articles was excluded based on risk of bias scores.
Histology
Histology was used as an outcome in 16 articles, either on para°n-embedded or snap-
frozen biopsies (Appendix C). The majority of articles used a (self-developed) numeric 
necrosis scale7,17,18,21,23,25 or applied immunohistology to measure expression rates of hypoxia 
markers.6,24,26,27 Five articles presented histology outcomes descriptively.11,12,20,22,28 The only 
group that described a negative e¡ect of perfusion on muscle vitality was Tsuchida et al.18 
They found the muscle ATP content at 24hr a®er replantation to be lower in the intervention 
group, in which rat hindlimbs were perfused for 5 hours with University of Wisconsin 
solution before allotransplantation, compared to the control group of limbs stored for 5 
hours at 25°C before allotransplantation. The remaining articles overall showed a positive 
e¡ect of perfusion on tissue vitality, expressed by lower rates of ATP depletion,8,17 less signs 
of necrosis on H&E stained biopsies6-8,11,21, 23,26 or lower expression of hypoxia markers.6,24,26,27 
E¡ect sizes seemed to be dependent on the type of perfusion uid and timing of outcome 
assessment, with longer perfusion periods corresponding to larger di¡erences between 
control and intervention groups, especially when the perfusion duration is beyond 6 hours. 
Nine articles presented su°cient data for quantitative synthesis and were combined into a 
summarizing Forest plot (Figure 2).
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Serum Markers
Di¡erent serum markers were measured in 15 articles (Appendix D). All but ve articles 
were missing outcomes in the control group, as these were not possible to obtain due to 
the non-perfusion setting. Articles describing the replantation phase were able to compare 
serum marker outcomes between both study groups a®er replantation of the tissue. Most 
commonly measured serum markers were pO2 or oxygen consumption, lactate and pH, all 
indirect derivatives of tissue vitality. Overall, studies present a rise in lactate and/or drop 
in pH during the perfusion period 7-9,28 that is either partly 4,28 or completely 4,9 restored to 
normal values a®er replantation. Two articles presented the creatinine phosphokinase 
(CPK) concentration a®er replantation as a direct derivative of muscle damage, with 
contradicting results. Usui et al.4 described lower CPK concentrations in uorocarbon 
perfused dog’s hindlimbs compared to the control group a®er 6 hours of ischemia 
followed by 6 hours of follow-up a®er replantation (group 1: oxygenated perfusion at room 
temperature; CPK stable around 800-900 U/L, group 2: oxygenated perfusion at 4°C; CPK 
steadily increasing to 1000 U/L, control: heparin ush and cold storage at 4°C, CPK rise to 
1435 U/L). In contrast, Tsuchida et al.18 showed a higher CPK rise in ve hour long perfused 
rat hindlimbs with University of Wisconsin uid at 24hr a®er allotransplantation (CPK 4712 
U/L), compared to the control limbs that were stored at room temperature for ve hours
and subsequently replanted (CPK 2007 U/L).
Tissue function
Seven articles used tissue function as an outcome measure, three in a descriptive way 
(Appendix E). Araki et al.12 performed walking tests on rats at 7 days a®er limb perfusion 
and replantation. Kueckelhaus et al.21 and Constantinescu et al.22 both assessed muscle 
contraction a®er nerve stimulation and showed that contraction was retained during three 
respectively twelve hours of perfusion. The remaining four articles originated from two 
research groups and assessed muscle contractility. Ozer et al.9,28 tested single muscle bre 
contractility by immersing a muscle biopsy in a calcium and ATP-rich solution and Taeger 
et al.26,27 tested contractility of the entire muscle using external eld stimulation. Both found 
a slower loss of muscle contractility during perfusion with autologous blood, Jonosteril or 
hydroxyethyl starch solution compared to control groups, inferring superior results during 
perfusion 26,27 and a®er replantation 9,28.
Oedema
The majority of articles described weight gain or oedema in the perfused groups, but 
only seven described results of both control and perfusion groups (Appendix F). Overall, 
perfused aps or extremities showed an increase in weight (range +8.1% to +99.9% of 
initial weight), compared to no or minimal weight gain in the control groups (range -2.4% 
to +13% of initial weight).12,21-23,26,27 Usui et al.4 were the only to describe a decrease in weight 
in perfused tissue a®er 6hr of uorocarbon perfusion (-4.5% in the normothermic perfusion 
group, -3.4% in the cold perfusion group). However, tissue weight still increased a®er 
replantation in this study (+24.9 in the normothermic perfusion group, +26.8% in the cold 
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perfusion group). When analysing weight increase separately for the used perfusion uid, 
the total mean weight increase was 37% (range +10% to +99%)4,12,21,26,27 of initial weight 
in tissues perfused with acellular perfusion uids compared to a mean increase of 20% 
(range +10% to +32%) in tissue perfused with blood products 9,22,23. The results of the above-
mentioned articles are presented in a summarizing Forest plot (Figure 3) and accessible in 
appendix F.
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applied?
2. Were the groups similar at baseline or adjusted for 
confounders? 
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4. Are the animals randomly housed during the experiment ? 
5. Were the caregivers/ investigators during the course of the 
exp. adequately blinded ?
6. Were animals selected at random during outcome 
assessment ?
7. Was the outcome assessment adequately blinded ?
8. Were incomplete outcome data adequately addressed? 
9. Is the study free of seletive outcome reporting?
10. Is there a statement on conflicts of interest?
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posthoc power calculation performed?






Table 2. Risk of bias screening, overview table (n=18) 
Abbreviations: Y=Yes, N=No, ?=unclear, N/A=Not Applicable.  
In case of use of the contralateral ap or extremity as control randomization is unnecessary and 
allocation sequence was scored as N/A. Blinding of investigators was impossible due to the nature of 
experimental settings, scoring N/A for all experiments on allocation concealment. Random housing 
was scores as N/A when animals were sacri¡ced immediately a¢er experiments or in case of in-animal 
controls (e.g. the contralateral limb). Selective outcome reporting was scored with unclear in case of an 
absent research protocol.  
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Discussion
Following the superior results of machine perfusion in organ preservation, research on 
extracorporeal perfusion of free tissue aps and extremities has gained popularity over 
the last years. This systematic review has examined all available evidence on this topic, 
comparing extracorporeal perfusion to non-perfused control groups. Although the intent 
of this review was to compare extracorporeal perfusion only to articles including cold 
storage as control, a vast number of articles would have been excluded in the full text 
selection process. Therefore, the decision was made to also include articles using other 
control groups, such as warm storage or sham surgery. Six studies assessing the e¡ect of a 
single ush with preservation uid followed by cold storage as an alternative to continuous 
perfusion were excluded to prevent further heterogeneity.30-36 Most articles focus on tissue 
damage as primary outcome, either by assessing biopsies on the presence of hypoxia-
induced changes or by measuring serum markers related to hypoxia and tissue damage. 
Fewer articles have assessed tissue function. Although the overall trend seems positive in 
favour of extracorporeal perfusion, this is hard to objectify due to generally low quality 
of available evidence and the large heterogeneity among articles. Many factors of the 
risk of bias assessment could not be scored due to incomplete methodological reporting. 
The heterogeneity among articles originates from large di¡erences in study group 
characteristics, methodology, machine perfusion settings and used outcome measures. 
There is a need for more high quality studies to further strengthen the seemingly positive 
e¡ect of extracorporeal perfusion on tissue preservation.
Focusing on histology, all but two articles present superior results in the perfused 
compared to the control groups. Constantinescu et al.22 reported no di¡erences between 
the 12-hour blood-perfused pig forelimbs and cold stored limbs, Tsuchida et al. presented 
inferior results in the perfused group. Interestingly, Tsuchida et al.18 found higher muscle 
ATP contents a®er ve hours of perfusion with University of Wisconsin compared to the 
control group, indicating better muscle preservation at this time point. Nevertheless, the 
ATP content in this group decreased to a lower level a®er limb replantation compared to the 
control group, contradicting the ndings at ve hours of perfusion. The author’s hypothesis 
for this phenomenon is perfusion induced damage to the endothelial cell lining that only 
becomes apparent in the replantation phase. This makes one wonder how reliable the 
outcomes of muscle biopsies are in the perfusion phase and to what extent they relate to 
results in the reperfusion phase and more importantly to long-term outcomes for tissue 
vitality. The scoring of hypoxia-induced injury of tissue in the extracorporeal perfusion 
setting poses an additional challenge. First, the physiological situation is changed to one 
lacking blood cells and serum proteins when using acellular- or plasma based perfusion 
uids, with a yet unknown inuence on tissue reaction to hypoxia. Second, clinical 
experience with hypoxia–induced damage in fat or muscle tissue is scarce, resulting in an 
absence of validated rating scales. Consequently, study groups used self-dened necrosis 
rating scales in an attempt to objectify their results, with the result of further enhancing 
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Figure 2. Summarizing Forest plot of studies included in the data synthesis for histology (n=9).  
Footnotes: 1) necrosis scale, 2) ATP spectrometry, 3) 5hr perfusion + 24hr observation a¢er replantation.
Figure 3. Summarizing Forest plot of studies included in the data synthesis for oedema (n=5).
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heterogeneity between articles. Measuring the expression of hypoxia-related enzymes 
seems to be a solution for this problem. Literature has described several proteins for this 
purpose; HIF-1-α (hypoxia inducible factor-1-alpha), Annexin-V and caspases.
Fi®een articles measured serum markers during the perfusion phase and/or during the 
reperfusion phase of the experiment. Despite of oxygenation of perfusion uids in most 
setups, perfused tissue seems to shi® to anaerobic metabolism at some point, given the 
metabolic acidosis that was commonly described by the pH drop and increasing lactate, 
both positively related to perfusion time. Yet, articles studying the reperfusion phase 
describe overall faster or better recovery of the acidosis in the perfused groups compared 
to the control groups.4,9,25,28 Taeger et al.6 studied perfusion with Histidine-Tryptophan-
Ketoglutarate (HTK) with and without oxygenation and found superior results in the 
oxygenated group. An important impracticality when using serum markers is the inability 
to measure them in the non-perfused control tissue, making comparisons between control 
and intervention groups in the perfusion phase impossible. On the other hand, serum 
markers seem to be of more predictive value in the reperfusion phase, where blood is again 
introduced into the perfused tissue and immunological reactions are reactivated. Direct 
derivatives of tissue damage such as CPK and LDH seem to be other promising outcomes for 
estimating the extend of tissue damage.
A well-known side e¡ect of continuous perfusion is the occurrence of oedema. Possible 
explanations for this phenomenon are: 1) a partial shi® of perfusion uids into the 
interstitial space, either due to osmotic pressure di¡erences or loss of endothelial cell 
integrity by perfusion and 2) as a result of inammatory reactions by the activated immune 
system (during blood perfusion or a®er replantation).4,25,27 Possible solutions can be sought 
in the addition of steroids or vasodilators to the perfusion circuit, using perfusion uids 
with higher oncotic pressure values or by adjusting perfusion settings aiming to reduce 
perfusion pressure.20,22,26 The prevention of oedema is one of the major focus areas for 
further research in extracorporeal perfusion, with the goal of further clarication of the 
cause of oedema and exploring preventive measures.
Summarizing the available evidence, questions regarding the type of perfusion solution, 
optimum temperature, perfusion settings and maximum safe perfusion period for 
replantation remain unanswered. Opinions on the type of perfusion solution of choice 
vary, with some authors favouring blood products and others strongly opposing against 
them. Blood products are thought to have superior oxygen carrying capabilities because 
of the presence of haemoglobin and possibly reduce oedema formation due to the closer 
resemblance to whole blood.37 On the other hand, limited availability, high costs of blood 
products and a higher rate of haemolysis and thrombosis can be major drawbacks.8,9,11,21,23 
In the process of thrombosis, free haemoglobin in stagnant blood has been implicated as 
a mediator of free radical production, attacking membrane phospholipids and eventually 
resulting in the loss of endothelial membrane integrity.38 Only two authors compared 
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perfusion with blood products to commercially available preservation solutions in an 
experimental setting. Slater et al.11 and Dragu et al.24 both found blood-perfused rectus 
abdominis muscle aps to have inferior results when compared to aps perfused with 
acellular uids.
The e¡ect of perfusion temperature on muscle viability remains unknown for the 
extracorporeal perfusion setup. Hypothermic perfusion has the advantage of reducing the 
tissue’s metabolic activity and decreasing oxygen needs, requiring less complex solutions 
for adequate perfusion.27 (Sub)normothermic perfusion is thought to minimize peripheral 
vasoconstriction and shunting, while maintaining intracellular mechanisms including 
cell adaptation and repair mechanisms. 27,37 Of the included articles in the current review, 
most applied (sub)normothermic perfusion temperatures (20-37°C).7,9,12,17,18,22,23,25-28 Usui et al.4 
were the only group to explore the e¡ect of temperature of the perfusion solution. They 
found cold perfusion (±4°C) with uorocarbon to be superior compared to perfusion with 
uorocarbon at room temperature. However, since this is the only article evaluating the 
e¡ect of temperature of the perfusion solution and considering the poor methodological 
quality of this study, more high-quality evidence is needed to draw an adequate conclusion 
on optimal perfusion temperature.
Although perfusion settings (eg. perfusion pressure, ow rate, addition of oxygen, total 
volume of perfusion solution, replenishment of the perfusion solution and additives) 
are thought to strongly a¡ect tissue vitality and functional outcomes, these important 
parameters are o®en missing or reported incompletely in the currently available articles 
(Table 1).
A limitation of this systematic review is the small amount of evidence that is currently 
available. The risk of publication bias could not be assessed in a funnel plot, but is 
estimated to be moderate to high, considering outcomes of published articles to be overall 
positive. Additionally, it was not possible to conduct a reliable meta-analysis due to 
large heterogeneity in methodology, study group characteristics and outcome measures 
between articles. Strength of this review is the systematic and elaborate search that was 
conducted in order to present an overview of available evidence, as complete as possible. 
To our knowledge, this is the rst systematic review in this eld of research. Although a 
meta-analysis was not possible, a summarizing Forest plot was presented whenever this 
was thought to be contributory to the reader. Also, an overview of all outcomes, including 
descriptive outcomes, was presented in additional tables in order to present the maximum 
amount of information available in current literature. By summarizing available evidence, 
knowledge gaps have become apparent and important suggestions can be given to improve 
future research and to verify previous results in literature.
Even though research on extracorporeal perfusion of free aps and extremities evolved 
not much later, it still falls behind when compared to machine perfusion in solid organs 
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(e.g. lungs, liver, kidney) where machine perfusion is already integrated as routine 
clinical practice.1,2 The reason for this is multifactorial. Many di¡erent preservation uids 
are available on the market and self-developed variants are used broadly by authors, 
introducing a large heterogeneity in the use of extracorporeal perfusion between articles. 
For research on extracorporeal perfusion to get closer to clinical application, focusing 
on acellular preservation uids would be of consideration, since these are fast and 
readily available in large quantities and easier in to apply and  transport compared to 
blood products. Additionally, the machine needs to be further adjusted to be compact 
for transportation, user-friendly and in the ideal situation also a¡ordable. Only then can 
this technique be used for the full range of indications, such as vascularized composite 
allotransplantation, traumatic  amputations and salvage procedures a®er complications 
in elective free ap procedures. Furthermore, only few authors described the reperfusion 
phase a®er replantation of ex-vivo perfused tissue, while this is the phase in which the 
ischemia-reperfusion injury becomes apparent. Ischemia-reperfusion injury is known to 
be a relatively unpredictable phenomenon, with multiple intertwining cascades.39 Reliable 
conclusions about the true e¡ectivity of prolonged extracorporeal perfusion can only been 
drawn a®er observing this phase. The total perfusion duration is also of importance. Ten 
authors described perfusion of free aps and extremities far beyond the commonly used 
maximum ischemic period of 4 to 6 hours 7-9,11,20-23,25,28, of which only ve also observed 
the reperfusion phase.9,20,23,25,28 For this technique to be benecial, a prolongation of the 
ischemia period with at least another 4 to 6 hours would make a clinical di¡erence by 
winning enough time, for instance for patient transportation, stabilization and complex 
surgical procedures. Therefore, a total ischemic period of minimal eight hours should be 
described for research to be of high clinical relevance.
Conclusions
Despite of the overall positive results, there is still a long way to go in the eld of 
extracorporeal perfusion of free aps and extremities. In the absence of clear guidelines 
or protocols and with the lack of high quality evidence from current trials, further research 
should be conducted in well setup experimental settings. These should focus on validating 
outcome measures, oedema prevention, perfusion uid temperature and maximum 
perfusion time for safe replantation. Preferably future research would be conducted on 
large animals, thereby increasing signicance of results for the clinical setting and posing 
the opportunity to apply the tested perfusion equipment directly into human research.22 
The ultimate goal of these experiments should be to establish evidence-based guidelines 
for extracorporeal perfusion of free aps and extremities.
563998-L-bw-vRaay




The authors thank Alice Tillema from the medical library of the Radboud University
Nijmegen for her kind help in the design of the search strategy.
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 39
39
Current insights in extracorporeal perfusion of free tissue flaps and extremities 
2
References
1. Hameed AM, Hawthorne WJ, Pleass HC. Advances in organ preservation for transplantation. ANZ 
J Surg. 2016.
2. Machuca TN, Mercier O, Collaud S, et al. Lung transplantation with donation a®er circulatory 
determination of death donors and the impact of ex vivo lung perfusion. Am J Transplant. 
2015;15(4):993-1002.
3. Hicks TE, Boswick JA, Jr., Solomons CC. The e¡ects of perfusion on an amputated extremity. J 
Trauma. 1980;20(8):632-648.
4. Usui M, Sakata H, Ishii S. E¡ect of uorocarbon perfusion upon the preservation of amputated 
limbs. An experimental study. J Bone Joint Surg Br. 1985;67(3):473-477.
5. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a 
review. Cardiovasc Surg. 2002;10(6):620-630.
6. Taeger CD, Muller-Seubert W, Horch RE, et al. Ischaemia-related cell damage in extracorporeal 
preserved tissue - new ndings with a novel perfusion model. J Cell Mol Med. 2014;18(5):885-894.
7. Herold C, Reimers K, Allmeling C, Rennekamp¡ HO, Vogt PM. A normothermic perfusion 
bioreactor to preserve viability of rat groin aps extracorporally. Transplant Proc. 2009;41(10):4382-
4388.
8. Gordon L, Levinsohn DG, Borowsky CD, et al. Improved preservation of skeletal muscle in 
amputated limbs using pulsatile hypothermic perfusion  with University of Wisconsin solution. A 
preliminary study. J Bone Joint Surg Am. 1992;74(9):1358-1366.
9. Ozer K, Rojas-Pena A, Mendias CL, Bryner B, Toomasian C, Bartlett RH. Ex Situ Limb Perfusion 
System to Extend Vascularized Composite Tissue Allogra® Survival in Swine. Transplantation. 
2015;99(10):2095-2101.
10. Fichter AM, Ritschl LM, Rau A, et al. Free ap rescue using an extracorporeal perfusion device. J 
Craniomaxillofac Surg. 2016;44(12):1889-1895.
11. Slater NJ, Zegers HJ, Kusters B, Beune T, van Swieten HA, Ulrich DJ. Ex-vivo oxygenated perfusion 
of free aps during ischemia time: a feasibility study in a porcine model and preliminary results. J 
Surg Res. 2016;205(2):292-295.
12. Araki J, Sakai H, Takeuchi D, et al. Normothermic preservation of the rat hind limb with articial 
oxygen-carrying hemoglobin vesicles. Transplantation. 2015;99(4):687-692.
13. Wol¡ KD, Mucke T, von Bomhard A, et al. Free ap transplantation using an extracorporeal 
perfusion device: First three cases. J Craniomaxillofac Surg. 2016;44(2):148-154.
14. Pound P, Ebrahim S, Sandercock P, Bracken MB, Roberts I, Reviewing Animal Trials Systematically 
G. Where is the evidence that animal research benets humans? BMJ. 2004;328(7438):514-517.
15. AS Kruit, 2016. Research protocol. Obtainable via: https://issuu.com/radboudumc/docs/
extracorporeal_perfusion_of_free_ti?e=28355229/48256631.
16. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. 
SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.
17. Tsuchida T, Kato T, Yamaga M, et al. E¡ect of perfusion during ischemia on skeletal muscle. J Surg 
Res. 2001;101(2):238-241.
18. Tsuchida T, Kato T, Yamaga M, et al. The e¡ect of perfusion with UW solution on the skeletal 
muscle and vascular endothelial exocrine function in rat hindlimbs. J Surg Res. 2003;110(1):266-
271.
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 40
40
Chapter 2
19. Sakata H. [An experimental study of the e¡ect of uorocarbon perfusion for amputated limb 
preservation. The e¡ect of inhibition for replantation toxemia and muscle tissue destruction]. 
Nihon Seikeigeka Gakkai Zasshi. 1984;58(5):497-508.
20. Domingo-Pech J, Garriga JM, Toran N, et al. Preservation of the amputated canine hind limb by 
extracorporeal perfusion. Int Orthop. 1991;15(4):289-291.
21. Kueckelhaus M, Fischer S, Sisk G, et al. A Mobile Extracorporeal Extremity Salvage System for 
Replantation and Transplantation. Ann Plast Surg. 2016;76(3):355-360.
22. Constantinescu MA, Knall E, Xu X, et al. Preservation of amputated extremities by extracorporeal 
blood perfusion; a feasibility study in a porcine model. J Surg Res. 2011;171(1):291-299.
23. Fichter AM, Ritschl LM, Borgmann A, et al. Development of an Extracorporeal Perfusion Device 
for Small Animal Free Flaps. PLoS One. 2016;11(1):e0147755.
24. Dragu A, Kleinmann JA, Taeger CD, et al. Immunohistochemical evaluation a®er ex vivo perfusion 
of rectus abdominis muscle aps in a porcine model. Plast Reconstr Surg. 2012;130(2):265e-273e.
25. Muller S, Constantinescu MA, Kiermeir DM, et al. Ischemia/reperfusion injury of porcine limbs 
a®er extracorporeal perfusion. J Surg Res. 2013;181(1):170-182.
26. Taeger CD, Friedrich O, Dragu A, et al. Assessing viability of extracorporeal preserved muscle 
transplants using external eld stimulation: a novel tool to improve methods prolonging bridge-
to-transplantation time. Sci Rep. 2015;5:11956.
27. Taeger CD, Friedrich O, Drechsler C, et al. Hydroxyethyl starch solution for extracorporeal tissue 
perfusion. Clin Hemorheol Microcirc. 2016;64(1):91-103.
28. Ozer K, Rojas-Pena A, Mendias CL, Bryner BS, Toomasian C, Bartlett RH. The E¡ect of Ex Situ 
Perfusion in a Swine Limb Vascularized Composite Tissue Allogra® on Survival up to 24 Hours. J 
Hand Surg Am. 2016;41(1):3-12.
29. Kreidstein ML, Pang CY, Levine RH, Knowlton RJ. The isolated perfused human skin ap: design, 
perfusion technique, metabolism, and vascular reactivity. Plast Reconstr Surg. 1991;87(4):741-749.
30. Bastiaanse J, Slaaf DW, oude Egbrink MG, et al. E¡ect of hypothermia and HTK on the 
microcirculation in the rat cremaster muscle a®er ischaemia. Clin Sci (Lond). 2005;109(1):117-123.
31. Bastiaanse J, Slaaf DW, oude Egbrink MG, Boeckx WD, Kon M. Do preservation solutions protect 
rat cremaster microcirculation during ischemia and reperfusion? J Surg Res. 2005;125(2):182-188.
32. Alper M, Ozek C, Erdem O, Denk M, Colen LB, Prewit R. E¡ects of University of Wisconsin and 
lactated Ringer’s solutions to ischemia-reperfusion injury in isolated cremaster ap. Microsurgery. 
2002;22(2):69-73.
33. Fowler JD, Li X, Cooley BC. Brief ex vivo perfusion with heparinized and/or citrated whole blood 
enhances tolerance of free muscle aps to prolonged ischemia. Microsurgery. 1999;19(3):135-140.
34. Chait LA, May JW, Jr., O’Brien BM, Hurley JV. The e¡ects of the perfusion of various solutions on 
the no-reow phenomenon in experimental free aps. Plast Reconstr Surg. 1978;61(3):421-430.
35. Mehl RL, Paul HA, Shorey WD, Schneewind JH, Beattie EJ, Jr. Patency of the Microcirculation in 
the Traumatically Amputated Limb--a Comparison of Common Perfusates. J Trauma. 1964;4:495-
505.
36. Tsai TM, Jupiter JB, Serratoni F, Seki T, Okubo K. The e¡ect of hypothermia and tissue perfusion 
on extended myocutaneous ap viability. Plast Reconstr Surg. 1982;70(4):444-454.
37. Werner NL, Alghanem F, Rakestraw SL, et al. Ex Situ Perfusion of Human Limb Allogra®s for 24 
Hours. Transplantation. 2017;101(3):e68-e74.
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 41
41
Current insights in extracorporeal perfusion of free tissue flaps and extremities 
2
38. Allen DM, Chen LE, Seaber AV, Urbaniak JR. Pathophysiology and related studies of the no reow 
phenomenon in skeletal muscle. Clin Orthop Relat Res. 1995(314):122-133.
39. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev 
Cell Mol Biol. 2012;298:229-317
563998-L-bw-vRaay





Final search performed on: 12-06-2016
Research question: What is the e¡ect of extracorporeal perfusion of free tissue aps or extremities on 
hypoxic injury and tissue function?
Search string: synonyms for ‘extracorporeal perfusion’ (= intervention) combined with synonyms for 
‘free tissue aps’ or ‘extremities’ (= domain).
Pubmed
(Extracorporeal Circulation[Mesh] OR ((perfusion[tiab] OR perfused[tiab]) AND (extracorporeal*[tiab] 
OR extracorporal*[tiab] OR extra-corporeal*[tiab] OR extra-corporal*[tiab] OR ex vivo[tiab] OR ex-
vivo[tiab] OR ex situ[tiab] OR ex-situ[tiab] OR pulsatile[tiab] OR continuous*[tiab])) OR Extracorporeal 
Circulations[tiab] OR Extracorporeal Circulation[tiab] OR Extracorporeal circulation[tiab] OR 
Extracorporal circulation[tiab] OR Extracorporeal bypass[tiab] OR Extracorporal bypass[tiab] OR 
Extracorporeal Preservation[tiab] OR Extracorporal Preservation[tiab] OR Extracorporeal Preserved[tiab] 
OR Extracorporal Preserved[tiab] OR Limb perfusion[tiab] OR Flap perfusion[tiab] OR Tissue perfusion 
[tiab]))
AND
(Free Tissue Flaps [Mesh] OR Surgical Flaps [Mesh] OR “Tissue Transplantation” [Mesh:NoExp] OR 
“Skin Transplantation”[Mesh] OR (((Free[tiab] OR Muscle[tiab] OR Island[tiab] OR Surgical[tiab] 
OR Pedicle*[tiab] OR Microsurgical[tiab] ) AND (ap[tiab] OR aps[tiab])) OR ((Extremity[tiab] OR 
Extremities[tiab] OR Limb[tiab] OR Limbs[tiab] OR Tissue[tiab] OR Muscle[tiab] OR Muscles[tiab]) 
AND (Preservation[tiab] OR Preserved[tiab] OR Replantation[tiab] OR Conservation[tiab] OR 
Conserved[tiab] OR transplantation[tiab] OR Transplant[tiab])) OR Free Tissue Transfer[tiab] OR 
Free Tissue Transfers[tiab] OR Muscle Tissue Transfer[tiab] OR Muscle Tissue Transfers[tiab] OR 
Composite Tissue Allogra®[tiab] OR Composite Tissue Allogra®s[tiab] OR Muscle Transplant[tiab] 
OR Muscle Transplants[tiab] OR Tissue Transplant[tiab] OR Tissue Transplants[tiab] OR Autologous 
Transplantations[tiab] OR Autologous Transplantation[tiab] OR Autotransplantion[tiab] OR 
Autotransplantions[tiab] OR Autogra®ing[tiab] OR Autogra®ings[tiab] OR Tissue Gra®ing[tiab]))
EMBASE
((perfusion:ab,ti OR perfused:ab,ti AND (extracorporeal*:ab,ti OR extracorporal*:ab,ti OR ‘extra 
corporeal*’:ab,ti OR ‘extra corporal*’:ab,ti OR ‘ex vivo’:ab,ti OR ‘ex situ’:ab,ti OR continuous*:ab,ti 
OR pulsatile:ab,ti) OR ‘extracorporeal circulations’:ab,ti OR ‘extracorporeal circulation’:ab,ti OR 
‘extracorporal circulation’:ab,ti OR ‘extracorporal circulations’:ab,ti OR ‘extracorporeal bypass’:ab,ti OR 
‘extracorporal bypass’:ab,ti OR ‘extracorporeal preservation’:ab,ti OR’extracorporal preservation’:ab,ti 
OR ‘extracorporeal preserved’:ab,ti OR ‘extracorporal preserved’:ab,ti OR ‘limb perfusion’:ab,ti OR ‘ap 
perfusion’:ab,ti OR ‘tissue perfusion’:ab,ti AND [embase]/lim) OR (‘extracorporeal oxygenation’/exp))
AND
((free:ab,ti OR muscle:ab,ti OR island:ab,ti OR surgical:ab,ti OR pedicle*:ab,ti OR microsurgical:ab,ti 
AND (ap:ab,ti OR aps:ab,ti) OR (extremity:ab,ti OR extremities:ab,ti OR limb:ab,ti OR limbs:ab,ti 
OR tissue:ab,ti OR muscle:ab,ti OR muscles:ab,ti AND (preservation:ab,ti OR preserved:ab,ti 
OR replantation:ab,ti OR conservation:ab,ti OR conserved:ab,ti OR transplantation:ab,ti OR 
transplant:ab,ti)) OR ‘free tissue transfer’:ab,ti OR ‘free tissue transfers’:ab,ti OR ‘muscle tissue 
transfer’:ab,ti OR ‘muscle tissue transfers’:ab,ti OR ‘composite tissue allogra®’:ab,ti OR ‘composite tissue 
allogra®s’:ab,ti OR ‘muscle transplant’:ab,ti OR ‘muscle transplants’:ab,ti OR ‘tissue transplant’:ab,ti 
OR ‘tissue transplants’:ab,ti OR ‘autologous transplantations’:ab,ti OR ‘autologous transplantation’:ab,ti 
OR autotransplantion:ab,ti OR autotransplantions:ab,ti OR autogra®ing:ab,ti OR autogra®ings:ab,ti 
OR tissue AND gra®ing:ab,ti AND [embase]lim) OR (‘tissue ap’/exp OR ‘free tissue gra®’/exp OR ‘free 
skin gra®’/exp OR ‘autotransplantation’/exp OR ‘muscle gra®’/exp OR ‘muscle transplantation’/exp OR 
‘tissue transplantation’/exp AND [embase]/lim))
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Chapter 3
Superior preservation of capillaries, myobrils 
and mitochondria aer long-term extracorporeal 
perfusion of free muscle 
aps 














Skeletal muscle is highly sensitive to ischemia, with a maximum hypothermic ischemia 
tolerance of six hours. Extracorporeal perfusion (ECP) is a promising technique for 
prolonged tissue preservation, but might have side e¡ects. For instance, increased radical 
oxygen species or capillary endothelial damage. This article assessed ultra-morphological 
muscle damage during 36-hour ECP of porcine rectus abdominis muscle aps, hypothesizing 
that it would delay the onset of damage compared to static cold storage (SCS). 
Methods
Bilateral aps were retrieved from three Dutch Landrace pigs. Three aps were preserved 
for 36 hours by hypothermic storage 4-6°C (control group) and three aps by ECP with 
cooled University of Wisconsin solution. Muscle biopsies were taken at 0h, 12h and 36h and 
assessed with transmission electron microscopy. 
 
Results
Muscle architecture was best preserved by ECP, with a delayed onset and decreased severity 
of muscle damage. A®er 36 hours, damage was two-fold lower in ECP-aps compared to 
SCS-aps. Myobril architecture was best preserved. Mitochondria were greatly preserved 
with swelling being the most prominent feature. Capillaries were moderately but di¡erently 
damaged during ECP, with focal endothelial thinning as opposed to luminal obstruction in 
SCS-preserved aps. 
Conclusion
This experiment described favourable cellular preservation of skeletal muscle aps during 
ECP compared to SCS. Results showed less severe ultra-morphological damage and a later 
onset of damage. 
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Introduction 
Skeletal muscle is highly sensitive to ischemia. Its ischemic tolerance can be compared 
to that of the heart, with a maximum cold ischemia time of approximately six hours.1-3 It 
therefore remains a challenge to safely prolong its tolerable ischemia time. The most 
important structures to preserve in skeletal muscle are mitochondria. Mitochondrial 
integrity is of high importance for muscle function. Damage to mitochondria causes 
a temporary or complete halt of muscle’s most crucial energy source: oxidative 
phosphorylation. With the resulting deciency in ATP and glucose, metabolism will rapidly 
deteriorate as will the contractile function of myocytes.3 4 Another prerequisite during 
tissue preservation is the optimal preservation of capillary endothelial integrity, preventing 
vascular leaking and thrombosis.5 6
A promising technique for prolonged skeletal muscle preservation is continuous 
extracorporeal perfusion (ECP) or machine perfusion. Preservation by ECP has multiple 
benets over static cold storage (SCS), such as the washout of toxic metabolites, bu¡ering 
and cell-protecting characteristics of the preservation solutions and the ability to oxygenate 
or cool the tissue.7-9 The overall e¡ect is a reduction of ischemia-reperfusion injury to the 
tissue resulting in improved (functional) outcomes a®er tissue replantation.9 10 ECP of 
muscle tissue will predominantly be applicable in the clinical setting of preservation 
of composite tissues that contain a large degree of skeletal muscle. The technique might 
improve outcomes a®er revascularization of traumatic amputated extremities or a®er 
transplantation of vascularized composite allogra®s (e.g. hand- or face transplantation).11-14 
Both are lengthy and complex procedures that push the boundaries of muscle preservation 
to its limits.
However, ECP might have potential side e¡ects. Concerns are the development of 
radical oxygen species in case of oxygenated perfusion or the onset of damage to the 
endothelial cell lining.2 Therefore, research aiming to gain more insight into the e¡ects 
of perfusion with the goal to further improve perfusion conditions is desirable. The 
work of Kueckelhaus et al. has set a rst step, when they compared 12h ECP to 4h SCS. 
They briey presented electron microscopy (EM) ndings that were superior in the 
ECP group a®er 7 days of revascularization.15 However, the cellular damage that occurs 
during ECP and the timing of onset of this damage still remain unclear. This descriptive 
experiment assessed the cellular changes in porcine musculocutaneous rectus abdominis 
aps during ECP and SCS using transmission electron microscopy. These aps provide 
a highly ischemia-sensitive model with optimal observational characteristics. The 
aim was to evaluate damage to myobrils, mitochondria and capillaries over time, 
hypothesizing that ECP could delay the onset of skeletal muscle damage compared to SCS. 
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Bilateral free rectus abdominis muscle aps measuring 9x12 cm were retrieved from three 
Dutch Landrace pigs (mean weight 57kg, range 40 - 67 kg). All aps received a ush with 
100cc of heparin- solution (200E heparin in 100cc NaCl 0.9%) via the superior epigastric 
artery directly a®er pedicle transection to washout blood. One of the two aps per pig 
was treated as control and was preserved for 36 hours in dry gauzes in a bag on ice slurry 
(SCS group, n=3). The contralateral ap was preserved by ECP for 36 hours with University 
of Wisconsin (UW) solution with a temperature of 8-10°C (perfusion group, n=3). The 
perfusion pressure was set to an in-line maximum of 50mmHg systolic pressure and the 
uid was oxygenated with a carbogen mixture (95% O2/5% CO2). Flaps were randomly 
assigned to either of the storage groups. The use of animals was approved by the local and 
national animal experimentation committee (protocol-number 2016-0034-001) and was 
in accordance with the European Directive 2010/63/EU for the use and care of laboratory 
animals and ARRIVE guidelines.16
Transmission electron microscopy
Muscle biopsies were taken from pre-dened locations at three time points in the 
experiment: 1) T=0; before vascular pedicle transection, serving as a normal control 
sample, 2) T=12; at 12h of ap preservation and 3) T=36; at 36h of ap preservation. Biopsies 
measured 2x4mm and were stored in 2% Glutaraldehyde bu¡ered with 0.1M Sodium,-
Cacodylate pH 7.4 and post xed in 0.5% Potassiumhexacyanoferrat (II)-Trihydrate in 1% 
Osmium tetroxide in Paladebu¡er. Samples were dehydrated in ethanol, propylenoxid and 
embedded in Epon. Semithin sections (0.7 µm) and ultrathin sections (80 nm) were cut 
using the Leica ultracut UC6 ultramicrotome. The ultrathin sections were examined using 
a Jeol TEM1400 transmission electron microscope. The electron microscopy images were 
photographed with a Catan digital micrograph camera. Five areas per biopsy were scored 
by two pathologists that were blinded to the method of ap preservation. A simple scoring 
system was designed to equally evaluate the samples, since none was available in literature. 
The degree of damage to myobrils, mitochondria and capillaries were scored from 0 to 2 
in this scoring system. A total score of 0 resembled no damage to the observed structure, a 
score of 2 resembled severe destruction (Table 1). A mean score (0 to 2) was calculated as a 
measure for overall muscle damage.
Analysis
The EM scores were used to compare the degree of muscle damage in aps taken from 
individual pigs, but also to compare the muscle damage between groups. Descriptive 
outcomes (mean, SD) were provided. Statistical analysis were not performed given the 
small number of aps per groups.
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Figure 1. Mean EM scores of aps per group per timepoint during 36-hour ap preservation
Scores: 0 = no damage, 1 = mild damage, 2 = severe damage.
Table 1. Self-developed scoring system for evaluation of skeletal muscle damage with transmission 
electron microscopy
Score 0 (no damage) 1 (mild damage) 2 (severe damage)
Myofibrils Normal architecture Mild or focal disturbances to 
architecture  
(e.g. minor Z-band changes, 
decrease of glycogen storage)
Severe architectural 
disturbances  
(e.g. major Z-band changes, 
depletion of glycogen 
storage)
Mitochondria Normal size and shape Some swelling, mild or focal 
signs of damage  
(e.g. vesiculation, distortion 
of cristae)
Severe swelling and 
destruction 
(e.g. rupture of membranes)
Capillaries No endothelial damage, 
open lumen
Some endothelial  
damage  
(e.g. small vacuoles or 
intraluminal debris)
Severe endothelial damage  
(e.g. loss of endothelial cell 
integrity, obstructed lumen)
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Mean preservation time was 36.5 hours in the control group (SCS) and 36.7 hours in the ECP 
group. The perfusion pressure of 50mmHg during ECP corresponded to a mean perfusion 
ow of 8-10ml/min. The mean initial ap weight was 245 ± 73g in the SCS group and 263 ± 
75g in the ECP group. The ap weight increased with an average of 86g (35 ± 24%) during 
UW perfusion, there was no weight increase during SCS (-1.8 ± 1.5%).
Electron microscopy
There was more muscle damage a®er 12 and 36 hours in the aps that were preserved by SCS 
compared to the contralateral aps from the same pig that were preserved by ECP (Figure 
1). When comparing groups, the onset and severity of damage to mitochondria, myobrils 
and capillaries were all decreased in the ECP group compared to the SCS group (Table 2). 
A®er 12h of SCS, the mean damage score was 1.1, representing mild damage, which was 
most prominently present in capillaries and mitochondria. Characteristic ndings at this 
timepoint were swelling or vesiculation of mitochondria, the presence of debris extending 
in the capillary lumen and mild Z-band changes in myobrillar arrangement. In contrast, 
a®er 12h ECP, the mean damage score was 0.56, with mild focal thinning of the capillary 
endothelium as most prominent feature. A®er 36h SCS, the ischemic damage further 
increased to a mean score of 1.4. EM images showed total mitochondrial degeneration and 
capillaries lled with debris and endothelial shedding, obstructing the lumen (Figure 2). 
Myobril architecture was best preserved and mainly showed di¡use Z-band streaming, but 
in some areas also separation of cells. The damage score a®er 36h ECP was 0.7. Mitochondria 
were greatly preserved throughout the entire 36-hour extracorporeal perfusion period; 
swelling was the only sign of damage. Capillaries were moderately damaged, with the 
main nding being focal endothelial thinning as opposed to luminal obstruction in the SCS 
group. Myobril architecture was well preserved until the end of the experiment (Table 2, 
Figure 2). 
Table 2. EM scores per structure per timepoint during 36-hour ap preservation  
(score 0-2; Mean with SD)
 Time (h) Extracorporeal perfusion (n=3) Static cold storage (n=3)
Myofibrils Mitochondria Capillaries Myofibrils Mitochondria Capillaries
0 0.44 (0.24) 0.28 (0.10) 0.49 (0.31) 0.45 (0.2) 0.26 (0.09) 0.50 (0.30)
12 0.52 (0.24) 0.34 (0.18) 0.83 (0.06) 0.75 (0.36) 1.20 (0.02) 1.21 (0.29)
36 0.46 (0.16) 0.58 (0.31) 1.07 (0.30) 0.94 (0.17) 1.47 (0.59) 1.44 (0.42)
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Discussion
Following positive results in organ preservation, ECP found its way into the reconstructive 
research eld over the past two decades. Despite of the growing interest in this technique, 
the evidence related to this topic is still limited.17 
This experiment is the rst to describe cellular changes in skeletal muscle during ECP 
using transmission electron microscopy and provided a unique insight into the processes 
during ECP. A 36-hour preservation period of porcine skeletal muscle aps was assessed 
and storage using ECP was compared to SCS. Results showed a drastic decrease in ischemic 
damage during ECP, both when comparing di¡erently preserved aps originating from 
the same pig as when comparing outcomes between groups as a whole. There was a more 
than two-fold decrease of muscle damage on EM evaluation when applying ECP. Myobrils 
and mitochondria were a¡ected less severely and much later during ECP compared to 
SCS. Capillaries seemed to be damaged less severely as well, but interestingly, the damage 
presented di¡erently compared to SCS. These results provide further evidence towards ECP 
as a successful technique for long-term skeletal muscle/VCA preservation.
Myobrils were the best preserved structure during preservation, and pronounced damage 
was only visible a®er 36 hours of SCS but not during ECP. The pattern of ischemic damage 
to myobrils agrees to the descriptions of ischemic changes in rabbit and rat limbs by 
Harman.4 Increasing with time, structural ischemic changes consisted of Z-band streaming, 
hypercontraction and eventually depletion of the glycogen storage and separation of the 
cells by structureless spaces. 
Mitochondria were greatly damaged during SCS, already showing profound damage at 12h 
follow-up. The rst signs of damage were mitochondrial swelling with distention of cristae, 
later followed by disruption of membranes and loss of cytosolic contents.15 Several factors 
account for mitochondrial ischemic damage; opening of universal membrane transporters 
causing ion shi®s, an increased cytosolic calcium concentration and increased levels of 
reactive oxygen species.2,18 The most common sign of damage a®er 36 hours of ECP was 
mitochondrial swelling, without destruction of mitochondrial architecture. Therefore it 
can be concluded that oxygenated ECP seems to have a protective rather than a destructive 
e¡ect on mitochondrial preservation. 
Capillary damage during SCS typically initiated with nger like protrusions of cell 
membrane extending into the lumen (12h of preservation) that evolved into complete 
capillary obstruction over time (36h of preservation).15 Blaisdell described this phenomenon 
in 2002 and the accompanying ‘no reow phenomenon’ that was clinically present upon 
reperfusion.1 Kueckelhaus et al. described disintegration of the endothelial lining a®er a 
period of only 4 hours of SCS of porcine limbs. In contrast, they found no signs of capillary 
damage a®er 12 hours of acellular ECP or reperfusion in their experiment.15 In this set-
up, all capillary lumens remained open during the entire ECP period. However, a feature 
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that typically presented at  ≥12 hours of ECP was a focal capillary wall thinning. Usually 
one or two spots per capillary were a¡ected, without complete endothelial wall damage. 
The underlying mechanism of this capillary wall thinning remains unclear and to our 
knowledge, this feature has not yet been described in literature before. Our hypothesis is 
that continuous articial perfusion ow is causing mechanical stress on the vessel walls. 
The currently used arterial perfusion pressure of 50mmHg might be too high for ECP of free 
aps. This might have contributed to the mean weight increase of 35% of initial ap weight 
a®er 36h ECP. Kueckelhaus et al. used a maximum perfusion pressure of 30mmHg and 
had a mean weight increase of only 10% a®er 12h ECP.15 On the other end of the spectrum, 















Figure 2. Representative electron microscopy images of muscle biopsies taken during extracorporeal 
perfusion and static cold storage throughout the preservation period. 
A: myobrillar arrangement during ECP showing preserved architecture with only minor Z-band changes. 
B: mitochondria during ECP showing mild swelling over time, but no degeneration. C: capillaries during 
ECP with focal thinning at 12h and 36h of preservation (1). 
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experienced a weight gain of 84% a®er 6 hours of ECP.19 It would be interesting to see how 
the characteristic capillary wall thinning would evolve a®er lowering the pressure during 
ECP, and if endothelial integrity will either restore or further damage a®er ap reperfusion 
with blood. Further experiments should therefore focus on optimizing perfusion pressure, 
assessing capillary wall thinning and weight increase.
This study is limited by its group size, but more importantly by the absence of a validated 
evaluation scale for skeletal muscle damage on electron microscopy.15 With the goal to 
uniformly evaluate the muscle biopsies and to quantify ischemic damage, a simple 2-point 


















D: myobrillar arrangement during SCS showing Z-band changes at 12h (2) and severe distortion of 
arrangement at 36h of preservation. E: mitochondria during SCS showing swelling at 12h and destruction 
at 36h with rupture of membrane and leaking of contents (3). F: capillaries during SCS with vacuoles and 
debris extending into the lumen (4) at 12h, evolving into luminal obstruction at 36h of preservation.
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technician (LE). We consider that this experiment has shown an advantage of ECP over 
SCS, but the ultimate proof of better preservation would be a replantation experiment 
comparing ECP to SCS with long-term follow-up.  However, the SCS preservation time in 
such an experiment should be decreased, since the profound damage in the SCS group at 
≥12h of preservation prevented successful replantation in this group.
Conclusion
This study is the rst to assess skeletal muscle damage during long-term extracorporeal 
perfusion using electron microscopy. Extracorporeal perfusion showed superior results to 
static cold storage during 36h ap preservation. This provides further evidence for ECP as a 
promising technique for prolonged skeletal muscle preservation. This research furthermore 
identied a di¡erent nature of capillary damage during ECP compared to SCS. The evolution 
of capillary thinning during ECP and its relation to perfusion pressure poses an interesting 
topic for future research.  
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Successful long-term extracorporeal perfusion of 
free musculocutaneous 
aps in a porcine model 















Extracorporeal perfusion is a technique that aims to safely prolong tissue preservation 
by reducing ischemia-reperfusion injury. Free muscle aps provide a sensitive research 
model, due to their low ischemic tolerance. However, long-term perfusion of free muscle 
aps is scarcely researched. The aim of this study was to compare tissue damage in 
musculocutaneous aps during 36 hours of extracorporeal perfusion versus static cold 
storage. 
Materials and methods
Bilateral free rectus abdominis aps were harvested from ve Dutch Landrace pigs (weight 
53-59kg). Flaps were treated for 36 hours according to the following study groups: 1. Cold 
storage at 4-6°C (n=4), 2. Perfusion with Histidine-Tryptophan-Ketoglutarate (HTK) at 
8-10°C (n=3), 3. Perfusion with University of Wisconsin (UW) at 8-10°C (n=3). Perfusion 
uid samples (CK, blood gas) and biopsies for qPCR were collected at multiple time 
points. Microcirculation was assessed at 24 hours of preservation using indocyanine-
green uorescence angiography. Flap weight was measured at the start and end of the 
preservation period.  
Results
Successful and stable perfusion for 36hr was achieved in all perfused aps. The mean 
CK-increase in the perfusion uid was comparable in both groups (UW: +43,144U/L, 
HTK: +44,404U/L), mean lactate was higher in the UW-group compared to the HTK-group 
(6.57mmol/L vs. 1.07mmol/L). There were homogenous and complete perfusion patterns on 
ICG angiography in both perfusion groups, in contrast to incomplete and inhomogeneous 
patterns during cold storage. Expression of genes related to apoptosis and inammation 
were lower in perfused aps compared to the cold storage group. Weight increase was 
highest in the HTK-group (78%, SD 29%), compared to UW (22%, SD 22%) and cold storage 
(0.7%, SD 4%). 
Conclusions
Long-term extracorporeal perfusion of free rectus abdominis aps is feasible. Outcomes in 
the perfusion groups seemed superior compared to cold storage. Hypotheses gained from 
this research need to be further explored in a replantation setting. 
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 75
75
Long-term perfusion of free musculocutaneous flaps
4
Introduction
Extracorporeal perfusion of free aps has been studied since three decades, initially 
to provide a model for ex-vivo investigation of human skin ap physiology and 
pharmacology.1, 2 The technique was adopted years later as a new method for prolonged ex-
vivo tissue preservation, aiming to reduce ischemia-reperfusion injury in free ap surgery 
or vascularised composite allogra® (VCA) transplantation.3-8 Documented perfusion times 
in literature varies from four to 240 hours in adipofascial aps and from one to six hours in 
muscle aps. Compared to skin and fat, muscle has the lowest ischemia tolerance in a VCA 
with a maximum ischemia time of only four to six hours.9, 10 A free muscle ap therefore 
provides a highly sensitive model to study the e¡ects of extracorporeal perfusion as a 
method for prolonged tissue preservation. 
Good tissue preservation has proven to be a major determinant for successful (functional) 
outcome in VCA transplantation. A®er prolonged ischemia time, the rejection risk is increased 
and the recovery of muscle is diminished.11-13 Similar principles apply to revascularisation of 
amputated extremities. The ability to better and longer preserve tissues containing muscle 
might therefore change future practise in the eld of traumatic replantation and vascularised 
composite allotransplantation.14 Translated to a clinical setting, more time will be available 
for stabilisation of trauma patients with avascular limbs, for transportation of these patients 
to specialised hospitals or for transportation of VCA gra®s to a recipient and to precondition 
these gra®s prior to transplantation. Additionally, drugs can be added to the system that are 
bypassing the patient’s circulation and only reaching the ap or VCA. To date, only Slater 
et al. have described extracorporeal perfusion of free rectus abdominis muscle aps beyond 
the critical ischemia time of six hours. They successfully perfused porcine muscle aps for 24 
hours with acellular preservation uids in their pilot study.15
Histidine-Tryptophan-Ketoglutarate (HTK) and University of Wisconsin (UW) solution are 
commonly used solutions for extracorporeal perfusion (ECP) in organ transplantation 
medicine, both resulting in decreased organ damage and failure.16, 17 HTK is a low viscosity, 
low potassium uid with high bu¡er capacities. UW has a higher viscosity and potassium 
concentration and has been the gold standard for preservation of liver gra®s since 1989.18 
Both solutions might have benecial characteristics for prolonged muscle preservation 
compared to cold storage.17
This study in a porcine model has the primary aim to assess muscle damage in free rectus 
abdominis aps during 36 hours of extracorporeal perfusion compared to static cold 
storage, thereby evaluating the clinical boundaries of perfusion of musculocutaneous 
aps. Serum markers, gene expression proles, ap perfusion patterns and weight were 
compared between static cold storage and extracorporeal perfusion to gain insight into the 
tissue’s ischemic injury and underlying cellular processes. As a secondary aim, perfusion 
outcomes of UW and HTK were compared. 
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Five female Dutch Landrace pigs (weight 53-59kg) were used for this experiment. Bilateral 
free musculocutaneous rectus abdominis aps measuring 12 x 9 cm were harvested under 
general anaesthesia, based on the superior epigastric artery. This model was established 
in prior experiments, with known adequate vessel diameter and a close resemblance 
to human anatomy in this area.15 Female pigs were chosen due to the need for bladder 
catheterization during the procedure. Flaps were divided into one of the three study groups 
by a random sequence generator, where bilateral aps from one individual were never 
assigned to the same group. Use of animals was approved by the local and national animal 
experimentation committee (protocol-number: 2016-0034-001) and was in accordance to 
the EU Directive 2010/63/EU for the use and care of laboratory animals.
Surgery and 
ap preservation
A single shot of 20mg/kg amoxicillin was administered intravenously before starting 
surgery as antibiotic prophylaxis. A®er complete surgical harvest of the free ap, the 
superior epigastric artery was cannulated with a 20G Becton-Dickinson venous catheter 
(Franklin Lakes, New Jersey, USA). All aps were rst ushed with 100cc of heparin-
Table 1. Composition of UW and HTK solution
Component UW-MP[83] HTK[84]
Osmolality (mOsm/L) 320 310
Potassium (mmol/L) 25 10
Sodium (mmol/L) 15
Sodium gluconate (mmol/L) 80
Sodium hydroxide (g/L) 0.70
Calcium (mmol/L) 0.5 0.015
Magnesium (mmol/L) 4
Magnesium gluconate (mmol/L) 5
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saline solution (200 units heparin per 100ml 0.9% saline solution). Flaps were then 
treated in accordance to one of the following groups; 1. Static Cold Storage (CS, n=4) 
as control group, 2. University of Wisconsin (UW) perfusion group (n=3) or 3. Histidine-
Tryptophan-Ketoglutarate (HTK) perfusion group (n=3). Control aps were placed in a 
sealed bag and stored for 36 hours on water in a refrigerator at 4-6°C. Intervention aps 
were continuously perfused for 36 hours with either UW or HTK preservation solution 
(Table 1). Once the rst ap was stored or attached to the perfusion system, surgery on 
the second ap commenced. A®er harvest of the second ap, the pig was euthanized with 
an overdose of Phenobarbital. 
Perfusion system
A semi-closed extracorporeal circuit was set up for continuous, oxygenated and non-
pulsatile perfusion with 1L of preservation solution (Figure 1). Muscle aps were placed on 
a raster with a lter on top of it in a hand-made perfusion box. Venous e¸uent of aps 
was collected by passive drainage before pumping it back into the system by a centrifugal 
pump (BP-50 Bio-Pump® Centrifugal Blood Pump, Medtronic). A gas mixture consisting 
of 95% O2 and 5% CO2 was continuously added to the preservation uid by a hollow bre 
oxygenator (Capiox RX05, Terumo). A heater-cooler machine (HCU30, Maquet) maintained 
uid temperature between 8-10°C. Perfusion pressure was set to an in-line maximum 
of 25mmHg and the corresponding ow was continuously measured by an ultrasonic 
ow meter (SonoTT ultrasonic Flow computer, Em-Tec). The perfusion solution was not 
relled or replenished throughout the entire perfusion period, enabling to measure the 
accumulation of ap metabolites in the solution. 
Figure 1. Schematic illustration of the extracorporeal perfusion set-up and photograph of a free 
musculocutaneous rectus abdominis ap connected to the extracorporeal perfusion system.
The semi-closed perfusion set-up (closable box) with a. Flap in perfusion box on top of raster and 
¡lter with passive venous drainage of preservation uid. b. Digital scale. c. Centrifugal pump, 
pressure regulated at in-line ≤ 25mmHg. d. Oxygenator (95% O2, 5% CO2) and heat-exchanger. e. Drug 
administration point and arterial sampling point. f. Arterial perfusion of ap through arterial cannula 
























Samples from the preservation solution were taken from the arterial sampling point at 0.5, 
3, 6, 12, 18, 24 and 36 hours of perfusion (Figure 1). Creatinine Kinase (CK) was measured 
at all time points as an indicator for muscle cell damage.19, 20 Venous blood gasses including 
lactate were analysed at all time points using a portable iStat device (CD4+ cartridges, 
Abbott, Princeton, USA). Lactate was measured as an indicator of anaerobic metabolism. 
pO2 and pCO2 outcomes were used to adjust the O2/CO2 ow in the perfusion setup with the 
goal to closely resemble physiological values in the perfusion uid. 
Indocyanine-green 
uorescence angiography
To gain insight into the microcirculation of the ap, the perfusion pattern of the 
muscle surface was visualised at 24 hours of preservation using the uorescent marker 
Indocyanine-green (ICG). ICG binds to plasma proteins a®er intravenous injection and is 
only distributed in the intravascular space, making it a suitable marker for assessment 
of ap perfusion.21 A volume of 0.2 ml (=1mg) of ICG-solution was injected into the aps’ 
circulation. ICG was either injected in the preservation uid via the drug administration 
point in the perfusion system (Figure 1e) or into the arterial cannula in the control 
aps which were subsequently ushed with 30ml of 0.9% saline solution. A hand-held 
camera detected the ICG uorescence signal induced by emission of near infrared light 
(PhotoDynamic Eye, Hamamatsu Photonics, Japan). Photographs of the ICG distribution 
pattern were taken at 90 seconds a®er ICG injection with the camera held 20cm above the 
ap. The perfusion homogeneity and percentage of ap perfusion were determined from 
these photographs using Matlab (MathWorks Inc, Massachusetts, USA). For calculation of 
the percentage of ap perfusion, the total exposed muscle surface and well-perfused areas 
within this area were marked rst. The biopsy sites and vessel clips were extracted from the 
total muscle surface, since these o®en cause a distortion of the ICG signal. The percentage 
of ap perfusion could then be calculated by dividing the well-perfused area of the ap 
through the total ap volume minus the biopsy sites. 
qPCR
The expression rates of genes related to hypoxia, apoptosis, inammation and regeneration 
were measured using quantitative Polymerase Chain Reaction (qPCR) to gain more insight 
into cellular processes during ischemia and extracorporeal perfusion. Muscle tissue 
biopsies measuring 3x5mm were taken from predened locations at 0 (before ap harvest; 
control sample), 12, 18, 24 and 36 hours of ap preservation. Biopsies were snap frozen in 
Isopentane at -130°C directly a®er acquisition and stored at -80°C until further use. Samples 
were homogenized using an Ultra-Turrax (Cole-Parmer, USA) for subsequent Trizol RNA-
isolation according to the manufacturer’s instructions. RNA yield and concentration were 
measured using NanoDrop spectrometry (ThermoFisher, Waltham, USA) and adequate 
quality was veried using the 2100 Bioanalyzer (Agilent, Germany).22 The isolated RNA 
was then converted into cDNA for the qPCR reaction (Light cycler, Roche diagnostics, 
USA). Assessed genes were chosen based on function and on prior microarray ndings and 
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included: TNF receptor superfamily member 10-A like (TNFRS10A), Regulator of G protein 
signalling 2 (RGPS2), nuclear factor-kappa beta inhibitor zeta (NFKBIZ), IL-1-beta (IL1B), 
HIF-1-alpha (HIF1A), Fibroblast growth factor 6 (FGF6), DNA damage inducible transcript 4 
(DDIT4), caspase-3 (casp3) and micro-RNA 133b (MIR133b). Micro-RNA 103-1 (MIR103-1) was 
used as a reference gene for MIR133b and GAPDH for all other genes. Outcomes are given in 
fold change, which is the gene expression in a sample related to the gene expression of the 
corresponding control sample taken at t=0. Fold changes were followed over time within 
groups and were compared between groups. An overview of the assessed genes and their 
main functions is given in appendix A.
Weight
Flap weight was recorded at the start and end of the experiment as an indicator for oedema 
during preservation. Finally, a subjective assessment of the ap’s macroscopical appearance 
was performed every hour.
Statistical analysis
Descriptive statistics were rst applied to calculate means per group and per time. A 
two-way ANOVA was used to compare di¡erences in ap weight gain between the three 
study groups. A mixed model analysis was used to compare di¡erences in time dependent 
variables (serum markers and gene expression per gene) between time points within 
each group and between groups at the di¡erent time points. Time and group and their 
interaction were used as xed factors in this model, the pig number and ap number were 
used as random factors. The data were LN-transformed for these analyses to better full the 
assumptions of the mixed model analyses.23 A likelihood ratio test was performed to detect 
di¡erences in gene expression between the three groups as a total by comparing this model 
to a similar model containing only time as xed factor (excluding study group and the 
interaction). All analyses were performed using SAS 9.4 (SAS Institute Inc, North Carolina, 
USA). No formal correction for multiple testing was applied because of the small number 




There was a stable perfusion in all aps with perfusion pressures of 10-20mmHg, 
corresponding to ow rates of 6 to 8 ml/min. Arterial pO2 was >100 kPa due to oxygenation 
with 95% oxygen. Mean arterial pCO2 in the preservation uid ranged between 5.2-8.3 kPa 
during the entire perfusion period. There was a slight potassium increase around 5mmol/L 
in the preservation uids of both ECP-groups over time, with di¡erent baseline values due to 
di¡erences in potassium concentrations in the preservation uids used (UW; mean baseline 
potassium 24.4mmol/L, rising to a maximum of 28.9mmol/L, HTK mean baseline potassium 
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Figure 2. Mean CK over time for UW and HTK perfused flaps with 95% confidence intervals 
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Figure 3. Mean lactate over time for UW and HTK perfused flaps with 95% confidence intervals 
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Figure 2. Mean CK over time for UW and HTK perfused aps with 95% con¡dence intervals 
Figure 3. Mean lactate over time for UW and HTK perfused aps with 95% con¡dence intervals 
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10.1mmol/L, rising to a maximum of 15.2mmol/L). The mean pH of UW solution dropped 0.5 
throughout the experiment, in contrast to the mean increase in pH of 0.2 in HTK solution. 
Serum Markers
Both ECP-groups showed a continuous increase of CK until the end of the experiment (mean 
total increase in UW solution +44,404U/L, 95%CI 41,452-53,801 and in HTK solution +43,144 
U/L, 95%CI 42,615-56,809. Likelihood ratio test, p=0.899). The CK initially tended to rise faster 
in the HTK group, however a®er 36 hours of perfusion the mean CK levels of both perfusion 
groups were comparable (Figure 2). The lactate concentration in the preservation uid 
was higher during UW perfusion compared to HTK perfusion, with statistically signicant 
di¡erences from 12 hours of perfusion on (mixed model analysis, p=0.000). The mean total 
Figure 4. (A-C) A complete and homogenous perfusion pattern of an HTK perfused ap as visualised 
with ICG-uorescence angiography at 90 seconds a¢er injection into the perfusion uid. (D-F) .An 
inhomogeneous and incomplete perfusion pattern of a control ap as visualised with ICG-uorescence 
angiography at 90 seconds a¢er injection and ush 
(A and D) Photograph of the aps at 24 hours of preservation. (B and E) ICG perfusion patterns at 24 
hours. (C and F) Colour scheme for calculating the well-perfused percentage of the aps. 
Red: total ap surface, green: poorly perfused surface, blue: biopsy sites and vascular clips.
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 82
82
Chapter 4
Figure 5. Diagrams showing the mean fold changes relative to normal gene expression per group at 12, 
18, 24 and 36 hours of preservation for a) TNFRS10A, b) Casp3, c) IL1B and d) NFKBIZ. 
Di°erences in gene expression over time and between study groups were calculated using mixed model 


















































































* Statistically significant dierences bewteen CS and HTK at 24 hr 
(p=0.01hr) and 36 hr (p=0.01) and bewteen CS and UW at 24 hr 
(p=0.01) and 36 hr (p=0.01).
** Satistically significant dierence between 18 , 24 and 36hr of 
HTK perfusion (p=0.00)
^Trend between CS and HTK at 18 hr (p=0.03) and between CS 
and UW at 18 hr (p=0.05).
* Statistically significant dierence between HTK and UW at 24 hr 
(p=0.01) 
^ Trend between between CS and HTK at 12 hr (p=0.02), 18 hr 
(p=0.02), and 24 hr (0.05) and between 18 and 24 hr CS (p=0.02) 
* Statistically significant dierence between CS and HTK at 36 hr 
(p=0.01)  
^ Trend between CS and HTK at 18 hr (p=0.05) and 24 hr 
(p=0.05),  between CS and UW at 36 hr (p=0.03) and between 12 
hr and18 hr of CS (p=0.05)
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lactate increase was 6.57 mmol/L (95%CI 4.1-9.7) in UW perfusion versus 1.07 mmol/L, 
(95%CI 0.13-0.51) in the HTK perfusion group (p<0.001, likelihood ratio test) (Figure 3). 
ICG 
uorescence angiography
All perfused aps showed homogenous vascularisation patterns on ICG uorescence 
angiography at 24 hours of perfusion in contrast to the control group, in which the perfusion 
patterns were overall inhomogeneous (Figure 4). The percentage of ap perfusion was 
highest in HTK perfused aps, with a mean well-perfused muscle surface of 98%, followed 
by UW perfused aps with a well-perfused surface of 92%. In the control aps only 86% of 
muscle surface appeared to be well-perfused.
qPCR
Four genes showed di¡erences in expression patterns over time or between groups on 
qPCR analysis. TNFRS10A expression shi®ed from slight downregulation to upregulation 
between 12 and 18 hours of preservation in the CS-group, whereas the expression in both 
ECP-groups was downregulated throughout the entire perfusion period. However, the 
overall comparison between groups was not statistically signicant (likelihood ratio 
test, p=0.132, Figure 5a). Casp3 expression was clearly upregulated during the rst 18 
hours of preservation by static cold storage, compared to a more stable expression in the 
perfusion groups (Figure 5b). HTK-perfused aps showed a continuous downregulation 
of casp3 expression, UW-perfused aps showed a mild upregulation at 18 and 24 hours of 
perfusion in an otherwise downregulated pattern of casp3. The overall di¡erence in gene 
expression of casp3 in the CS-group versus the ECP-groups showed a trend towards lower 
expression in the latter (likelihood ratio test, p=0.028). For IL1B there was a statistically 
signicant lower gene expression in the ECP-groups compared to the CS-group (likelihood 
ratio test, p=<0.001). The inter-group di¡erences became more pronounced over time due to 
increasing upregulation of IL1B expression in aps that were preserved by CS (Figure 5c). 
The expression of NFKBIZ was downregulated until 18 hours of perfusion in UW-perfused 
aps, compared to an upregulation of expression in the CS and HTK-groups at all time 
points (Figure 5d). The overall di¡erences between groups were not statistically signicant 
(likelihood ratio test, p=0.685). All other assessed genes did not show clear di¡erences 
between the CS-group and ECP-groups or had incoherent gene expression patterns over 
time.
Weight
The mean weight increase a®er 36 hours of perfusion was higher in HTK perfused aps 
(mean 78% of initial ap weight, SD 29%) compared to UW perfused aps (mean 22%, SD 
22%). Although this  di¡erence seems clinically relevant, it was not statistically signicant 
(two-way ANOVA, p=0.124). There was no weight increase in the CS-group (mean increase 
0.7% of initial ap weight, SD 4%) (Table 2).
563998-L-bw-vRaay




The aps in the CS-group showed a dull purple aspect from 6hr of storage on, whereas 
ECP-aps gradually developed a swollen and dull purple appearance around 18 to 24hr of 
perfusion.
Discussion
The aim of this study was to compare muscle damage during long-term extracorporeal 
perfusion to static cold storage. Continuous extracorporeal perfusion of free 
musculocutaneous rectus abdominis aps was found to be feasible for 36 hours, with stable 
perfusion pressure and ow in all aps throughout the experiments. As there is no validated 
model for free ap perfusion nor consensus with regard to variables in the perfusion setting 
that relate to clinical outcomes a®er replantation, we felt that the rst step in research on 
this topic was to gain more insight into underlying processes during continuous perfusion 
before initiating a replantation experiment. Using these results, we aimed to estimate the 
ultimate time for safe perfusion of musculocutaneous gra®s. ICG and qPCR were assessed as 
important outcomes for this purpose, gaining insight into the microcirculation of the aps 
and cellular responses to prolonged hypothermic and oxygenated perfusion. The ultimate 
goal of these experiments is to improve quality of composite gra®s a®er revascularization 
by enhancing and safely prolonging ex-vivo preservation time. 
Overall, there seemed to be less muscle damage in the perfusion groups compared to the 
cold stored aps. ICG-uorescence angiography at 24 hours of preservation showed a 
superior perfusion pattern and PCR data show lower expression of genes active in apoptosis 
and inammation. The two assessed genes that are related to apoptosis (TNFRS10A and 
casp3) both showed a trend towards higher gene expression in the CS-group, suggesting 
more induction of apoptosis-pathways. Also, the upregulated expression of IL1B, and to a 
lesser extend also NFKBIZ, in the CS-group suggest that there is a stronger inammatory 
response in the CS-group compared to the perfusion-groups. This strong inammatory 
response might result from more tissue damage in the CS-group. Additionally, the 
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macroscopic appearance of the perfused aps remained normal for at least 12 more hours 
compared to CS-aps.
CK was measured in the perfusion uid of both ECP-groups as a marker for muscle damage 
given its important role in energy metabolism of skeletal muscle. An increase in CK can 
result from release by damaged muscle cells, increased cell membrane permeability or 
decreased elimination. The observed CK increase in the extracorporeal perfusion set-up 
might result from all three mentioned mechanisms. The true accumulation of CK in a litre 
of preservation uid has been measured in this experimental setup, since the preservation 
uid was not replenished or relled and organs eliminating CK are not present.24 The 
literature on CK levels in preservation uid is limited, with no studies comparing CK 
levels during perfusion to outcomes a®er replantation. Duraes et al. measured the CK 
increase a®er 6 hours and 12 hours of perfusion of a pig’s forelimb with autologous blood, 
and found a CK rise to 30,000U/L resp. 50,000U/L.25 However, the blood was partially 
replenished every three hours and the limbs were not replanted a®er perfusion. Tsuchida 
et al. measured the serum CK levels following allotransplantation of rat hindlimbs a®er 
5 hours of cold ischemia or UW-perfusion.26 They found higher CK levels in the perfused 
group (4712 IU/L vs. 2007 IU/L), but levels of CK in the perfusion uid before replantation 
were not presented. Usui et al. performed a similar experiment and assessed the CK 
increase a®er storage and subsequent replantation of dog hind limbs, either perfused with 
uorocarbon or stored on ice water for 6 hours.27 Contradicting Tsuchida’s results, the CK 
increase was higher in the ice water group compared to the uorocarbon perfusion group 
(1435 U/L vs. 900 U/L). With the currently available literature on CK increase in a perfusion 
or replantation setting it remains di°cult to relate the level of CK increase to the degree 
of tissue damage post-replantation. A cut-o¡ value for abnormal CK accumulation remains 
absent in these animal models and appears heard to determine. With more knowledge on 
CK release in the extracorporeal perfusion setting and relating these CK-levels to the clinical 
outcomes a®er replantation, there might be a future role for CK as a marker for the degree of 
ischemia-reperfusion injury or possibly even in predicting replantation outcome.
The weight increase in UW-perfused aps was smaller compared to HTK-perfused aps. 
This probably resulted from the strong osmotic actor that is added to UW; Hydroxyethyl 
starch (HES). HES is responsible for the uid’s characteristically high viscosity and prevents 
extravasation of the solution. HTK contains a similar concentration of the large molecule 
mannitol compared to UW, but lacks HES in the solution (Table 1). Another di¡erence is the 
onset of oedema; this tended to develop earlier in the HTK-group (between 6 to 12 hours of 
perfusion), in contrast to the UW-group, in which the oedema started to develop between 
12 and 18 hours of perfusion. In a non-perfusion setting, oedema can be used as a marker 
to estimate the extent of ischemia-reperfusion injury, although it seems to be less accurate 
compared to histology ndings.10 In the perfusion setting, oedema is a broadly described 
side-e¡ect, of which the precise clinical value remains unclear. One downside of oedema 
is the lower di¡usion capacity of oxygen and nutrients to cells, which can possibly lead to 
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an energy deciency in the cells. Another downside of signicant oedema is a technically 
more di°cult replantation procedure. Interestingly, we did not only observe a variety in the 
degree of oedema between the two ECP groups, but also within groups. A hypothesis for 
this phenomenon is a variety in the ap’s vascular anatomy, with di¡erences in dominance 
of the deep or supercial venous system. Since the larger calibre of the supercial vein, 
a dominance of this venous system might lead to a larger outow of perfusion uid and 
subsequently lower vascular resistance, resulting in less oedema.
Preservation solutions are designed to counteract tissue necrosis caused by energy depletion 
during ischemia.10 When comparing the outcomes of perfusion with UW and HTK, we found 
di¡erences in mean lactate rise and in overall weight increase, as mentioned above. Mean 
CK rise and ICG perfusion patterns were similar between groups. The mean lactate in the UW 
solution started to exceed the levels in HTK solution at 6 hours of perfusion. The reason for 
this di¡erence might possibly be found in the intended function of both preservation uids. 
UW is designed as a protective uid by preventing oedema (ra°nose, HES), supplementing 
precursor ATP (adenosine) and antioxidants (glutathione) and not primarily by inhibiting 
cell metabolism. In contrast, HTK was designed to decrease the metabolism of cells though 
the addition of low-permeable amino acids (tryptophan and alpha-ketoglutaric acid) that 
stabilize the cell membrane potential and bring cells to a ‘resting phase’ (Table 1).18 The 
resulting lactate rise in the UW groups could therefore be the result of ongoing glycolysis 
during perfusion.
Gene expression proles between the two perfusion groups were mostly comparable. 
Both showed a decreased expression of IL1B, the gene coding for the pro-inammatory 
cytokine IL-1β. This suggests a decreased inammatory response in both perfusion 
conditions. However, NFKBIZ expression seemed to be di¡erent in the ECP groups. The 
expression of this inammation related gene was upregulated in HTK perfused aps 
and seemed comparable to the expression pattern of the CS-group. In contrast, NFKBIZ 
expression tended to be lower in the initial 18 hours of UW perfusion compared to CS and 
HTK perfusion. It would be interesting to further explore the expression patterns of these 
inammation-related genes in the replantation phase and compare these results to the 
perfusion phase in ex-vivo ap preservation experiments. The expression of two apoptosis-
related genes (casp3 and TNFRS10a) were lower in both perfusion groups compared to 
the CS-group. Casp3 showed a small upregulation in the UW-perfusion group at 18 and 24 
hours of perfusion and at 18 hours of HTK perfusion, possibly indicating a threshold for 
cell survival and a maximum perfusion time. Current data are insu°cient to determine the 
outcome that is most predictive for post-replantation results, and which uid therefore has 
a preference over the other. To further investigate the preservation potential of both uids 
in the setting of free muscle aps, replantation experiments will be the subject of future 
experiments. Based on the results of this study, the maximum safe perfusion period for 
continuous perfusion has been estimated to be 18 hours. This estimation is mainly based on 
the above presented qPCR data and the appearance of the aps during perfusion. 
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A limitation of this experiment were the small study groups, possibly introducing a type II 
error during data analysis. Therefore, this must be kept in mind when interpreting the data. 
For instance, there were considerable and probably also clinically relevant di¡erences in 
weight increase between the two perfusion groups, however these data were not signicant 
on statistical analysis. When looking at the experimental set-up, a restriction is caused by 
the acellular environment during perfusion. The blood is washed out of the circulation 
during the ush and the perfusion solutions lack the humeral and cellular mediators of 
inammation that are present in blood. Since these mediators play a crucial role in the 
ischemia-reperfusion cascade, this might cause an underestimation of the ischemic 
injury of the aps during the preservation period. Therefore, replantation experiments are 
necessary to relate the biochemical and gene expression data to clinical outcomes.
Future use of extracorporeal perfusion of free aps and limbs might be benecial for 
multiple surgical elds. The extra safe ischemia time can be used for stabilization of 
multi-trauma patients and allows more time for transportation and surgical procedures 
of vascularized composite allogra®s. The perfusion system in our set-up was deliberately 
kept basic for it to be reproducible and a¡ordable. Due to our choice of animal model, the 
machine and materials would be directly applicable to human tissue. Since muscle tissue 
is the tissue most sensitive to hypoxia, results of long-term perfusion of this experiment are 
expected to be extrapolable to other (combined) tissues such as nerve, skin and bone and 
thus VCA preservation.
Conclusion
In this study, the longest extracorporeal perfusion period in a free ap model to date has 
been described. We found 36 hours of perfusion to be feasible with outcomes that seemed 
to be superior in the perfusion groups compared to static cold storage. At 24 hours, we 
found more complete and homogenous perfusion patterns on ICG-uorescence and there 
was an overall lower induction of apoptosis and inammation in the extracorporeal 
perfusion setting compared to static cold storage. Hypothesis gained from this research 
need to be further explored in a replantation setting. Based on the results described above, 
a superiority of one of the commercially available preservation solutions above the other, 
could not be established in our setting.
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With the introduction of vascularized composite allotransplantation (VCA) as new surgical 
technique, the need arose for strategies that could safely prolong gra® preservation. 
Ex-vivo machine perfusion is a promising technique and is currently applied in solid 
organ transplantation. There is still limited evidence in the eld of VCA and free ap 
transplantation. This gene expression study aimed to assess the degree of ischemia 
reperfusion (IR) injury a®er preservation and replantation of free muscle aps in a porcine 
model.
Materials and methods
A microarray analysis was rst conducted on muscle aps preserved by ex-vivo perfusion 
versus cold storage, to select genes of interest for further investigation. The expression of 
these selected genes was then examined in a muscle ap replantation model a®er 18 hour 
ex-vivo perfusion (n=14) using qRT-PCR. Two preservation solutions were compared to static 
cold storage: University of Wisconsin-mp (n=5) and Histidine-Tryptophan-Ketoglutarate 
solution (n=5).
Results
A selection of 8 genes was made based on micro-array results: Tumour necrosis factor 
receptor superfamily member 10-A like, Regulator of G-protein signalling 2, Nuclear factor 
kappa beta inhibitor zeta, Interleukin-1 beta, Fibroblast growth factor 6 and DNA damage-
inducible transcript 4, Hypoxia-inducible factor 1-alpha and Caspase-3. The muscle ap 
replantation experiment compared their expression patterns before and a®er preservation 
and replantation and showed overall comparable gene expression between the preservation 
groups.
Conclusions
The expression of genes related to ischemia, apoptosis and inammation was comparable 
between the ex-vivo perfusion and static cold storage groups. These results suggest that ex-
vivo perfusion might be a promising technique for 18-hour muscle preservation in terms of 
decreasing ischemia-reperfusion injury.
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Introduction
Vascularized composite allotransplantation (VCA; e.g. face- or hand transplantation) 
is a relatively new technique that was established in the late twentieth century. 
Over hundred procedures have been performed worldwide since the first hand 
transplantation in France in 1998.1 Grafts are temporary depleted of  blood circulation 
during these procedures, inducing an increasing degree of irreversible cell damage 
through ischemia as time progresses. Due to the time-consuming nature of VCA 
procedures and the forthcoming pressure to restrain ischemia time, there is a need 
for strategies that can safely prolong the preservation of these grafts. Ex-vivo machine 
perfusion is one of these innovating techniques and is currently applied in solid 
organ transplantation, but only scarcely researched in the setting of VCA and free flap 
transplantation.2, 3 
Ex-vivo perfusion aims to reduce ischemic injury during tissue preservation. As 
a result, ischemia-reperfusion-injury (IRI) is decreased a®er transplantation. IRI 
activates a cascade of multiple overlapping processes in response to cellular ischemia. 
This eventually leads to either cell death or recovery of cells, depending on the level 
of injury endured. Processes involved are: superoxide production with activation and 
degranulation of neutrophils, leakage of contents out of the damaged cells that stimulate 
the release of pro-inammatory cytokines (e.g. CK, lactate, potassium), disruption of 
the endothelial lining with uid extravasation, and activation of the intrinsic clotting 
system.4, 5 Hypotheses on the benecial e¡ects of ex-vivo perfusion on IRI are: 1) the 
washout and dilution of toxic metabolites, 2) bu¡ering capacities of the perfusion 
uids with protection of cells and conservation of the endothelial lining, 3) reducing 
cell metabolism and thereby the tissue’s oxygen needs and 4) (partly) maintaining 
the aerobic cell metabolism when applying oxygenated perfusion.6-8 Since muscle 
tissue is most vulnerable to hypoxia with a maximum ischemia tolerance of only 4-6 
hours5, research on VCA tissue preservation o®en focuses on muscle vitality as major 
outcome.9-13 Currently available results on ex-vivo perfusion are promising, with better 
preservation of morphological structure and lower expression of apoptosis-related 
proteins on immunohistochemical staining (e.g. HIF-1-alpha, caspases, annexin V).14, 
7, 8, 15, 16 However, the insight into cellular processes and tissue response during ex-vivo 
perfusion and replantation is still very limited.17, 18 
In this gene expression study, the preservation of free muscle aps using ex-vivo perfusion 
was compared to cold storage in a porcine model. Gene expression in 0, 12 and 36-hour of 
either static cold storage (CS) or preservation by extracorporeal perfusion was examined 
by microarray analysis rst to select genes for further investigation. The objective of this 
study was to compare the expression of at least 2-fold up or down-regulated genes related 
to ischemia, inammation and regeneration. In a PCR experiment, the expression patterns 
of aps that were replanted a®er 18 hours of ex-vivo perfusion were compared to aps that 
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were replanted a®er 4 hours of static cold storage. Two commercially available acellular 
perfusion uids were tested: University of Wisconsin machine perfusion (UW-mp) solution 
and Histidine-Tryptophan-Ketoglutarate (HTK) solution.
Knowledge of the underlying mechanisms during ex-vivo perfusion and reperfusion of 
muscle might help to dene future strategies to optimize tissue preservation techniques, 
with the end goal of safe prolongation of VCA ischemia time. 
Materials and methods 
Part one: microarray analysis, selection of genes
Muscle samples for microarray analysis were collected during tissue preservation as the rst 
step in this experiment with the primary goal to select genes of interest for further analysis. 
Seven abdominal muscle aps were harvested from four Dutch Landrace pigs (weight 55 
±4.1kg). Use of animals was approved by the local and national animal experimentation 
committee (protocol-numbers: 2016-0034-001 and 2016-0034-002) and was in accordance to 
the EU Directive 2010/63/EU for the use and care of laboratory animals. 
Figure 1. Photograph showing the perfusion setup consisting of a semi-closed circuit with active arterial 
inow and passive drainage of the uid which was suctioned back into the system. 1) perfusion box, 2) 
arterial inow, 3) venous outow, 4) reservoir, 5) ow meter. 
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Free bilateral musculocutaneous rectus abdominis aps measuring 12x9 cm were harvested 
under general anaesthesia. Flaps were based on the superior epigastric artery.11 All aps 
were ushed with 100cc of heparin-saline solution directly a®er pedicle transaction to wash 
out blood and prevent clotting during ap preservation (2E/ml heparin-saline solution). 
The pig was euthanized with an overdose of phenobarbital a®er completion of the surgical 
harvest of both aps. 
Flaps were divided into two groups. Flaps in group I (n=4) were preserved for 36 hours at 
4-6°C (static cold storage) and served as control group. Flaps in group II (n=3) were preserved 
for 36 hours with continuous non-pulsatile ex-vivo perfusion with UW-mp solution with a 
uid temperature of 8-10°C.19-22 Perfusion was performed in a semi-closed circuit with arterial 
inow of the preservation uid and passive drainage of the uid which was assembled 
in a perfusion box and suctioned back into the system (Figure 1). A pressure-controlled 
perfusion mode was used, with a maximum in-line pressure of 30mmHg. The UW solution 
was continuously oxygenized with a gas mixture consisting of 95% O2 and 5% CO2. This 
so-called carbogen mixture was chosen based on its readily availability and good results in 
experiments on cardiac preservation.23, 24 Cardiac tissue is thought to be tissue most closely 
resembling skeletal muscle tissue and therefore results from cardiac preservation studies 
are o®en used as directory for skeletal muscle preservation. 
Muscle biopsies measuring 5x5mm were taken at three time points at predened locations 
from all aps: during harvest surgery prior to transection of the vascular pedicle (t=0hr, 
normoxic control) and at 12 and 36hr of cold storage (group I) or ex-vivo perfusion (group 
II) (Table 1). These groups and time points were selected based on the expected largest 
di¡erences between these conditions and time points. For practical and nancial reasons, 
the HTK group was not included in the microarray analysis. Biopsies were snap frozen 
in -130°C isopentane directly a®er acquisition and preserved in a -80°C freezer until 
further use. Samples were homogenized in 1ml TRIzol using an Ultra-Turrax high-speed 
homogenizer (Cole-Parmer). RNA was extracted according to the TRIzol isolation protocol 
Table 1. Study groups with their biopsy sampling points for microarray and qRT-PCR analyses.
Group Treatment n Preservation Replantation
0 hr 12 hr 36 hr 1 hr 6 hr 12 hr
I CS 4 • • •
II UW-mp 3 • • •
III CS + RPLT 4 • • • •
IV UW-mp + RPLT 5 • • • •
V HTK + RPLT 5 • • • •
CS: Cold Storage, UW: University of Wisconsin (solution), HTK: Histidine-Tryptophan-Ketoglutarate 
(solution), RPLT: replantation.
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(Invitrogen) and dissolved in 100µl nuclease free water. RNA concentration and purity were 
determined using a Nanodrop-1000 spectrophotometer (Thermo Fisher Scientic). For 
microarray analysis, the RNA was further puried using the RNAeasy Mini Kit (QIAGEN) and 
RNA integrity was assessed on the 2100 Bioanalyzer (Aligent Techonologies). A minimum 
RNA integrity number (RIN) of 7 was found eligible for further analyses.
Microarray analysis was performed by MAD Genomics (University of Amsterdam, The 
Netherlands). The RNA was labelled using the Gene Chip WT PLUS Reagent Kit and 
hybridized to Porcine Gene 1.0 ST Arrays (Thermo Fisher Scientic), based on the 2009 pig’s 
genome sequence. Gene-expression values were derived from the CEL le using the model-
based Robust Multiarray Average (RMA) algorithm as implemented in Partek so®ware 
(Partek Genomics Suite 6.6). RMA performs normalization, background correction and data 
summarization. 
Part two: real time q-PCR expression analysis
The second part of the study was conducted on a new group of pigs. In this experiment, ap 
preservation was followed by replantation of the aps to their original vascular pedicle. 
Only one ap per animal was used to enable the contralateral abdomen to serve as in-pig 
control a®er replantation.
This group consisted of 14 pigs with a mean weight of 69.7kg (range 62.9-83.5kg). Unilateral 
right-sided aps were harvested, ushed and preserved according to the prior described 
procedures. Control aps were replanted a®er 4 hours of cold storage (group III, n=4), 
intervention aps a®er a prolonged ex-vivo preservation of 18 hours using either UW-mp 
(group IV, n=5) or HTK perfusion (group V, n=5).  All aps were observed for 12 hours a®er 
replantation (skin colour, skin temperature and capillary rell), a®er which the pigs were 
euthanized with an overdose of phenobarbital.
Muscle biopsies used for qRT-PCR were taken during harvest surgery prior to transection 
of the vascular pedicle (t=0hr, normoxic control sample) and at 1, 6 and 12hr a®er ap 
replantation (Table 1). The biopsy sampling and processing techniques were identical to 
the procedures for microarray. An amount of 1µg RNA was used to generate cDNA using 
the QuantiTect Reverse Transcription Kit (QIAGEN) according to the manufacturer’s 
instructions. Primers the genes of interest and reference gene were designed using Primer3 
so®ware, samples were analysed in triple on separate plates (Appendix A). Real-time PCR 
analysis was performed using LightCycler 480 SYBR Green I Master mix (Roche Diagnostics). 
A non-template negative control was included to check for non-specic PCR amplication. 
A two-fold dilution series was used to calculate the primer e°ciency of each primer pair.
The expression stability of 10 potential reference genes was analysed using the geNorm 
algorithm.25 Histone (H2A) was eventually chosen as reference gene, showing stable 
expression that was not a¡ected by hypoxia. Relative gene expression per time point was 
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calculated according to the mathematical model for relative quantication in real-time PCR 
as described by Pfa¸, with the control being the sample taken at t=0hr (equation 1).26 
Equation 1: Pfa’s equation
Ratio (Fold Change)= ((E target) ΔCP target (control – sample)) / ((E ref) ΔCP ref (control – sample))
E = E¤ciency. CP = crossing point
Statistical analysis
Descriptive statistics were applied to calculate means per group and per time. To compare 
microarray results between the CS (group I) and UW perfusion group (group II), di¡erentially 
expressed genes between these conditions were calculated using ANOVA in Partek Genomic 
Suite (Partek Inc. Chestereld. USA). Fold change (FC) di¡erences >2 were dened as cut-o¡ 
value. No outliers were removed during this analysis because of the small research groups. 
However, data of single analyses were plotted into graphs to visualize outliers; these were 
considered during the nal gene selection process. A mixed model analysis was performed 
in SAS 9.4 (SAS Institute Inc, North Carolina, USA) to compare gene expression on PCR 
between treatment groups (group III, IV, V) and within groups at the di¡erent time points 
(t=1, 6 and 12 hr a®er replantation). Time and group and their interaction were used as xed 
factors in this model, pig and ap number were used as random factors. Data were LN-
transformed to better full the assumptions of the mixed model analyses.27 A likelihood 
ratio test was also performed to detect di¡erences in gene expression between the groups as 
a whole by comparing this model to a similar model containing only time as xed factor. No 
formal correction for multiple testing was applied because of the small number of animals 
in the groups. Therefore, only p-values of ≤ 0.01 were considered statistically signicant. 
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All aps were vital a®er the surgical harvest procedure. Photographs of all aps were 
obtained as visual reference for further follow-up (Figure 2). All aps in the UW-mp 
perfusion group (n=3) had a stable and uneventful ex-vivo perfusion for 36 hours. Mean ap 
weight was 246g (range 239-250g) in the UW-perfusion group and 232g (range 216-250g) in 
the CS group (n=4).
Control of data was performed prior to analysis of microarray results and showed normal 
labelling and hybridization patterns and absence of sample clustering. The expression 
patterns of 27,558 porcine genes were identied. When comparing gene expression during 
UW perfusion to cold storage, 4599 genes were down-regulated, 4944 genes were up-
regulated and 18,015 genes showed similar expression (FC range -2.70 to 3.43). A total of 
50 genes was selected for further assessment based on a fold change of >2 or <-2 when 
comparing UW perfusion to CS for samples taken at 12 or at 36hr (Figure 3). Of these, 25 
genes were up-regulated and 19 were down-regulated during perfusion. For six genes the 
expression went both directions at the di¡erent time points. A nal selection of 6 genes 
was made for PCR validation by taking the following three criteria into account: 1. the fold 
changes between control (t=0) and the intervention at 12 and 36 hr, 2. outliers and 3. global 
gene function (Appendix A). The nal selection included: Tumour necrosis factor receptor 
superfamily member 10-A like (TNFSR10A), Regulator of G-protein signalling 2 (RGS2), 
Nuclear factor kappa beta inhibitor zeta (NFKBIZ), Interleukin-1 beta (IL1B), Fibroblast 
Figure 2. Le¢: photograph of a representative and vital ap directly during ap  harvest.  
Right: schematic drawing showing 1) The musculocutaneous rectus abdominis ap, skin side facing up, 
2) Super¡cial vein, used as one of the two venous outow pedicles in the replantation procedure, and 3) 
Contralateral abdomen, serving as reference for ap control (skin colour, temperature, capillary re¡ll). 
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growth factor 6 (FGF6) and DNA damage-inducible transcript 4 (DDIT4). Based on their 
known important roles in cellular hypoxia and apoptosis Hypoxia-inducible factor 1-alpha 
(HIF1A) and Caspase-3 (CASP3) were added to these genes independent of their fold change 
of <2 28 (Table 2). 
qRT-PCR experiment
Ex-vivo perfusion was successful during the full 18 hours in all perfused aps, with a ow 
<10ml/min. Mean initial ap weight was 297gr (range 273-353gr) in the CS group (n=4), 
295gr (range 264-353gr) in the HTK perfusion group (n=5) and 307gr (range 285-337gr) in the 
UW perfusion group. There was a stable ap weight in a®er UW perfusion, compared to an 
almost 50% weight increase a®er 18-hour HTK perfusion, leading to visible oedema. Mean 
ap temperature during ex-vivo perfusion was 16.8⁰C in the HTK group and 19.5⁰C in the 
UW group. There were no relevant di¡erences in ap temperature, ap colour or capillary 
rell a®er replantation within aps or between groups. The results for gene expression 
are presented in fold change, describing the mean gene expression ratio between biopsies 
taken at t=0 and the time point of interest a®er ap replantation. When assessing the three 
preservation groups, all genes showed an overall up-regulated gene transcription a®er 










Figure 3. Scatter plot of the 50 selected genes from microarray analysis, showing the comparison 
between UW-mp perfusion and cold storage at 12 hours (x-axis) and 36 hours (y-axis). Red dots 
represent the ¡nal selection of genes (n=6).  
Abbreviations: FC; Fold Change, CS; static Cold Storage. 
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IL1B is a key regulator in the immune response, inducing a pro-inammatory response that 
stimulates the production of cytokines and growth factors.29 The mean gene expression of 
IL1B was upregulated a®er replantation of muscle aps in all preservation groups. At two 
time points there was a down-regulation in gene expression; at 6hr a®er replantation in the 
HTK group and at 12hr a®er replantation in the CS group (Figure 4a). There was a trend, 
but not a signicant di¡erence in IL1B expression in the preservation groups over time (p= 
0.027, likelihood ratio test). 
NFKBIZ is member of the IKB-family and is thought to regulate nuclear NFKB activity 
through a negative feedback loop.30 NFKB acts as downstream moderator in the TRL-IL1 
pathway, stimulating the innate immune response and cell survival and proliferation.31 
A®er an initial peak in expression at 1 hour a®er replantation, NFKBIZ expression decreased 
signicantly over time in all groups (Figure 4b). The expression levels were lowest a®er 
ap replantation in the CS group, followed by the HTK group. NFKBIZ expression remained 
up-regulated in UW perfused aps in contrast to the other two groups (group di¡erence on 
likelihood ratio test: p=0.129).  
Hypoxia and cellular stress 
HIF1A transcription is increased under hypoxic circumstances and plays an important role 
in the adaptation to hypoxia through activation of many other genes, for instance those 
involved in glucose metabolism, cell survival and angiogenesis.32, 33 HIF1A expression 
was increased a®er ap replantation in all groups (Figure 4c). This increase was more 
pronounced in the perfusion groups at the end of the observation period, but di¡erences 
Table 2. Micro-array analysis of samples taken during muscle preservation: ex-vivo perfusion with 
University of Wisconsin solution vs. static cold storage.
UW-mp perfusion vs CS
12 hour 36 hour Global gene function
Gene FC p-value FC p-value
TNFRSF10A 1.32 0.133 2.25 0.000* Apoptosis
RGS2 2.37 0.000 3.01 0.000* Blood vessel relaxation
NFKBIZ 1.70 0.090 2.153 0.022 Inflammation/stress response
IL1B -1.17 0.530 -2.03 0.016 Inflammation
HIF1A 1.07 0.707 -1.31 0.152 Hypoxia
FGF6 1.54 0.052 2.16 0.002* Muscle proliferation/di«erentiation
DDIT4 -1.63 0.220 -2.07 0.080 Cellular stress response
CASP3 -1.25 0.088 -1.21 0.147 Apoptosis
FC; Fold Change, UW-mp; University of Wisconsin machine perfusion (solution) 
* Statistically signi¡cant di°erence (p≤0.01) on ANOVA, comparing the overall di°erences between the 
groups.
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between groups did not reach statistical signicance (p= 0.202, likelihood ratio test). 
DDIT4 (also known as REDD1) is another regulator in the response to hypoxia and is partially 
regulated by HIF1A.34 Other stressors might also inuence DDIT4 expression through di¡erent 
pathways (e.g. nutrition, exercise, sepsis, diabetes).35, 36 DDIT4 showed a stable up-regulated 
expression a®er ap replantation in the CS and HTK groups. DDIT4 expression in UW aps 
was comparable to the other groups at one hour a®er replantation, but showed an increasing 
trend over time therea®er (Figure 4d). There were no statistically signicant di¡erences 
between the groups as a whole (p=0.113 on likelihood ratio test) or at specic time points. 
Apoptosis 
Caspase-3 is the end product of the intrinsic and extrinsic apoptotic pathways and plays a 
central role in the execution of apoptosis.37 CASP3 transcription was minimally up-regulated 
in all groups following replantation of the aps. The expression remained up-regulated in 
the UW group during the post-replantation period. In contrast, HTK preserved aps showed 
down-regulation of CASP3 expression at 6 hours a®er replantation and CS aps at 12 hours 
(Figure 4e). The CASP3 expression per group showed a trend towards di¡erent expression 
over time on likelihood ratio testing (p=0.059). 
The TNF-receptor initiates the extrinsic apoptotic pathway in cells upon stimulation by 
TNF-related apoptosis inducing ligand (TRAIL).38, 39 The protein coded by TNFRSF10A (also 
known as TRAIL1R) is part of the TNF-receptor superfamily. There were small di¡erences 
when comparing the expression of TNFRSF10A a®er ap replantation between the three 
groups (p=0.912, likelihood ratio test). All groups showed an up-regulation of expression 
a®er replantation, except for the initial down-regulated TNFRSF10A expression at one hour 
a®er replantation in UW perfused aps (Figure 4f). 
Muscle cell regulation 
Regulator of G protein signalling 2 belongs to the family of RGS proteins. RGS proteins are 
able to inactivate G proteins and drive them to their GDP-bound form, promoting vascular 
(smooth muscle cell) relaxation.40, 41 All preservation groups showed an increased RGS2 
expression at the sampling points a®er ap replantation. This increase was highest in aps 
preserved with UW perfusion and statistically signicant when compared to CS preserved 
aps at 12 hours a®er replantation (Figure 4g). The expression patterns for groups as a 
whole were not di¡erent on statistical testing (p= 0.134, likelihood ratio). 
The pathways of acting of FGF6 remain restricted to skeletal muscle, where it is thought 
to play a role in cell regeneration, di¡erentiation and progenitor cell control through the 
stimulation of FGF4-receptors.42, 43 In this experiment, FGF6 was the only gene of which the 
expression was decreased in all preservation groups a®er ap replantation (Figure 4h). 
There were no di¡erences in expression between the groups (p=0.356, likelihood ratio test), 
however, di¡erences in FGF6 expression over time were statistically signicant. 
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Figure 4. Mean relative gene expression per group per sampling point a¢er ap replantation for:  a. 
IL1B, b. NFKBIZ, c. HIF1A, d. DDTI4, e. CASP3, f. TNFRSF10A, g. RGS2 and h. FGF6. Error bars show 95% 
con¡dence intervals, p-values were calculated using mixed model analysis.
^ Trend between UW and HTK at 6hr after RPLT (p=0.05) 




^ Statistical trend in down-regulation of expression 
in the CS group when comparing 1hr to 6hr 
(p=0.02) and 6hr to 12hr after RPLT (p=0.03)
^
* Statiscitally significant decrease in expression 
between 1hr and 6hr after RPLT in all groups (p=0.00)




^ Trend between UW and HTK at 6hr after RPLT (p=0.05) 




^ Statistical trend in down-regulation of expression 
in the CS group when comparing 1hr to 6hr 
(p=0.02) and 6hr to 12hr after RPLT (p=0.03)
^
* Statiscitally significant decrease in expression 
between 1hr and 6hr after RPLT in all groups (p=0.00)
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^ Trend between UW and HTK at 6hr after RPLT (p=0.05) 
and between UW and CS at 12hr after RPLT (p=0.04)
* Statistically significant decrease expression at 
6hr compared to 1hr (p=0.00) and at 6hr 
compared to 12hr after RPLT (p=0.01) in the  
HTK group
*
* Statistically significant difference between UW 
and CS at t=12hr after RPLT (p=0.01)




* Statistically significant decrease in expression in the 
HTK group between 1hr and 6hr and between 6hr and 
12hr after replantation (p=0.00) 
^ Trend in down-regulated expression between 1hr and 
6hr (p=0.02) and 6 and 12hr after replantation (p=0.02) 
in the UW grroup and between 1 and 6 hr after RPLT in 
the CS group (p=0.02)
^ Trend between UW and HTK at 6hr after RPLT (p=0.05) 
and between UW and CS at 12hr after RPLT (p=0.04)
* Statistically significant decrease expression at 
6hr compared to 1hr (p=0.00) and at 6hr 
compared to 12hr after RPLT (p=0.01) in the  
HTK group
*
* Statistically significant difference between UW 
and CS at t=12hr after RPLT (p=0.01)




* Statistically significant decrease in expression in the 
HTK group between 1hr and 6hr and between 6hr and 
12hr after replantation (p=0.00) 
^ Trend in down-regulated expression between 1hr and 
6hr (p=0.02) and 6 and 12hr after replantation (p=0.02) 
in the UW grroup and between 1 and 6 hr after RPLT in 
the CS group (p=0.02)
e. CASP3 f. TNFRSF10A












































^ Statistical trend in down-regulation of expression 
in the CS group when comparing 1hr to 6hr 
(p=0.02) and 6hr to 12hr after RPLT (p=0.03)
^
* Statiscitally significant decrease in expression 
between 1hr and 6hr after RPLT in all groups (p=0.00)




Time after replantation (hr) Time after replantation (hr)
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This gene expression study assessed ischemia-reperfusion injury (IRI) on translational 
level a®er preservation and replantation of free muscle aps in a porcine model. Prolonged 
muscle ap preservation by continuous oxygenated ex-vivo perfusion with UW and HTK was 
compared to short static cold storage. Muscle has a low tolerance towards ischemic injury 
and therefore served as a sensitive model to investigate this phenomenon. The expression 
of genes related to inammation, hypoxia, apoptosis and muscle regulation were compared 
before and a®er ap preservation. The gene expression patterns were overall comparable 
between the preservation groups. These results suggest that ex-vivo perfusion might be a 
promising technique for prolonged muscle preservation in terms of preventing IR-injury. 
The inammation response a®er ap preservation was evaluated by assessment of IL1B 
and NFKBIZ expression. As expected, these genes showed an up-regulated expression a®er 
ap replantation, suggesting an activation of the inammatory response. This response 
gradually decreased in all groups during the 12-hour observation period a®er replantation. 
At the end of the experiment, the inammation response was lower compared to t=0 in the 
CS group, was comparable to t=0 in the HTK group and was still slightly increased in the 
UW group. 
The expression of genes related to hypoxia, cellular stress and apoptosis were increased 
a®er replantation and remained high until the end of the experiment. These data suggest 
that all preservation techniques lead to some degree of cellular ischemia and cell death, of 
which the processes are still active at 12 hours a®er replantation. Although the hypoxia and 
cellular stress levels (HIF1A, DDIT4) seemed to be somewhat higher in aps preserved with 
UW perfusion compared to the other groups, the expression rates of apoptosis related genes 
were comparable between the three groups (TNFRSF10A and CASP3).
RGS2 is known to be involved in the regulation of smooth muscle relaxation in blood vessels 
through G-protein signalling.40 Our data show an up-regulation of RGS2 expression in all 
preservation groups a®er muscle ap preservation and replantation. Interestingly, this 
expression was signicantly higher in UW compared to HTK perfused aps at 12 hours a®er 
replantation. RGS2 activity is positively related to endothelium-derived hyperpolarizing 
factor activity and thus to smooth muscle relaxation.44 These ndings suggest a higher 
potential towards arterial relaxation in UW preserved ap. This could possibly be the 
result of better endothelium preservation. Kueckelhaus et al. similarly described a superior 
preservation of capillaries on electron microscopy at 7 days follow-up in their recent study 
comparing 12-hour Perfadex perfusion to short static cold storage in porcine forelimb 
preservation.45 In contrast, the outcomes of several studies in the setting of heart perfusion 
indicate adverse e¡ects of UW preservation on coronary artery function. The suggested 
mechanism is endothelial dysfunction due to the high potassium concentration in UW 
solution.46, 47 It seems that the e¡ect of UW solution on blood vessel relaxation cannot be 
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directly compared between organs. Our results in skeletal muscle point towards a protective 
role of ex-vivo perfusion on smooth muscle relaxation, which is superior in UW compared 
to HTK solution. 
FGF6 expression is known to be transiently up-regulated following muscle damage, with 
roles in muscle regeneration and di¡erentiation.42, 48 Therefore, an up-regulation of this gene 
was expected a®er replantation, but surprisingly this was the only gene that was constantly 
down-regulated in all groups a®er replantation. The role of this down-regulation unclear, 
but might be related to activity related to the di¡erentiation of muscle phenotype, rather 
than muscle regeneration. Another reason might be that regeneration takes more time to 
become apparent. It would therefore be interesting to further assess muscle phenotype 
and regeneration in an experiment with longer follow-up a®er muscle preservation and 
replantation.49
When comparing results a®er perfusion with UW-mp and HTK, it should be considered 
that HTK solution has a lower viscosity and thus a lower vascular resistance than UW 
solution. This resulted in a higher ow at a similar perfusion pressure during perfusion 
and subsequently in a lower mean ap temperature during HTK perfusion. The resulting 
di¡erence in ap temperature between the HTK and UW groups could have possibly 
inuenced ap preservation at expense of the UW group. Another limitation in this study 
was the small sample size, reducing its internal and external validity. However, in line with 
the standards in animal research, the number of animals should be reduced whenever 
possible to prevent unnecessary harm to animals. Since the main goals of this study were 
hypothesis generation and pilot testing, a small sample size was seen t. The trends found 
in this experiment need to be further validated in a larger group. An advantage of this 
study is the high sensitivity of qRT-PCR compared to histological examination of biopsies. 
Although histology can give an illustrative insight into the degree of damage, obvious 
signs of muscles damage o®en take several hours to become apparent.5 Changes on a 
translational level appear much faster. 
In future, ex-vivo perfusion could possibly decrease the extent of ischemia problems in 
composite tissues during complex and/or time-consuming situations. Experiments with a 
longer follow-up a®er replantation are necessary to assess long-term tissue vitality, and also 
evaluate the infection rate as a possible complication a®er the prolonged preservation. With 
successful elongation of ischemia time, more time will become available for transportation 
of VCA donor-tissue to a recipient and for VCA transplantation procedures. 
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In this gene expression experiment, ischemia-reperfusion injury was assessed a®er muscle 
ap preservation. First, microarray analysis was performed to select genes for further 
evaluation. Eight genes were selected, related to inammation (IL1B, NFKBIZ), hypoxia 
(HIF1A, DDIT4), apoptosis (CASP3, TNFRSF10A) and muscle regulation (FGF6 and RGS2). 
Using qRT-PCR, gene expression a®er ap preservation and replantation was compared 
between short static cold storage and prolonged ex-vivo perfusion with HTK or UW. Based 
on comparable expression of genes related to inammation, hypoxia and apoptosis, ex-
vivo perfusion seems to be a potential substitute for static cold storage and prolong muscle 
preservation time. Based on the current results, no preference over one of the tested 
preservation solutions could be made. It is recommended to further validate the results in 
replantation experiments with a larger sample size.
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Appendix A. Overview of assessed genes with their main functions and primer sequence
Gene (full name. 
abbreviation)
Relevant functions Primer sequence 
Tumour Necrosis Factor 
receptor superfamily 
member 10-A like 
(TNFRSF10A)
Initiation of apoptosis via the TRAIL pathway, 
extrinsic apoptosis pathway 38,39
F: AACTTCTGGGAGTTGTGCCC 
R: CAGGTTGTACACGGTAAGC
Regulator of G-protein 
signalling 2 (RGS2) 
Inhibition of signal transduction by G 
protein-coupled receptor signal cascades. 
Plays a role in blood pressure regulation via 
inhibition of smooth muscle contraction 41
F: GACTGCGGACCCATGGAC 
R: TAGCTCAAACGGGTCTTCCAA
Nuclear Factor Kappa-B 
Inhibitor Zeta (NFKBIZ)  
Also known as MAIL or 
INAP
Atypical IkB protein that regulates nuclear 
NFKB activity and might induce cell death 
upon overexpression.30 NFKB plays a role 
in the immune response via the canonical 
pathway (IL-1/TNF stimulated,  promoting the 
innate immune response and cell survival) and 
the alternative pathway (stimulated by NF-
related cytokines [e.g. lymphotoxinB, CD40L], 




Also known as catabolin
IL1B is a pro-inflammatory cytokine that 
is rapidly released on tissue injury or 
inflammation. Also involved in lymphocyte 
proliferation, di«erentiation and apoptosis. 
Induces the secretion of other cytokines (e.g. 
IL-2, IL6, IL-8, IFN-beta) and growth factors 





Encoding the alpha subunit of HIF1, a 
heterodimer protein. Key regulator in the 
cellular and systemic response to hypoxia 
that stimulates the metabolic adaptation to 
hypoxia. Fast responder protein, degrades 
quickly under normoxic conditions 33 
F: GAAGAACTTCTGGGCCGCTC 
R: CCTGTACTGTCCTGTGGTGAC
Fibroblast growth factor 6 
(FGF6)
A suggested regulating role in skeletal muscle; 
regeneration/ di«erentiation. Might also be 
involved in maintenance of the progenitor 




transcript 4 (DDIT4)  
Also known as REDD1
Active during cellular stress (e.g. hypoxia, 
DNA damage, osmotic stress, glucocorticoids). 
Inhibits mTORC1,  leading to a decrease of 
protein synthesis in cells 35 
F: TTTAGCTCCGCCAACTCTCC 
R: TGATGACTCGGAAGCCAGTG
Caspase-3 (CASP3) Key regulator in apoptosis. Casp-3 is an 
executional caspase, the terminal e«ector of 
the extrinsic and intrinsic apoptosis pathways 
and amplifies the death signal 55
F: TGGGATTGAGACGGACAGTG 
R: GAACCAGGATCCGTCCTTTGA
Histone (H2A) Reference gene in this experiment F: GGGATCTCGCTTGGTGACTG
R: CGCCTTTGTCTTGGCCTTTC
1. PCR cycle: 5-minute pre-incubation at 95°C followed by 40 cycles of ampli¡cation (95°C/10 sec, 60°C/20 sec, 72°C/20 sec) 
during which uorescence was measured automatically. Temperature was increased to 95°C for melting curve construction.
2. Abbreviations: TRAIL: Tumour necrosis factor related apoptosis inducing ligand, mTORC1: mammalian target of 
rapamycin complex 1, lymphotoxinB: lymphotoxin-beta, CD40L: CD 40 ligand, NF: nuclear factor, IkB: inhibitor of NF-KB. 
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Cold storage still is the clinical standard for composite tissue preservation but is time-
limited. A long ischemia time during surgery will adversely a¡ect postoperative outcomes 
due to ischemia-reperfusion injury. Extracorporeal perfusion (ECP) seems a promising 
alternative for prolonged preservation, but more evidence is needed to support its use and 
to identify optimal perfusion uids. This article assessed musculocutaneous ap vitality 
a®er prolonged ECP and compared outcomes a®er replantation to short static cold storage 
(SCS). 
Methods
Unilateral musculocutaneous rectus abdominis aps were raised from 15 pigs and preserved 
by 4h SCS (n=5), 18h mid-thermic ECP with Histidine-Tryptophan-Ketoglutarate (HTK, n=5) 
or University of Wisconsin solution (UW, n=5). Flaps were replanted and observed for 12h. 
Skeletal muscle histology was assessed (score 0-12; high scores equal more damage), blood 
and perfusate samples were collected and weight was recorded as a marker for oedema. 
Results
Mean histological scores were 4.0 a®er HTK preservation, 5.6 a®er UW perfusion and 5.0 
a®er SCS (p=0.366). Creatinine kinase (CK) was higher a®er ECP compared to SCS (p<0.001). 
No weight increase was observed during UW perfusion, but was 56% increased during HTK 
perfusion. Following 12h reperfusion, mean weight gain reduced to 39% in the HTK-group, 
was 24% in the UW-group and 17% in the SCS-group. 
Conclusion
Skeletal muscle seemed well preserved a®er 18h ECP with HTK or UW perfusion, with 
comparable results to 4h SCS upon short reperfusion. The high oedema rate during HTK 
perfusion remains a challenge that needs to be further addressed. 
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Introduction
Skeletal muscle is one of the most vulnerable tissues to ischemia, with a maximum ischemia 
time of six hours at hypothermia.1-5 Final tissue damage is determined not only by the injury 
during preservation, but also by the tissue’s response to reperfusion (ischemia-reperfusion 
injury).6 7 This reperfusion response can activate a local or systemic inammatory response 
that may exacerbate injury or produce injury in distant organs (e.g. lung oedema, kidney 
failure).4 Therefore, the evaluation of tissue damage following ischemia is only complete 
when the reperfusion phase is also assessed. 
To date, cold storage still is the gold standard in composite tissue preservation and early 
revascularisation remains the mainstay in the approach to minimise ischemic damage.8 
It is not always possible to reduce ischemia time to the 6h maximum, for instance when 
vascular anastomoses are di°cult and revisions are needed or in complex procedures 
such as vascularised composite allotransplantations (VCA, e.g. abdominal wall transplant) 
or limb replantation.9 This raises the need for new techniques that can safely prolong 
composite tissue preservation.10 Extracorporeal perfusion (ECP) found its origin in organ 
transplantation and slowly gained interest for preservation of composite tissues.11 To date, 
ECP for composite tissue preservation is still experimental and studies that evaluated the 
reperfusion phase are scarce.12 The longest described acellular ECP period followed by 
successful replantation is 24 hours in porcine forelimbs.13
In the current study, it is hypothesized that prolonged ECP is also possible in free aps 
consisting almost entirely of skeletal muscle. Skeletal muscle is one of the important 
tissues to preserve in composite gra®s, since it is most ischemia-sensitive and accounts for 
gra® function.5 14 15 Based on clinical appearance and gene expression patterns in previous 
experiments that assessed 36 hours of ECP in musculocutaneous aps, the maximum 
period of 18-hour ECP was chosen. Outcomes a®er prolonged ECP were compared to a 
negative control group, consisting of aps preserved by 4 hours SCS.14 15  
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Unilateral musculocutaneous free rectus abdominis aps were raised from 15 Dutch 
Landrace pigs (mean weight 70.3kg, range 62.9-83.5kg). The contralateral side remained in 
situ, functioning as a control for ap appearance a®er replantation. All aps were randomly 
assigned to the study groups. The use of animals was approved by the local and national 
animal experimentation committee (protocol-number 2016-0034-002) and followed the 
European Directive 2010/63/EU for the use and care of laboratory animals.
Surgical procedure
All procedures were conducted under sterile conditions. Prophylactic antibiotics 
(amoxicillin 20mg/kg) were administered intravenously before surgery. Pigs were 
heparinised up to 2 times the normal activated clotting time during surgery and to 1.5 
times between procedures. All aps were based on the superior epigastric artery and 
Figure 1. Schematic illustration of the extracorporeal perfusion set-up 
The semi-closed perfusion set-up (closable box) with a ap in the perfusion box on top of a metal grid. 
There is passive venous drainage of the preservation uid into the collection reservoir. The centrifugal 
pump is pressure regulated at in-line ≤ 30mmHg and the uid is infused with a mix of 95% O2, 5% CO2 
at the oxygenator. The heater-cooler machine cools the uid to 8-10°C. There is a drug administration 
point and uid sampling point. Before entering the ap via the artery, the ultrasonic ow meter 
measures ow per minute.
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measured 12x9cm. Directly a®er ap procurement, aps were ushed with 150cc heparin-
saline solution (2U/ml) for a complete washout of blood. In the SCS group (n=5), aps were 
preserved for four hours wrapped in dry gauzes in a sealed bag on ice-water. In the ECP 
groups, aps were perfused for 18 hours. The abdominal wound was covered with moist 
gauzes and sterile impermeable foil during ex-vivo ap preservation. Flaps were replanted 
to their original vascular pedicle a®er preservation and were observed for another 12 hours. 
A®er ending the experiment, pigs were euthanized with an overdose of Phenobarbital.
Perfusion system
A semi-closed system was assembled for continuous, non-pulsatile extracorporeal 
perfusion with 1L acellular preservation solution (Figure 1). Two solutions were compared: 
University of Wisconsin-machine perfusion solution (UW-mp, n=5) and Histidine-
Tryptophan-Ketoglutarate (HTK, n=5).16 Both solutions improved muscle preservation in 
several set-ups, including immersion and perfusion studies on muscle and solid organs.17 18 
Methylprednisolone (40mg) was added to the solution to prevent cellular swelling during 
perfusion. A centrifugal pump (BP-50 Bio-Pump® Centrifugal Blood Pump, Medtronic) was 
used to perfuse the tissue through an arterial catheter with a maximum in-line pressure 
of 30mmHg. Venous outow was passively collected in a reservoir before being ltered 
and pumped back into the system. A carbogen gas mixture of 95% O2 and 5% CO2 was 
continuously added to the preservation solution by a hollow bre oxygenator (Capiox RX05, 
Terumo).19  This oxygen percentage was necessary for the uid to reach adequate oxygen 
tension.20 The solutions were cooled to 8-10°C by a heater-cooler machine (HCU30, Maquet) 
according to the manufacturer’s recommendations. The observers were blinded for the 
used perfusion uid (Table 1). 
Baseline measurements
Baseline samples of porcine arterial blood were taken from the femoral line before surgery 
and before pedicle transection. Samples were analysed for cytokine levels (IL-1β, IL-6, 
TNF-α), creatine kinase (CK) and blood gas analysis including lactate. Flap weight was 
measured before preservation.
Table 1. Composition of UW-mp and HTK solution38,39
Component UW-mp HTK
Osmolality (mOsm/L) 320 310
Potassium (mmol/L) 25 10
Sodium (mmol/L) 80 15
Calcium (mmol/L) 0.5 0.015
Scavangers Glutathione, allopurinol Tryptophan, mannitol
Bu«ers Phosphate Histidine
Energy delivery Adenosine, phosphate Ketoglutarate
Impermeants HES, lactobionic acid, ranose Mannitol
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Flap core-temperature was measured using a needle probe thermometer. Perfusion solutions 
were not relled nor replenished, enabling measurements of ap metabolite accumulation 
in the solution (CK, lactate). Perfusion uid samples were taken at nine and 18 hours of ECP 
to measure pO2 and ap metabolites. Flap weight was measured a®er preservation. 
Measurements aer 
ap replantation 
Flap monitoring (skin colour, temperature and capillary rell) was performed hourly. In 
the case of abnormal controls, the pedicle was visually inspected and intervention took 
place if necessary. To visualize the perfusion of aps, indocyanine-green (ICG) uorescence 
angiography was used. ICG is a uorescent dye that remains in the intravascular 
compartment a®er injection. The uorescent signal can be visualized with a hand-held 
camera using near-infrared emission (PhotoDynamic Eye, Hamamatsu Photonics, Japan).21 
A dose of 0.15mg/kg was administered through the femoral artery line at 30min, 4h, 8h, 
and 12h a®er replantation. The percentage of the uorescent surface was recorded. Porcine 
arterial blood samples were taken at 1, 6 and 12 hours a®er replantation for analysis of 
Figure 2. Morphological features of degenerative muscle ¡bres due to ischemia-reperfusion injury in 
transverse muscle sections stained with H&E at 12h a¢er ap replantation. 
Upper le¢: variation in muscle ¡bre shape and size. Oedema and inammation are also seen. Upper 
right: hypoxic myocyte (rounded en hypereosinophilic). Lower le¢: neutrophil inux in the myocyte. 
Lower middle: necrotic, pale ¡bres and phagocytized myocytes. Lower right: Masson trichrome staining, 
¡brotic myocytes are stained green.
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cytokines, CK and blood gas. Flaps were explanted a®er euthanizing the pigs, weight was 
recorded and aps were xed in bu¡ered formaldehyde for histological sampling. 
Histology
Transverse sections spanning the total ap width were cut at 3-µm and stained with 
hematoxylin-eosin (H&E) and Masson trichrome. All slides were evaluated by a blinded 
pathologist with light microscopy in 10 randomly selected high-power elds using x20 
magnication. A self-developed and simplied version of the ‘Histologic injury severity 
score’ as presented by Muller et al was used for histological scoring since no specic 
score is available.22 Four subgroups of histologic alterations that are indicators for muscle 
damage were scored on a scale from 0 (no damage) to 3 points (severe damage). These 
subgroups are: 1) damaged muscle bres (= hypoxic bres + necrosis + phagocytic cells), 
2) inammation, 3) interstitial oedema, and 4) variation in shape and size of myocytes 
(Figure 2). The sum of all categories resulted in a total score between 0 and 12 points 
(Table 2).1
Statistical analysis
The di¡erences in distribution between groups were analysed with Kruskall-Wallis tests for 
single measurement parameters. Parameters with repeated measures were analysed using 
a mixed model analysis (e.g. weight, CK, lactate). Analyses were performed in SAS 9.4 (SAS 
Institute Inc, North Carolina, USA), p-values of ≤0.05 were considered statistically signicant.
Table 2. Histologic scoring system for hypoxia-induced muscle tissue injury in extracorporeal perfusion.
Morphological changes Categories
















* Sum of damages ¡bers at 10 high-power ¡elds at 20x magni¡cation 
Total score 0-12, a higher score equals more muscle damage.  
The scoring system is based on ¡ndings of Scully and Hughes1 and the histologic ischemia severity score 
(HISS) by Muller et al.1,22
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Mean pig weight, ush duration, and replantation time were comparable between groups 
(Table 3). Mean o¡-pedicle preservation time was prolonged with >13.5h in ECP-groups. 
Measurements during 
ap preservation 
The core-temperature in the SCS preserved aps dropped to ≤8°C within 3 hours of SCS. 
Flap core temperature during UW-mp perfusion was signicantly higher at all times 
compared to HTK perfusion (mean 19.4°C, SD 2.1 vs 16.8°C, SD 0.8; p=0.027). The mean 
pO2 was >99mmHg in inux perfusion solution and 30-40mmHg in e¸ux solution. These 
values approximate physiological circumstances. The accumulation of CK and lactate in the 
preservation solutions during ECP was comparable between groups. 
Measurements aer 
ap replantation
Flap #1 (SCS group) developed venous congestion directly a®er replantation that 
did not clear a®er revision nor anastomosis of a second vein. The ap additionally 
showed a decreased and later absent arterial inow on ICG angiography. Since 
there was no obvious explanation for this problem (e.g. pedicle thrombosis), the 
ap was excluded from the study, leaving four aps in the SCS group (Figure 3). 
Two aps from the ECP-groups developed acute arterial thrombosis a®er replantation. Flap 
# 14 (HTK-group) at eight hours a®er replantation, for which successful revision surgery was 
performed without further problems. Flap #5 (UW-group) developed arterial thrombosis at 
11.8h a®er replantation. Since this event was near the end of the experiment, no revision 
was undertaken (Figure 3). All other aps had uneventful follow-up, with complete and 
homogenous perfusion patterns on ICG angiography. 
Table 3. Characteristics of the three preservation groups presenting means, standard deviation and 
p-values.






Pig weight (kg) 72 ± 8 67 ± 4 71 ± 6 0.946
Flush duration (min) 18 ± 6 22 ± 8 18 ± 7 0.738
Replantation time (min)   73 ± 18  59 ± 25 58 ± 25 0.201
Total o«-pedicle time (hr)  5 ± 0.3  19 ± 0.8 19 ± 0.5 0.009*
The ap from pig 1 in the cold storage group was excluded due to technical problems directly a¢er 
replantation. 
* Kruskal-Wallis analysis, p≤0.05 is considered statistically signi¡cant.
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Figure 3. Photographs of all aps at 12 hours a¢er replantation  
* Flap 1 was excluded due to therapy-resistant venous congestion and later arterial obstruction 
** Flap 5 at 11 hours and 12 hours a¢er ap replantation (before and a¢er acute arterial thrombosis) 
*** Flap 14 underwent successful revision of the arterial pedicle at 8 hours a¢er replantation
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Figure 4. Mean CK, potassium and lactate per pig. Arterial measurements were taken during ap 
retrieval and a¢er ap replantation. 
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Laboratory measurements 
Systemic cytokine levels were low or undetectable in all aps. Porcine arterial CK levels 
increased over time in all groups a®er ap replantation but was signicantly lower in the 
SCS-group compared to the ECP-groups (mixed model analysis, p<0.001). A comparison 
between the ECP-groups showed a trend towards lower CK in the HTK-group at six hours 
a®er replantation (p=0.051) but comparable CK levels at 12 hours (p=0.095). The arterial 
potassium and lactate levels a®er replantation were comparable between all groups 
(potassium; p=0.529, lactate; p=0.522, Figure 4).
Histology
The mean score of ischemia-induced alternations (HISS) was 5.0 (SD 1.8) in SCS, 5.6 (SD 
1.9) in UW-mp, and 4.0 (SD 2.0) in HTK preserved aps (Kruskal Wallis, p=0.366). There 
were small di¡erences in sub-scores between the preservation groups, without reaching 
statistical signicance (Figure 5). The number of damaged muscle bres was lowest in the 
HTK-group (mean 0.2, SD 0.4), followed by the UW-group (mean 0.6, SD 0.5) and SCS-group 
(mean 1.0, SD 0.0; p=0.214). 
Figure 5. Boxplot showing an overview of histological changes at the study endpoint indicating 
ischemia-reperfusion injury per ap and group.  
* Cell count per 10 high-power-¡elds at 20x magni¡cation 
Scoring for inammation and interstitial oedema: 0=no, 1=minimal, 2=intermediate, 3=di°use.
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In contrast to UW-mp perfused aps, HTK-perfused aps showed a visible weight increase 
during ECP (HTK +156.5g (53%); UW -0.22g (0%), mixed model analysis p≤0.001). A®er 
replantation, SCS and UW-mp aps showed a moderate weight increase (SCS: +47.3g (17%), 
UW: +66.8g (24%), p=0.674), but weight in HTK-preserved aps decreased with a mean of 
72.6g (-27%). When comparing the nal ap weight, there was a statistically signicant 






















Figure 6.  Mean ap weight over time per group.  
Time points of ap weight measurements:1. directly a¢er ap retrieval, 2. a¢er 4h cold storage or 18h 
ECP, 3. a¢er 12h reperfusion 
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Discussion 
Tissue preservation by the current standard of SCS is limited by the ischemic tolerance 
per tissue type.4 Since short ischemia time cannot always be guaranteed, there is a need 
to explore techniques that can safely prolong tissue preservation.This study assessed the 
early reperfusion phase a®er 18-hour porcine rectus abdominus ap preservation using 
oxygenated mid-thermic ECP with acellular uids. Histology and clinical appearance were 
found to be comparable to 4-hour SCS. 
Upon histological evaluation, muscle damage a®er 36h ECP interestingly seemed to 
be comparable to 4h SCS (Figure 4). These ndings conrm that ap histology is well 
preserved in the early replantation phase following prolonged ECP with retained muscle 
architecture. The limb preservation study by Kueckelhaus et al. described similar results 
a®er acellular perfusion and even suggested superiority of 12-hour ECP with Perfadex over 
4-hour SCS.23 Of important note is that ischemia-reperfusion injury histologically presents 
as a heterogenic phenomenon, which therefore is prone to sampling error.4 To minimise 
this, complete aps were xed in formaldehyde and cross-sections spanning the total ap 
width were taken for histological scoring. 
CK is an enzyme that is present in cells that rapidly consume ATP (e.g. skeletal or cardiac 
muscle). In response to muscle activity or damage, CK leaks into blood, leading to increased 
serum levels.24 CK levels in this experiment were higher a®er ECP than SCS, suggesting 
more muscle damage and inammation. However, since the di¡erent preservation times 
of aps in the ECP and SCS groups consequently led to di¡erences in anaesthesia time, 
this could not be ruled out as an inuencing factor on CK levels. Especially since pigs tend 
to develop muscle spasms during anaesthesia. Nevertheless, when comparing CK levels 
between ECP groups, it showed a trend towards lower values a®er HTK perfusion, in line 
with the lower histological scores in this group. Although a total increase of CK to 40,000-
50,000 IE/L seems high, other articles which presented good tissue preservation described 
similar levels. Fahradyan et al. described an increase of CK to 64,333 U/L a®er 24 hours 
of blood-based perfusion in porcine limbs.25 Duraes and colleagues found mean CK levels 
to be >27,000 U/L a®er 12 hours normothermic blood-based porcine limb perfusion, while 
muscle contraction was 100% preserved.26 This illustrates that CK levels yet remain to be 
related to the extent of muscle damage in this eld of research. 
Muller et al. measured systemic cytokine levels to assess the immune response a®er porcine 
limb replantation.22 However, we could not reproduce these measurements. Systemic 
cytokine levels a®er ap replantation remained very low or undetectable, which can be 
interpreted as a failure to detect cytokines though dilution in the systemic circulation, but 
also as the absence of a systemic immune response, indicating a low degree of ischemic 
injury. For future research purposes, sensitivity would increase if local cytokines levels 
could be measured. 
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The choice between UW-mp and HTK solution for composite tissue ECP remains a topic of 
debate.11 In this experiment, HTK perfusion seemed to result in slightly better histological 
outcomes, while UW-mp perfusion resulted in lower weight increase during perfusion. 
The development of oedema is very common in tissue reperfusion and fairly di°cult to 
circumvent. While oedema will mostly disappear in the rst days a®er reperfusion, extreme 
oedema should be prevented as it may compromise cellular microcirculation. The reported 
weight gain a®er acellular perfusion is variable, with rates between 10 to 84% a®er 6-12h 
perfusion.27-29 This large range can be explained by the heterogeneity of perfusion uids. In 
this experiment, UW-mp perfusion resulted in a stable weight, which can be explained by 
its high viscosity.30 Interestingly, HTK aps responded more favourable to replantation and 
showed a reduction in mean weight, while the SCS and UW-mp aps increased in weight 
in this period. Since weight increase is related to muscle damage, this feature might in turn 
reect a lower degree of reperfusion damage in HTK aps.31 Given the promising results of 
HTK in this study, future research could explore the possibility of a modied HTK solution 
aiming to reduce weight gain during perfusion, for instance by adding a plasma-expander 
to the uid.
The ap failure rate of 6.7% (1/15) is in line with the rate of approximately 5% in human 
research, considering the higher thrombogenic potential of pigs compared to humans.32-34 
Furthermore, previous research has learned that muscle aps provide a very sensitive model 
for failure.35 Two ECP aps develop acute arterial occlusion in this experiment. Perfusion 
damage to the endothelial layer was assessed as a possible causing factor, but could not 
be conrmed on histology. To our knowledge, there is one other study that presents some 
information on gra® failure a®er ECP in pigs. This study by Muller et al. had a complication 
rate of 32% a®er 12-hour ECP and replantation of porcine limbs. Infection and thrombosis 
were both scored as a complication but not further elucidated.22
A disadvantage of this study is the short follow-up a®er replantation. This article therefore 
only focussed on the acute phase a®er ECP. The twelve-hour follow-up period a®er 
replantation was a pragmatic choice, supported by the fact that in free ap replantation, 
80% of ap compromise occurs within 24 hours a®er surgery of which again 80% of the 
cases presents within the rst 12 hours.36 Following evidence indicating that histological 
ndings at 3hr post-transplantation already correlate to the ndings at one week a®er 
transplantation, the results from this research might serve as a guide for follow-up 
experiments.23  Due to strict Dutch regulations in animal welfare, an animal survival study 
with longer follow-up was not yet found an ethically approvable option based on currently 
available evidence and therefore remains a future goal. An advantage of this study was the 
use of a large animal model and very ischemia-sensitive tissue, enhancing the translational 
value to a human population. Furthermore, ap viability was evaluated during both 
perfusion and replantation, enabling the assessment of the early ischemia-reperfusion 
reaction. 
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Conclusion
Prolonging preservation time from 4 to 18h with acellular ECP seems feasible in highly 
ischemia-sensitive muscle aps. This is a three-fold elongation of current maximum 
allowable muscle ischemia.
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Successful 18-hour acellular extracorporeal 
perfusion and replantation of porcine limbs


















The current standard for composite tissue preservation is static cold storage (SCS) and is 
limited to 6h until irreversible muscle damage occurs. Extracorporeal perfusion (ECP) is 
a promising technique for prolonged preservation, however, functional results have been 
scarcely researched. This article assessed neuromuscular function and compared results to 
histological alterations to predict muscle damage a®er ECP. 
Methods
Forelimbs of twelve Dutch landrace pigs were amputated and preserved by 4h SCS at 4-6°C 
(n=6) or 18h mid-thermic ECP with University of Wisconsin solution (n=6). Limbs were 
replanted and observed for 12h. Sham surgery was performed on contralateral forelimbs 
(n=12). Histology analysis scored four sub-groups representing di¡erent alterations (higher 
score equals more damage).
Results
Muscle contraction a®er median nerve stimulation was comparable between ECP, SCS, and 
sham limbs (p=0.193). Histology scores were higher in ECP limbs compared to SCS limbs 
(4.8 vs 1.5, p=0.013). This was mainly based on more oedema in these limbs. 
Conclusion
In-vivo muscle contraction was well preserved a®er 18h ECP compared to short SCS, 
although histology seemed inferior in this group. Histology, therefore, did not correlate to 
muscle function at 12hr a®er replantation. This leads to the question whether histology or 
neuromuscular function is the best predictor for transplant success. 
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Introduction
Over the years, vascularised composite allotransplantation (VCA) has gained increasing 
interest. Since the rst hand transplantation in 1998, more than 100 upper extremity/
hand transplantations have been performed worldwide.1, 2 Due to the complexity of these 
procedures and the need to transport tissue from donor to recipient, these procedures cohere 
with the pressure to keep ischemia time as short as possible. The degree of ischemic tissue 
damage during VCA, but also during limb replantation surgery, will inuence (functional) 
outcomes, with decreased muscle and nerve recovery and possibly an increased risk of 
acute rejection.3 The current gold standard for composite tissue preservation still is static 
cold storage (SCS) on ice at 4-6 °C, preceded by a ush with heparin solution or acellular 
preservation uid in case of VCA. SCS is preferably limited to six hours since longer periods 
will lead to irreversible damage.4 This damage rst occurs in muscle and nerve, the two 
most vulnerable tissues to ischemia.5 Furthermore, exceeding the tolerable ischemia time 
can also have severe consequences for the recipient, since ischemia-reperfusion injury 
can ultimately lead to multi-organ failure or even death due to a systemic inammatory 
response.6, 7 Therefore, the need exists for a technique that can safely prolong composite 
tissue preservation. This will not only improve postoperative outcomes but also hugely 
inuence logistic aspects, by increasing the donor pool in VCA procedures or increase time 
for stabilisation of multi-trauma patients. 
Extracorporeal perfusion (ECP) is a relatively new technique for prolonged tissue 
preservation, with good results in the eld of organ preservation.8 During ECP, the tissue 
is continuously provided with a preservation solution containing oxygen and nutrients 
while toxic metabolites are removed.9-11 ECP has shown promising results for composite 
tissue preservation and e¡ectively increased tissue preservation to 12 or even 24 hours in 
large animal studies.12-14. These studies mostly relied on muscle histology outcomes and are 
limited by the lack of functional assessment. Muscle contraction has only been scarcely 
researched on muscle biopsies or in non-replantation experiments.13, 15-17 It therefore remains 
unanswered how histology relates to functional outcome.
This porcine limb replantation study was designed to assess in-vivo muscle function and 
compare results to muscle histology. The results of 18-hour limb preservation with ECP were 
compared to 4-hour SCS and sham surgery. 
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Twelve female Dutch Landrace pigs were randomly divided into two study groups. The 
pigs were sedated, intubated, and anesthetized following local protocols. A bladder 
catheter was inserted and continuous arterial blood pressure monitoring was possible 
through a femoral artery line. This experiment followed a mid-thermic perfusion protocol 
and used a commercially available acellular solution (University of Wisconsin machine 
perfusion solution; UW-mp), based on positive results in previous experiments with 
musculocutaneous ap replantation.18, 19 Primary outcomes were muscle contraction 
upon nerve stimulation and muscle histology. Secondary outcomes were skin perfusion 
(indocyanine-green angiography), biochemical parameters, and limb weight. The use 
of animals was approved by the local and national animal experimentation committee 
(protocol-number 2016-0034-003) and was in accordance with the European Directive 
2010/63/EU for the use and care of laboratory animals. 
Figure 1. Schematic illustration of the extracorporeal perfusion set-up 
The semi-closed perfusion set-up with: (A) the porcine forelimb in the perfusion box on top of a (B) 
metal grid, (C) passive venous drainage of the preservation uid, (D) 15mm needle probe measuring 
muscle temperature, (E) collection reservoir, (F) centrifugal pump, regulating pressure at  ≤ 30mmHg, 
(G) the oxygenator, infusing the uid with a mix of 95% O2, 5% CO2. (H) heater-cooler machine, cooling 
the uid to 8-10°C. (I) drug administration point/uid sampling point. (J) Ultrasonic ow meter.
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Limb procurement
Intravenous prophylactic antibiotics (amoxicillin 20mg/kg) were administered before 
surgery. Pigs were heparinized up to 2 times the normal activated clotting time during 
surgical procedures and up to 1.5 times between procedures. The experiments were 
conducted under sterile conditions. The right forelimb was used as intervention limb, the le® 
for sham surgery. During harvest surgery, the median nerve was dissected and stimulated 
whilst still intact to obtain a reference value. The nerve was then transected proximally and 
amputation commenced at mid forelimb level, carefully preserving the brachial artery and 
surrounding veins. With only the vascular pedicle and bone intact, 0.15mg/kg Indocyanine-
Green (ICG) was injected into the arterial line to obtain a reference perfusion pattern. The 
median nerve was stimulated again to also obtain a reference value a®er nerve transection. 
Finally, the vascular pedicle was transected followed by an exarticulation of the limb at 
elbow level. This level was cautiously chosen to obtain an adequate volume of muscle in 
the amputate. The limb was weighed on a digital scale. The brachial artery was cannulated 
with the largest possible sheath (5-6Fr) and ushed with 200ml heparinized saline solution 
(200IU heparin per 100ml). 
Limb preservation – SCS group
A total of six limbs was preserved by SCS. Following the ush, the sheath was removed from 
the artery. These limbs were stored for four hours in dry gauzes in two sealed bags in water 
on ice to reach a temperature of 5 ±1°C (static cold storage group, SCS). 
Limb preservation – Perfusion group
Six limbs were attached to the extracorporeal perfusion set-up and continuously perfused 
for 18 hours with 1L of oxygenated UW-mp solution (perfusion group, Figure 1).18 To reduce 
oedema, 40mg methylprednisolone was added to the solution. The solution was cooled to 
8-10°C according to the manufacturer’s recommendations (Heater-cooler HCU30, Macquet, 
Hilversum, The Netherlands). The centrifugal pump (BP-50 Bio-Pump® Centrifugal Blood 
Pump, Medtronic) was set to perfuse the limb with a maximum in-line pressure of 30mmHg. 
The hollow bre oxygenator (Capoid RX05, Terumo, Leuven, Belgium) continuously added 
a carbogen mixture (95% O2, 5% CO2) to the solution. Perfusion settings were checked 
hourly, with the registration of perfusion pressure, ow, and muscle core temperature 
(15mm needle temperature probe; Myocardial 400 needle temp. probe; MTS40015, Smith 
Medical, Rosalyn, the Netherlands). During the preservation period, the pigs remained 
under general anaesthesia. Sham surgery was performed on the contralateral limbs, which 
served as an internal control.
Sham surgery – contralateral limbs
During the sham procedure, limb procurement surgery followed similar steps to the 
intervention forelimbs. All structures were transected, except the brachial artery, large veins 
and bone. The median nerve was stimulated before and a®er nerve transection, following 
the standard protocol. The skin was closed using interrupted sutures.
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A®er four hours of SCS or 18 hours of ECP, limbs were again weighed. The humeral bone 
was 1cm shortened to create tension-free vascular anastomoses. Temporary osteosynthesis 
was performed using two perpendicular placed K-wires. The brachial artery and cephalic 
vein were microscopically anastomosed to their original vessels. The median nerve 
was le® unrepaired since nerve regeneration fell beyond the scope of this research. 
The 15mm needle temperature probe was inserted into a deep extensor muscle for 
continuous temperature control. Eventually, the skin was closed with interrupted sutures. 
Measurements aer replantation
Limbs were monitored for 12 hours a®er reperfusion whilst the pig was still under general 
anaesthesia enabling repeated measurements and sampling. Micro-controls were recorded 
hourly and involved muscle core temperature, skin colour and Doppler signals. Indocyanine 
green angiography was performed every 4 hours a®er reperfusion, the perfusion patterns 
were compared to the sham limb and to the baseline measurement of the intervention limb 
before limb amputation. Arterial blood samples (CK, lactate, pO2, pCO2) were taken every 4 
hours from the femoral artery cannula. 
Figure 2. Nerve stimulation setup  
A. The median nerve is stimulated directly by two electrodes on previous marked points. The lowest 
voltage to obtain visible limb movement (exion) a¢er two repeated measurements is recorded.  
B. Brachial artery.
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Muscle contraction
Nerve stimulation enabled the assessment of not only muscle function, but the entire nerve-
muscle complex as a functional unit (axons - neuromuscular junction - muscle bres). The 
median nerve was stimulated directly by two electrodes on a previously marked point with 
2cm between the cathode and anode (s11b stimulator, Grass medical instruments, Quincy, 
USA). The lowest voltage of two repeated measurements needed to obtain a visible exor 
muscle contraction was recorded (Figure 2). Nerve stimulation was performed twice during 
limb procurement and a®er limb replantation at 2h, 4h, 8h, and 12h of follow-up. All 
surgical procedures and measurements were performed by the same researcher (ASK).
Histology
A®er 12h of reperfusion, the pig was euthanized using an overdose of phenobarbital. Both 
forelimbs were amputated and the intervention limb was weighed again. The skin of both 
forelimbs was removed, the fascia incised and limbs were xed in bu¡ered formaldehyde. 
A predened exor- and extensor muscle were excised in-toto from the intervention and 
sham limbs. Cross-sections of these muscles were taken from the proximal and distal 
muscle bellies resulting in four muscle samples per limb. The para°n-embedded cross-
sections were cut at 3-µm thick and stained with standard haematoxylin-eosin and Masson 
trichrome. All slides were evaluated with light microscopy for ischemia-reperfusion 
induced alterations by a blinded pathologist.14 A simplied version of the ‘Histologic 
injury severity score’ (HISS) as presented by Muller et al. was used as no specic score is 
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*Damaged muscle ¡bres: a sum of necrotic, hypoxic and phagocytic myocytes
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Figure 3. Haematoxylin-eosin stained muscle samples showing histological alterations as scored in the 
modi¡ed Histology Injury Severity Score (HISS).  
A. Muscle sample showing marked interstitial oedema and variation in muscle ¡bre size. Limb no. 13 
from ECP group; HISS oedema score 3, HISS shape/size variation score 3.  
B. Muscle sample showing some interstitial oedema and a marked interstitial inammatory in¡ltrate, 
mainly consisting of neutrophils. Limb no. 3 from SCS group; HISS oedema score 1, HISS inammation 
score 2.  
C. Muscle sample showing damaged cells with a hypoxic ¡bre (*) and multiple necrotic ¡bres (arrow). 
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available.12 All slides were scored in 10 randomly selected high-power elds using x20 
magnication. Four subgroups of histologic alterations were scored on a scale from 0 (no-
minimal damage) to 3 points (severe damage): interstitial oedema, inammation, variation 
in shape and size of myocytes, and damaged muscle bres (necrotic + hypoxic + phagocytic 
myocytes). The sum of subcategories resulted in a total score that ranged from 0 points (no 
degeneration) to 12 points (severe degeneration) (Table 1, Figure 3). The total score per 
limb was composed of the mean HISS of the four muscle slides per limb. 
Statistical analysis
Descriptive statistics were used to calculate means and standard deviation per group. 
The di¡erences between groups for single measurement parameters were analysed with 
Kruskal-Wallis tests. Parameters with repeated measures were analysed using mixed 
model analysis a®er an LN-transformation of the data to better full the assumptions of 
this analysis. Analyses were performed in SAS 9.4 (SAS Institute Inc, North Carolina, USA), 
p-values of ≤0.05 were considered statistically signicant.
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Baseline characteristics between the SCS and ECP groups were comparable (Table 
2). The mean total ex-vivo preservation time was 19.8 hours in the ECP group versus 
5.5 hours of ischemia in the SCS group (p=0.002). All perfused limbs had successful 
extracorporeal perfusion, with stable pressure <30mmHg, stable ow (mean 16ml/min, SD 
1.7) and temperature (mean 16°C, SD 3.4, Figure 4). The creatinine kinase (CK) level in the 
preservation uid rose to a mean of 15,629 U/L a®er 18 hours of ECP. Lactate levels remained 
low, with a mean of 0.7 mmol/L a®er 18 hours of ECP. Following replantation, the ICG peak 
perfusion patterns of the intervention limbs were comparable to the control images and 
contralateral sham limb. Small areas of hypoperfusion tended to resolve within 4 hours of 
reperfusion following the rewarming of the limbs.  
Muscle contraction
The mean nerve stimulation threshold to obtain visible muscle contraction was comparable 
between limbs a®er SCS, ECP and sham limbs (mixed models analysis, p=0.193). Sham limbs 
had a stable muscle contraction threshold throughout the entire follow-up period with 
values between 4.3-4.9mV. The mean contraction threshold a®er replantation of SCS limbs 
ranged between 4.0-5.4mV and showed a small increase at two hours a®er replantation. 
UW-mp perfused limbs had contraction thresholds between 4.1-9.3mV with a statistically 
signicant increase at 2 hours a®er replantation (Kruskal Wallis, p=0.038). However, values 
decreased to reach their original values between 4 and 8 hours a®er replantation. When 
comparing the muscle contraction thresholds at the end of the experiment, there were no 
di¡erences in strength of stimulation needed to reach visible muscle contraction between 
the three groups (Figure 5).
Histology
The mean histology score was 0.4 in sham limbs in the perfusion group and 0.8 in sham 
limbs in the SCS group (p=0.786). When comparing the intervention groups, the mean 
histology score was higher in the ECP group (4.5) compared to the SCS group (1.5; Kruskal-
Wallis, p=0.013). This di¡erence in histology scores resulted from a signicantly higher 
sub-score for oedema in ECP limbs (p=0.003). The other sub-scores showed high individual 
Table 2. Baseline characteristics (mean, SD) of the static cold storage (SCS) and extracorporeal 






Pig weight (kg) 68, 2.4 71, 3.9 0.879
Limb harvest time (min) 209, 38.6 207, 15.9 0.937
Flush time (min) 11, 2.9 13, 3.1 0.765
Replantation time (min) 90, 21 102, 7.1 0.310
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Figure 4. Mean perfusion parameters measured hourly during continuous oxygenated extracorporeal 
perfusion with UW-mp solution (n=6).
	
*	
Figure 5. Mean threshold for visible muscle contraction upon median nerve stimulation per group over 
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variation and did not show statistically signicant di¡erences; muscle bre damage 
(p=0.147), variation in cell shape and size (p=0.074), and inflammation (p=0.859, 
Figure 6). Overall, all intervention limbs showed preserved muscle architecture and 
minimal to intermediate muscle damage.
Biochemical parameters
The mean CK was higher a®er replantation of ECP preserved limbs compared to SCS 
preserved limbs (p=0.006, mixed models analysis, Figure 7a). Mean arterial lactate levels 
remained below 1.1mmol/L at all times and were comparable between SCS and ECP 
(p=0.429, Figure 7b). Mean potassium levels equally increased in both groups a®er limb 
replantation and remained within normal ranges throughout the experiment (p=0.401, 
Figure 7c). 
Limb weight
The mean limb weight was stable during UW-mp perfusion (-2.7%) and static cold storage 
(+1.6%). At the end of the experiment, there was a small and comparable limb weight 
increase in both groups (SCS +11.6%; ECP +18.6%, p=0.180 on Kruskal Wallis analysis). 
Macroscopically, there was no signicant limb oedema a®er ECP. A®er 12h of reperfusion, 




Figure 6. Mean histology injury severity sub-scores (0-3) of the exor and extensor muscle samples at 
12 hours a¢er limb replantation. * Statistically signi¡cant di°erence (p=0.03)
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Figure 7. Biochemical parameters during the experiment, means per group. 
A. Mean CK levels per group over time, showing higher levels in the perfusion preserved limbs a¢er 
replantation (Porcine reference values: 153-5427 U/L) B. Mean lactate levels per group over time 
(porcine reference values: unknown) C. Mean potassium levels per group over time, showing an equal 










In this study, six porcine forelimbs were successfully replanted a®er 18 hours of acellular 
mid-thermic ECP. The muscle contraction thresholds a®er limb replantation in this group 
were comparable to that of sham limbs and to the current preservation standard of short 
SCS. To our knowledge, this is the rst large-animal experiment that assessed in-vivo nerve 
stimulation a®er replantation of limbs preserved by ECP. In contrast to neuromuscular 
function, histological analysis at 12 hours a®er replantation showed more ischemia-
reperfusion related alterations in the ECP group compared to the SCS and sham groups, and 
especially more interstitial oedema. This unexpected di¡erence warrants further analysation. 
A simple but e¡ective setup was used to assess muscle contraction thresholds upon nerve 
stimulation. When nerve stimulation is performed within the window of a maximum of 
3 days a®er nerve transection, it remains una¡ected by Wallerian degeneration.21 Nerve 
stimulation was not performed during preservation since the low temperature would 
have a¡ected the excitability.22 Other factors that could inuence nerve conduction were 
measured, such as limb temperature and oedema. Eventually, their inuence on muscle 
contraction was negligible and outcomes were not corrected for these factors. Interestingly, 
nerve stimulation values were increased in ECP limbs at two hours of reperfusion, to 
reached normal values again a®er 4-8 hours of reperfusion. This transient decrease in 
neuromuscular response could be explained by an increased extracellular potassium 
concentration during limb preservation, leading to reduced cell excitability. Jennice et al. 
previously described this phenomenon a®er 3 hours of rabbit limb ischemia, followed by 
near-normalization a®er 1.5 hours of reperfusion.23 ECP with the potassium rich UW-mp 
solution could have possibly aggravated this process. 
In contrast to neuromuscular function, histology scores were higher in limbs preserved 
by ECP compared to the other groups. Therefore the correlation between muscle function 
and histology could not be determined in this experiment. Hypotheses for the mismatch 
between muscle function and histology in this experiment are: 1) the used histological 
scoring system overestimated true muscle damage, 2) the observed di¡erences in histology 
scores are ‘true’, but clinically less important for muscle function than we previously 
thought or 3) the chosen nerve simulation method is not able to detect these smaller 
di¡erences in muscle vitality. The last hypothesis was considered less likely, following 
the results of a pilot experiment on three limbs. One of the limbs showed acute arterial 
thrombosis a®er replantation. The nerve stimulation thresholds in this limb showed a rapid 
and ongoing rise a®er the onset of the thrombosis (from 4 to >150mV). To further explore the 
relation between histology and muscle function, replantation studies with a longer follow-
up need to be conducted.
Several points that a¡ect objective muscle histology outcome scoring need to be addressed 
to further explore this ambivalence. Firstly, a standardized method for the histological 
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scoring of ischemia-reperfusion injury in muscle tissue is lacking. Most histological 
features are non-specic, making it hard to determine exactly which histological changes 
are attributable to true muscle damage and which are not (e.g. vacuolization, interstitial 
oedema). This results in a large heterogeneity in scoring systems between research groups, 
making it hard to objectively compare results.9 In this article, a simple system was proposed, 
enabling a systematic scoring on several items. The items can be separately analysed to 
determine which categories are most predictive for true muscle damage. The second point 
to be addressed is that ischemia-reperfusion injury seems to present as a heterogenous 
phenomenon in skeletal muscle.5, 14 The microscopical evaluation of muscle cross-sections 
showed di¡usely spread areas of ischemic damage, surrounded by well-preserved areas. 
Therefore, single muscle biopsies seem to be insu°cient to evaluate ischemia-reperfusion 
muscle damage in an experimental setting. We recommend to evaluate a larger area of 
muscle or at least obtain multiple biopsies per time point. 
Biochemical markers for muscle damage (creatine kinase and potassium) were increased 
a®er limb replantation in our experiment with persistently higher CK in ECP preserved 
limbs compared to SCS. Interestingly, Dureas et al. described similar results during blood-
based perfusion of porcine limbs. CK levels increased to >27,000U/L a®er 12 hours of ECP, 
but muscle contraction upon stimulation also remained completely preserved.24 However, 
there are other articles that describe lower levels biochemical markers in the ECP group. 
For instance, Krezdorn et al. found signicantly lower levels of potassium and myoglobin 
following porcine limb replantation a®er 24-hour ECP compared to 4-hour SCS, despite 
of increased levels during ECP.14 The shorter anaesthesia time in the SCS group in this 
experiment might have possibly inuenced the CK levels in porcine blood, especially since 
pigs tend to develop muscle spasms during anaesthesia. The predictive value of biochemical 
markers for the estimation of muscle damage or functional results to date remains unclear. 
A cut-o¡ value for muscle damage using these biochemical markers is yet to be determined. 
The observed weight increase of 19% in the current experiment is low compared to other 
research; Krezdorn et al. reported a 42% weight increase and Kuckelhaus et al. a 44% 
increase in similar setups using modied STEEN resp. Perfadex solution.14, 25 
Disadvantages of this experiment were the small sample size and the short follow-up a®er 
limb replantation. Animals were anesthetized during the entire experiment. An animal 
survival study with long follow-up remains a future goal but was not yet found ethically 
approvable by the animal ethical committee based on currently available evidence. The 
follow-up period of twelve hours a®er replantation was based on the fact that the majority 
of vascular compromise occurs within this period.26 The experiment therefore only assessed 
the acute post-replantation phase and results need to be interpreted accordingly. This 
research was not able to assess nerve recovery or limb survival and hypotheses need to be 
further explored in experiments with a longer follow-up. Since the focus of this experiment 
was to assess the e¡ect of prolonged ECP on histological and neuromuscular function and 
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not to investigate the immune reaction following tissue transplantation, an autologous 
replantation model was used to rule out any bias from transplantation reactions. 
This research adds important new information to the existing evidence promoting 
extracorporeal perfusion as a safe technique for prolonged tissue preservation. 
Interestingly, despite of the short follow-up, a discrepancy in outcomes was found between 
nerve stimulation and histology, where neuromuscular function remained intact but 
histology showed more damage in ECP preserved limbs. Further exploration of this funding 
is suggested as the focus of future investigation with a longer follow-up. Next steps would 
include a large animal survival-experiment with a follow-up of at least one week, assessing 
in-vivo muscle response to nerve stimulation (up to 3 days) and whole muscle contractibility 
and comparing results to histology. Long-term clinical appearance and limb function could 
then both be used to further rene the histological assessment scale to match limb viability. 
Conclusion
Six limbs were successfully replanted a®er 18 hours of ECP with UW-mp solution. This is a 
3-fold elongation of the current maximum static cold storage time. Although histology results 
in ECP preserved limbs seemed to be inferior to 4-hour SCS, muscle contraction thresholds 
were completely preserved at the end of the experiment with outcomes comparable to 
the current gold standard of limb preservation and to sham limbs. Histological ndings 
therefore did not seem to correlate to neuromuscular function at 12 hours a®er replantation. 
This leads to the question of whether histological features or functional measures (or a 
combination) are the best predictors for transplant success, which will need to be evaluated 
in follow-up studies. 
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Is the rst bilateral hand transplantation 
feasible in the Netherlands?












Worldwide, more than 100 hand-arm transplantations have been performed since 1998. 
However, in the Netherlands an upper limb transplant has not yet been performed. 
Following the presentation of a feasible recipient candidate in 2015, a platform has been 
created in the Radboud University Medical Centre in Nijmegen, the Netherlands, to be 
ready for the rst upper limb transplantation. The patient in question lost both her legs 
below the knee and both hands due to severe sepsis in 2014 and is highly motivated and 
psychologically strong, making her an ideal candidate for a bilateral forearm transplant. 
The aim of this paper is to describe the history of limb transplantation and the ethical and 
medical aspects of initiating a vascularised composite allotransplant program. Recipient 
screening and donor selection are highlighted, the surgical procedure is portrayed and 
postoperative protocols including immunosuppressive therapy and rehabilitation are 
presented.
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Introduction
In the Netherlands, a hand or forearm transplantation has not been performed before. 
Following the presentation of a suitable recipient, a platform has been created in the 
Radboud University Medical Centre in Nijmegen, the Netherlands, to be ready for the rst 
upper limb transplantation. The patient is a 44-year-old former hairdresser who su¡ered 
severe sepsis with acute kidney failure and di¡use intravascular coagulation in 2014. Both 
hands and legs were amputated due to necrosis: her le® hand at the radiocarpal level, 
the right and dominant hand at the metacarpal level and both legs below the knee. She 
recovered remarkably well with full restoration of kidney function. She is mobile with her 
leg prostheses but only wears a le® arm prosthesis if necessary, for demanding activities. 
She nds the arm prosthesis heavy and o®en restricting. The patient is not a good candidate 
for sophisticated robotic hands as there is no space for the computerised hardware. The aim 
of this article is to create awareness of the possibility of hand and forearm transplantation 
and to investigate the requirements for such an endeavour.
History
The rst attempt at human hand transplantation was performed in Ecuador in 1964 by a 
team led by Robert Gilbert. However, due to limited immunotherapy options at that time 
a strong rejection reaction led to removal of the gra® two weeks a®er transplantation.1 
A®er the discovery of cyclosporine in the 1980s and later the development of tacrolimus 
(FK-506) and mycophenolate mofetil, research on limb transplantation commenced on rats 
and monkeys.2-6 Following good results for organ transplantation in humans on these new 
immunosuppressive regimes, the rst successful hand transplantation was performed in 
Lyons, France, in 1998. The patient was 48 years old and lost his right forearm in a circular 
saw accident in prison.7 This case was quickly followed by a second in January 1999, 
performed by the Louisville team in the United States. This 37-year-old patient lost his le® 
hand in a reworks accident 8 These two cases perfectly illustrate the importance of cautious 
patient selection and the need for life-long immunotherapy. The rst patient lost his gra® to 
rejection at 27 months a®er transplantation and was noncompliant to immunosuppression, 
while the second patient has always been compliant and to date the gra® is still working.9-11 
The rst bilateral hand transplantation was performed in Lyons in 2000. This complex 
procedure required a 50-member surgical team with surgeons from around the world.12, 13 
The rst bilateral arm transplantation in a paediatric patient was performed in Philadelphia 
in 2015. The eight-year-old Zion was already on immunosuppressive drugs due to a prior 
kidney transplantation.14 
Current situation
The most current update of the worldwide experience with hand-arm transplantation 
was provided by Shores, Brandacher and Lee in February 2015.10 A total of 107 hand-
arm transplants were performed on 72 patients at the time of their writing. At least three 
additional double and one single upper limb transplantation were performed therea®er.15 
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A large proportion of the upper limb transplants were performed in Europe, with a total 
of 33 patients receiving 54 upper limb transplants (21 bilateral transplants). Procedures 
were performed in France, Germany, the United Kingdom, Austria, Belgium, Italy, Poland, 
Spain and Turkey. A total of 31 upper limb transplantations in 22 patients were performed 
in the United States (9 bilateral transplants). Other countries that have performed hand 
transplantations are Australia, Malaysia, Mexico, Iran and China, accounting for another 22 
transplants in 17 patients (5 bilateral transplants). 
When excluding patients who received multiple vascularised composite allogra®s during 
transplantation (i.e. combined face and hand transplant), good results remain. Only 
one Mexican patient died due to sepsis, resulting in a very low mortality rate. However, 
the resulting mortality rate of 99% is based on case reports and anecdotes and might 
underestimate the actual rate due to publication bias. To date, a 5- or 10-year mortality 
rate remains unpublished. Gra® survival in Europa and the United States is estimated to 
be 94.1%, with a total of ve gra®s that had to be removed in the non-acute phase a®er 
transplantation. Based on the available information, four of these losses can possibly be 
assigned to noncompliance of the patients to their immunosuppressive therapy. It has been 
estimated that a compliant patient with an upper limb transplant has a long-term gra® 
survival of 88-90% per limb a®er initial surgical success.10, 16 This illustrates the importance 
of careful patient selection to achieve good results a®er hand transplantation.
Recipient selection and ethical aspects
Only a select group of patients are suitable candidates for upper limb transplantation. 
Apart from general requirements of the patient’s overall health and age (<65 years), 
there are procedure-specic criteria that need to be considered. Hand transplantation 
should generally not be performed in under-aged patients due to the side e¡ects of 
immunosuppressants and the assumed incompetency at that age to make such an 
important and life changing decision.
The level of amputation is most favourable between the elbow and wrist, but might be 
more proximal. A both personal and also widely advocated requisite is the bilateral loss 
of hands.17 The need for lifelong immunotherapy and initial higher level of functioning 
and psychological well-being of unilateral compared with bilateral amputees are the most 
important arguments. For less functional gain, unilateral transplant patients will have to 
endure the same side e¡ects. A patient with reasonable functionality with prosthetic hands 
can still be a potential candidate for a hand transplantation, as hand transplants have 
proven to be superior to prosthesis regarding functionality (especially sensation), aesthetic 
appearance as well as their unique quality to complete the body image of the patient again.10 
Based on previous experience, the psychological state of the recipient is a very important 
factor in patient screening.18 Apart from being motivated and compliant, the patient must 
understand the risks of the procedure and of lifelong immune suppression therapy and 
be able to weigh these risks against the expected functional improvement. It is important 
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that the patient is fully aware of these risks, including the increased risk of solid cancers, 
lymphoproliferative diseases and lethal infections as the most devastating side e¡ects of 
immunosuppressive therapy. As vascularised composite allogra® (VCA) transplantation 
procedures are non-life saving, the decision to transplant has to be weighed more carefully 
compared with organ transplantation.19-21,22
Legal aspects
The Central Committee on Research Involving Human Subjects of our hospital reviewed the 
intended procedure under the scope of legislation under the Medical Research involving 
Human Subjects Act (the WMO) and concluded that this procedure concerns patient care 
and not research since it has already been performed over 100 times worldwide.
Concerning the donor, the process workow of the donor hand-arm program was set up 
together with a highly motivated team of transplantation coordinators. A selection of 
Dutch ICUs with regular donor procedures is participating in the donor screening. Since 
registration for hand-arm donation is not possible in the Dutch donor registry, the Dutch 
Transplant Foundation (NTS), Ministry of Health, Welfare and Sport (VWS) and Euro 
transplant were contacted to explore the legal framework of this procedure. They concluded 
that the hand is considered as an organ based on the Organ Donation Act (WOD). Initially, 
the decision was taken that only families of patients with positive registration in the donor 
register without exclusion of any organ or tissue could consent for hand-arm donation. 
However, since December 2018 an addendum to this rule was made, allowing to also include 
patients as possible hand-arm donors if they were not registered in the donor register or if 
they appointed their family to make the nal decision for them. If the potential donor is 
eligible by law, the family will be asked to decide a®er a comprehensive explanation of the 
process by a dedicated transplant coordinator together with a designated intensivist. In this 
process, the visible loss of both arms and attachment of life-like prostheses require special 
attention. One of the lead surgeons will be available for additional family counselling. 
The consent should be unanimous between all important family members and granted in 
writing. Additionally, the family should be informed extensively about the media attention 
that this procedure will generate and the likelihood that the family will see the recipient in 
the media, including seeing the hands of their deceased family member.
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Figure 1. Photographs of the recipient’s arms  
A) dorsal le¢ arm, D) dorsal right arm, B/E) palmar view with 3D printed incision guide applied to the 
wrist, C/F) thermal camera images; note the decrease in temperature towards the distal arm. 
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Medical aspects
Preoperative planning and recipient assessment 
An upper limb transplant can be considered as specialized individual medical care, with a 
need for extensive preoperative assessment and planning. 23 A team of rehabilitation doctors 
and hand therapists assessed our patient’s functionality and composed a list of desirable 
goals a®er transplantation (i.e. holding a bottle; dressing herself; cutting and eating with 
hands). Photographs of the forearms were taken, with additional thermal camera images 
(FlirOne thermal camera) to objectify the temperature di¡erence that was noted across the 
patient’s arms (Figure 1). The nutritional and cardiopulmonary status of the patient were 
checked. Multiple blood tests were performed for evaluation of the patient’s metabolic 
(e.g. liver and renal function), haematological (e.g. ABO and HLA prole, blood count, 
coagulation) and infectious prole (e.g. viral infections).
Extensive evaluation of the arms followed to obtain more information and to plan the level 
of transplantation. The osseous state (X-ray, CT with 3D reconstruction of bones), location 
and quality of arteries and veins (CT-angiography, MR-angiography) and quality of the 
muscles and nerves in the forearm (MRI, nerve ultrasound and EMG) were mapped 
(Table 1). A personalized cutting guide was manufactured based on the 3D reconstruction 
of the bones to facilitate the osteosynthesis process during transplantation (Figure 2).
Donor and gra selection
Apart from legal donor prerequisites, there are also medical and procedural conditions to 
consider during the donor selection process. To minimize ischemia time (time between the 
harvest of the donor arms and their revascularization on the recipient’s vessels) which is 
related to gra® failure, hand-arm donation can only occur in a brain death donor within an 
approximately two-hour travel distance from the acceptor hospital. The hands need to be 
in overall good condition and match the recipient. A close match of the donor hands to the 
recipient is not only important for the aesthetical result, but also for functional recovery. 
Therefore, for every recipient an individual list of criteria needs to be dened to obtain such 
a match (e.g. hand size, skin colour, age). The most important contraindications for donor 
arms are: donor too old, hand size di¡erence >15%, systemic diseases a¡ecting the hand or 
the postoperative healing process and large vessel thrombosis (Table 2).23, 24 The donor is 
rst assessed by ICU physicians.25 To structure and uniform this process, detailed protocols 
describing the steps have been developed. When contraindications are ruled out, blood 
will be withdrawn for HLA matching. A cautious HLA matching procedure is warranted, 
since skin is highly immunogenic tissue and forms a major component of the hand-arm 
transplants. The risk of rejection is therefore higher compared with solid organ transplants, 
although most rejection episodes are reversible.10 In case of a match in HLA proles of 
donor and recipient, all catheters need to be removed from the donor’s arms and perfusion 
to the extremities should be protected to preserve the arms in optimal condition for the 
gra® procurement procedure. 
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During the past 18 months, the surgical team has practiced extensively on cadaveric limbs 
on gra® procurement, hand-arm dissection, osteosynthesis and replantation of the limbs. 
When initiating the actual procedure, the team will be divided into a donor and recipient 
team, both consisting of a minimum of four members. The donor team travels to the 
donor hospital to procure the arms of the heart-beating donor and attach the prosthetic 
arms (Figure 3). At a backside table, 4°C University of Wisconsin uid is ushed through 
the brachial artery of the donor arms at a pressure of 30-60 mmHg to remove blood and 
preserve the tissue. The ischemic period is initiated and the arms are brought to the 
recipient hospital as fast as possible, wrapped in sterile bags and cooled on melting ice. 
Meanwhile, a®er nal preparations, the other team has already started operating on the 
recipient in the Radboud University Medical Centre. The two teams merge in the operating 
room and start working simultaneously on donor and recipient arms. During this procedure, 
communication between all teams is of utmost importance and is secured by a coordinator 
who is not performing surgery and checking progress. All structures will be tagged with 
labels during the procedure, easing later identication (Figure 2). A®er complete dissection 
Table 1. Components of the extensive preoperative planning and screening of a bilateral hand 
transplant recipient.
Recipient Screening tests
Physical examination incl. hands
Nutritional status
Cardiopulmonary
ECG, chest radiography, pulmonary function tests
Haematological 
Complete blood cell count, platelet count, coagulation, ABO blood type, rhesus factor, HLA typing, 
reactive antibodies
Metabolic 
Serum electrolytes, liver function, creatinine clearance and urinalysis
Infectious disease 
CMV, EBV, VZV, HIV, hep B, hep C, toxoplasmosis, Syphilis, ParvoB19, Strongyloides
Imaging 
Normal photographs
X-ray hands and forearms
CT/MR-angiography, including 3D bone reconstructions
Nerve ultrasound, EMG conduction studies
Ultrasound of peripheral arteries and veins (neck and groin area, for intraoperative catheters)
Psychosocial screening and functional assessment
Hospital Anxiety Depression Scale (HADS), RAND (SF-36), Disability of the Arm Shoulder and Hand 
(DASH)
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 163
163
Is the first bilateral hand transplantation feasible in the Netherlands?
8
of donor and recipient arms, osteosynthesis with plates and screws follows, assisted by the 
3D manufactured cutting guides. Subsequently, the vascular anastomoses are made and 
blood is reintroduced into the arms. The total ischemia time is preferably less than 6-8 hours 
to decrease ischemic cell damage and obtain good functional outcomes of the gra®. Further 
reconnection of tendons, additional vessels and nerves will be made, cautiously taking 
the right balance between exors and extensors into account. Nerves will be connected as 
distally as possible to promote early ingrowth into the donor arms. If necessary, tendon 
transfers can directly be performed to optimize functional outcome. The physiotherapy 
team provides the rst postoperative splints and the recipient will be transferred to the ICU 
for recovery. 
Postoperative care
During the rst days a®er surgery, monitoring of the vascularization of the gra®s is 
important. Any pressure to the gra®s needs to be prevented, as protective sensation is 
missing. Prophylactic drugs (antibiotics and antiviral agents) are administered to prevent 
infection, and extensive blood tests and urinalysis are performed regularly to check the 
patient’s wellbeing. In case of any signs of acute rejection, skin biopsies need to be taken 
and immediately assessed.
Figure 2. Practising the arm transplantation procedure at a cadaveric patient. All tendons, nerves and 
vessels are tagged. A custom made cutting guide is applied with K-wires to the distal radius and ulna to 
de¡ne the osteotomy plane and position of ¡xation screws. 
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A®er revascularisation of the transplanted gra®, the immune response immediately 
initiates. Innate immune cells present donor antigens to lymphocytes and activate them 
with two signals. T-helper-cells (CD4+) are the key cells in this activation process and are 
involved in cytotoxic-T-cell (CD8+) activation in the cellular response and in initiating 
B-cell activation in the humoral immune response.26 The closer the HLA proles of donor 
and acceptor match, the lower the rejection risk will be. Our patient developed anti-HLA 
antibodies, especially in Class II. These antibodies must be considered during the matching 
procedure and decrease the chance of an HLA match. The predicted chance of a match 
based on blood-type is 88% for her blood group A. This chance is reduced to 8.8-20% 
when additionally taking her HLA prole into account, depending on the level of desired 
cautiousness.
Without immunosuppressive therapy, a gra® will be destroyed within two weeks. As skin 
is a higher antigenic tissue compared with most solid organs, an adequate suppression of 
the immune system is very important in VCA.9, 27 Immunosuppression therapy consists of 
high-dosed induction therapy followed by oral maintenance therapy. Induction therapy 
starts at the day of surgery and consists of intravenous recombinant antithymocyte 
globulin (rATG), highly dosed corticosteroids, a calcineurin inhibitor and a selective T-cell 
immunosuppressant. The goal is to deplete the T-cell population during the rst two weeks 
through rATG and to additionally inhibit lymphocyte activation and proliferation by the 
other drugs. Administration of rATG can usually be discontinued a®er three days. The other 
drugs will be decreased stepwise over a period of months but should not be stopped. A 
large study by Ekberg et al. set ground for the commonly used triple therapy maintenance 
regime in VCA consisting of a calcineurin inhibitor (tacrolimus), corticosteroids and 
a selective T-cell inhibitor (most commonly mycophenolate mofetil).28 This is further 
endorsed by the Kidney Disease Improving Global Outcome (KDIGO) guidelines, 
recommending the same regime as preferred choice maintenance therapy in kidney 
Figure 3. Prosthesis for the donor patient, overview (le¢) and close-up of the hands (right). 
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transplantation.29 Calcineurin inhibitors inhibit T-cell activation, mycophenolate mofetil 
inhibits lymphocyte proliferation and prednisone adds a more general immunosuppression 
to these agents. An advantage of tacrolimus is its positive e¡ect on nerve regeneration.30 
The key to adequate immunotherapy, however, is to nd the right balance between under-
suppression (rejection) and over-suppression (opportunistic infections, malignancies and 
metabolic side e¡ects) of the immune system. In case of under-suppression, T-cells are not 
su°ciently blocked and rejection occurs through a cellular rejection (CD8+ cells), humoral 
rejection (donor-specic antibodies) or a combined response.31, 32 The gra® will show signs 
of acute rejection, clinically recognisable by a maculopapular erythematous rash which 
may be di¡use, focal or patchy over the donor skin. Biopsies of the involved skin need to 
be taken and scored using the Ban¡ classication (Table 3).33 Immunotherapy will have 
to be adjusted depending on the severity of the rejection to prevent damage to the gra®. 
Optionally, topical therapy be added (i.e. corticosteroid cream). One of the lessons learned 
from previous experience in VCA is to be cautious when minimising immunotherapy, as this 
o®en causes under suppression and leads to acute rejection. In case of severe side e¡ects, a 
switch to another drug is therefore preferred above stopping an agent.
Rehabilitation – hand therapy
Rehabilitation protocols should always be personalised and adjusted to the patient’s 
individual goals and hand dominance. Generally, the postoperative rehabilitation protocol 
is divided into three phases.34, 35 The rst three to four weeks are devoted to protective 
splinting in a resting position and oedema prevention, but also include a passive range of 




Donor age <20 or >60 years
No match to recipient 




Blood type A or O
Hand condition
Skin conditions (e.g. scleroderma), arthritis, polyneuropathies, severely injured (trauma or cannula), 
prior large hand surgery
Systemic conditions 
Chronic infections (HIV, hepatitis), sepsis, neurodegenerative conditions (e.g. ALS, MS), malignancy <5yr 
with osseous metastasis, clotting disorders, auto-immune diseases
Relative contraindications
Long ICU admission (a«ecting condition of arms)
Malignancy >5yr
Old hand fractures (X-ray for evaluation)
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motion exercises to prevent adhesion and promote movement. Active motion exercises are 
introduced in the intermediate phase (1-2 months), starting with tenodesis exercises and 
slowly increasing tensile strength to the tissues. Electrostimulation is also initiated during 
this phase. From two months on, the patient can fully train the hands to increase function 
and strength as well as practise routine activities.36 Neurocognitive rehabilitation according 
to Perfetti can be introduced early in the protocol, promoting the recovery of sensory, motor 
and cognitive function of the gra®s.37 
Routine screening
A®er discharge from the hospital, the patient will be routinely checked and continue 
hand therapy on a very frequent outpatient basis. The check-ups follow an elaborate 
schedule and involve: physical examination, blood and urinalysis, X-rays, drug 
level monitoring, virus screening and assessment of hand function. Yearly controls 
additionally consist of analysis of skin biopsies and screening for donor specic 
antibodies as well as evaluation of the skin for malignancies. Furthermore, the patient 
will be enrolled into preventative screening programs for breast, cervix and colon cancer 
as o¡ered by the Dutch government and is advised to take yearly inuenza vaccines. 
Long-term complications
The most important long-term complications a®er upper limb transplantation are the 
consequences of lifelong immunosuppressive therapy and the risk of chronic rejection 
of the gra®. With the longest survival of an upper limb transplant gra® being currently 
19 years, much of the knowledge on long-term complications is derived from solid organ 
transplantation. Although upper limb transplant patients are generally healthier than 
solid organ recipients, it appears that the long-term e¡ects of immunotherapy are similar.26, 
38 Side e¡ects include leukopenia/anaemia, nephrotoxicity, neurotoxicity, diarrhoea, 
cutaneous and metabolic e¡ects (e.g. skin atrophy, Cushing, diabetes, osteopenia).16 
More severe complications include malignancies or potentially lethal infections. Chronic 
rejection occurs as a long-term reaction of the recipient to the gra® and is related to 
under-suppression of the immune response. The rejection response can be cell-mediated 
Table 3: The Ban VCA working classification system33
Grade Inflammatory infiltrate Involvement of epithelium
0 (no rejection) None/rare None
I (mild rejection) Mild perivascular None
II (moderate rejection) Moderate-severe perivascular Mild (limited to spongiosis 
or lymphocytic exocytosis)
III (severe rejection) Dense Apoptosis, dyskeratosis, and/or 
keratinolysis
IV (acute necrotising rejection) Frank necrosis of the epidermis 
or other skin structures
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with brosis and inammation or antibody-mediated with vasculopathy and eventually 
small-vessel thrombosis. 32 Chronic rejection usually starts with a decrease in function 
due to sti¡ness and eventually leads to ischemia and loss of parts of the gra® or the entire 
gra®. Early therapy consists of increasing or changing immunotherapy regimes.39 The 
vasculopathy is di°cult to monitor with regular ultrasound or CT-angiography since it 
rst presents in small vessels. New trials are currently being performed, investigating new 
methods for the detection of vasculopathy in the digital arteries, such as ow MRI.
Outcomes 
Most forearm transplantation recipients function at a level similar to that with prostheses 
a®er a year and continue to improve therea®er.34 A 2010 report from the International 
Registry on Hand and Composite Tissue Transplantation described the outcomes of 31 
patients with a follow-up >1 year. Around 85% of patients had an acute rejection episode 
within the rst year of transplantation, of which nearly half experienced ≥2 episodes. The 
events were o®en preceded by a change in immunotherapy, either as a team decision (side 
e¡ects) or when a patient was not compliant to the therapy. Importantly, all episodes were 
reversible if quickly reported by the patient and treated.40 All patients developed protective 
sensation, 84% developed discriminative sensibility. The majority of patients could perform 
most activities of daily living (i.e. writing, eating or shaving) and were able to work again.10 
Functional MRI demonstrated that the hand representation in the motor cortex regained a 
normal pattern in the years a®er transplantation, illustrating plasticity of the brain, even in 
adult patients.
Future aspects
Following the presentation of a feasible recipient candidate for bilateral arm 
transplantation, a platform for VCA transplantation has now been created in the Radboud 
University Medical Centre in Nijmegen. This patient is the rst and only patient on the 
Dutch waiting list at the moment. However, the program will not be limited to this patient. 
More feasible recipients will be screened and treated in the future following this program. 
Furthermore, a research line has been connected to the transplantation program, testing 
methods for prolonged ex-vivo preservation of VCAs.41 Pilot experiments with long-term 
hypothermic oxygenated extracorporeal perfusion have shown promising results.42, 43 In the 
future, ex-vivo perfusion might be clinically applied to increase gra® preservation, with a 
prolonged maximum safe ischemic period leading to improved gra® outcomes.
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De eerste dubbelzijdige handtransplantatie 
in Nederland 
Resultaten na 1 jaar











The rst bilateral hand transplantation in the Netherlands – Results aer 1 year
 
Background
Although more than 130 hand-arm transplantations have been performed worldwide, the 
rst Dutch hand transplantation has been performed only recently. This bilateral hand-
arm transplantation was performed in June 2019 in the Radboud University Medical Centre, 
Nijmegen. This report describes the preparation, procedure and 1-year follow-up results. 
Case description
This 44 years-old female patient had an amputation of both lower legs and hands in 2014, 
following a severe sepsis with peripheral tissue necrosis. The patient was mobile with 
her leg prostheses at time of presentation. However, the loss of hand function formed a 
continuous invalidation and could not be improved adequately with prosthesis due to the 
distal amputation level of her hands.
Conclusion
The total procedure took 24 hours and was successful. Both the aesthetical and functional 
results were good and are still improving. The patient considered the transplanted hands 
immediately as her own.
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Ondanks dat er wereldwijd reeds meer dan 130 hand-armtransplantaties zijn verricht, 
is de eerste transplantatie in Nederland pas recent verricht. Deze dubbelzijdige hand-
onderarm transplantatie werd in 2019 verricht in het Radboudumc. Dit artikel beschrij® de 
voorbereiding, procedure en 1-jaars resultaten van deze ingreep. 
Casus
Van de betre¡ende 44-jarige patiënte waren in 2014 beide onderbenen en handen 
geamputeerd na een ernstige sepsis met weefselnecrose. De patiënte is ten tijde van 
presentatie goed mobiel met onderbeenprothesen. Het verlies van handfunctie was echter 
onvoldoende te verbeteren met prothesiologie en vormde hierdoor een continue invalidatie. 
Conclusie
De totale procedure duurde 24 uur en is succesvol verlopen. Zowel esthetisch als functioneel 
is goed resultaat behaald. De patiënte ervaart de handen als bij haar behorend.
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Sinds de eerste succesvolle handtransplantatie in 1998 zijn er wereldwijd meer dan 130 
hand-onderarm transplantaties uitgevoerd.1, 2 Hieronder vallen meerdere dubbelzijdige 
transplantaties. De beschreven functionele resultaten zijn goed en de gemiddelde overleving 
van transplantaten is 90%, zeker bij gemotiveerde en therapietrouwe patiënten.3,4 Nadat 
een zeer gemotiveerde en geschikte patiënte zich bij ons presenteerde, werd in juli 2019 
de eerste hand-onderarm transplantatie in Nederland verricht in het Radboudumc te 
Nijmegen. 
Ziektegeschiedenis
De 44-jarige voormalig kapster bezocht de polikliniek plastische chirurgie in verband met 
pijnklachten aan de amputatiestomp van haar been. Beide handen (rechts op radiocarpaal, 
links op metacarpaal niveau) en onderbenen waren geamputeerd bij necrose als gevolg van 
een ernstige sepsis in 2014. Op het moment van dit polibezoek was de patiënte volledig 
Figuur 1. Foto’s van de getransplanteerde rechter (linker rij) en linker onderarm (rechter rij), 1 jaar na 
de ingreep.
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mobiel met onderbeenprothesen. Haar handfunctie was echter zeer beperkt. Er was 
slechts sprake van een metacarpale 1e straal rechts, waarmee enige klemfunctie mogelijk 
was. Haar linker onderarm fungeerde volledig als steun en was koud en vaak ook pijnlijk. 
De belangrijkste motivatie van de patiënte voor transplantatie was het terugwinnen van 
haar zelfstandigheid. Zo waren handelingen als aankleden moeizaam, hygiëne slecht 
mogelijk en was zelfstandig eten sterk aangepast. Handprothesen beperkten de patiënte 
juist tijdens het merendeel van de handelingen door hun gewicht en onhandigheid. Het 
plaatsen van geavanceerde robotische prothesen was niet mogelijk bij onvoldoende ruimte 
voor de hardware. In overleg met het revalidatieteam werd gesteld dat een hand-onderarm 
transplantatie bij deze patiënte een goede optie vormde ter functionele verbetering. 
Een dergelijke procedure is echter niet geschikt voor elke patiënt. Belangrijk was dat 
deze patiënte sterk gemotiveerd was en ook psychologisch opgewassen bleek tegen deze 
ingrijpende procedure. Bovendien dienen de risico’s van de procedure (acute en chronische 
rejectie, in het ergste geval leidend tot verwijdering van [delen van] het transplantaat) en 
van levenslang gebruik van immunosuppressiva (o.a. huidtumoren, opportunistische 
infecties en metabole bijwerkingen) extra zwaar mee te wegen in de beslisvorming rondom 
een dergelijke niet-levensreddende transplantatie. Hiertoe is een uitvoerig medisch ethisch 
beraad gevoerd met alle betrokkene partijen, met positieve uitkomst. 
Voorafgaand aan de procedure vonden uitgebreide voorbereidingen plaats. Deze bestonden 
uit het aÓaarten van het medico-legale gebied omtrent donor en acceptor (met toestemming 
van de Nederlandse Transplantatie Stichting en VWS), medische scholing (snijzaal 
oefening, protocollen opstellen), ontwikkelen van specieke operatiebenodigdheden 
(huid incisie- en osteotomie mallen) en opzetten van samenwerking met Nederlandse IC-
afdelingen.5 In 2018 werd ze als eerste patiënt op de Nederlandse wachtlijst gezet voor 
dubbelzijdige hand-onderarm transplantatie.
In juli 2019 werd een geschikte donor aangemeld via de transplantatie coördinator, regio 
Oost. Deze heart-beating donor was een vrouw van middelbare lee®ijd, waarbij de handen 
onaangedaan waren tijdens de opname en van gelijke huidskleur en passend formaat 
waren voor onze acceptor. Er werd aparte en unanieme toestemming verkregen bij de 
familie van de donor voor een dubbelzijdige armdonatie. Bij de kruisproef was er een 
adequate HLA-match tussen donor en acceptor, waarna de procedure denitief doorgang 
vond. De armen werden 5 cm proximaal van de elleboogplooi afgenomen door ons eigen 
team in het donorziekenhuis. Hierna werden bovenarm prothesen bij de donor geplaatst. 
De donorarmen werden doorgespoeld met gekoelde preservatievloeistof, op smeltend ijs 
bewaard en zo snel mogelijk naar het Radboudumc vervoerd. Daar was het acceptorteam 
inmiddels gestart met het prepareren van de armen van de acceptor, waarbij alle pezen, 
bloedvaten en zenuwen werden gemarkeerd met tags. Na een soortgelijke procedure aan 
de donorarmen werden allereerst de radius en ulna met behulp van patiënt-specieke 
‘cutting guides’ op de juiste lengte doorgenomen, gevolgd door plaatxatie. Hierna werden 
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eerst de diepe exorpezen aangesloten, waarna anastomosering van de arteria radialis, 
arteria ulnaris en minimaal één vene prioriteit hadden om de ischemietijd zo kort mogelijk 
te houden. Na circulatieherstel werden achtereenvolgens de exorpezen, zenuwen, 
extensorpezen en extra venen aangesloten. Belangrijk voor optimale handfunctie is het 
herstel van de juiste balans tussen exoren en extensoren. 
De operatie duurde 24 uur, waarbij de totale ischemietijd van de rechterarm 6,8 uur en links 
9,5 uur bedroegen. Links duurde langer door de slechtere conditie van de acceptorarm. 
Postoperatief werden onderarm spalken aangelegd en werd direct gestart met 3 keer per 
dag handtherapie. Het zogenoemde ‘triple therapie’ immunosuppressieve regime is 
vergelijkbaar met dat na orgaantransplantatie en bestond uit inductietherapie met anti-
thymocyten globuline, gevolgd door onderhoudstherapie met prednison, tacrolimus en 
mycofenolaat mofetil.6 Op 2,5 week postoperatief was er sprake van milde rejectie, bestaande 
Tabel 1. EQ-5D score.  
Resultaten preoperatief versus 1 jaar postoperatief; scores per categorie (0-5).
Preoperatief 1 jaar postoperatief
Mobiliteit (1-5)* 2 2
Zelfzorg (1-5) 2 1
Dagelijkse activiteiten (1-5) 3 2
Pijn/discomfort (1-5) 2 2
Angst/depressie (1-5) 1 1
EQ-VAS (%)** 70 90
* Level 1 = geen problemen, 2 = milde problemen, 3 = matige problemen, 4 = ernstige problemen, 5 = 
extreme problemen. 
** EQ-Visueel Analoge Schaal (VAS): 0-100% (100% is best mogelijk functioneren).
Tabel 2. Michigan Hand Outcome Questionnaire (MHOQ)- Nederlandse versie.  
Resultaten preoperatief versus 1 jaar postoperatief; scores per categorie (0-100).
Preoperatief 1 jaar postoperatief
Algemene handfunctie (0-100)* 15 43
ADL (0-100) 10 27
Werkprestatie (0-100) 55 60
Pijn (100-0)* 100 15
Esthetica (0-100) 63 88
Tevredenheid handfunctie (0-100) 23 40
* Per categorie score 0-100, waarbij hogere score staat voor een betere handfunctie, behoudens bij het 
onderdeel ‘pijn’ waarbij een hogere score staat voor meer klachten.  
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uit rode vlekkerige uitslag op de rechter onderarm, dit werd veroorzaakt door een zeer 
sterke misselijkheid en braken in de beginfase. Er werd succesvol behandeld met topicale 
corticosteroïden zalf en tijdelijke ophoging van de immunosuppressiva. Bijna 2 maanden 
na operatie werd patiënte vanuit het ziekenhuis overgeplaatst naar een revalidatiecentrum. 
Drie maanden na transplantatie kon zij naar huis en was zij zelfstandig. 
De patiënte werd in het eerste jaar met intervallen van 3 maanden poliklinisch vervolgd. 
Tijdens deze afspraken werd de algemene gezondheid uitgevraagd, handfunctie gemeten 
en werden psychologische vragenlijsten afgenomen (Tabel 1, 2, 3). In de eerste maanden 
ervoer ze enkele bijwerkingen van de immuuntherapie (haaruitval, verlies eetlust en 
een lichte tremor), welke na verder verlagen van de doseringen volledig verdwenen. Na 
de eerste rejectie in het ziekenhuis zijn er geen afstotingsverschijnselen meer geweest. 
Patiënte merkt een toegenomen zelfstandigheid zonder hulpmiddelen en een nog steeds 
verbeterende handfunctie, waarbij de meeste functionele doelen zijn bereikt. Zo kan 
ze onder andere eten met bestek, zichzelf aankleden, koken en autorijden, maar lukt 
dichtdoen van knoopjes nog niet. Het gevoel in haar hand en vingers is gedeeltelijk terug, 
waarbij het herstel nog vordert. Naar verwachting zal de handfunctie blijven toenemen 
tot circa 2 jaar postoperatief. Niet alleen functioneel maar ook psychologisch ervaart zij 
de getransplanteerde handen als bij haar behorend. Ze is zeer tevreden met haar handen. 
(Figuur 1). 
Tabel 3. Actieve range of motion.  
Resultaten van 1 maand postoperatief versus 1 jaar postoperatief.
1 maand postoperatief 1 jaar postoperatief
Totale actieve mobiliteit vingers*, °
   Rechts 390 810
   Links 40 600
Flexie pols
   Rechts 38 78
   Links 42 52
Extensie pols
   Rechts 26 54
   Links 15 54
Kracht (pincetgreep – vuistgreep), kg
   Rechts 0,41 – 3,58 0,41 – 7,92
   Links 0,0 – 1,26 0,34 – 1,68
* Totale actieve mobiliteit (TAM) vingers = som van de totale bewegingsuitslag van alle vingers per 
hand, in graden.
563998-L-bw-vRaay




Succes na handtransplantatie is a×ankelijk van meerdere factoren, zoals patiënt-
participatie en -therapietrouw, operatietechniek en ischemietijd. Een succesvol behandelde 
acute rejectie lijkt geen invloed op de handfunctie te hebben.7 In onze casus is vooral 
de combinatie van psychische kracht van patiënte en therapietrouw t.a.v. medicatie en 
handtherapie het belangrijkst geweest. De gedegen voorbereiding is essentieel gebleken 
voor een goede medische behandeling. 
Met als doel weefselschade tijdens toekomstige transplantaties te kunnen beperken, wordt 
in het Radboudumc onderzoek gedaan naar extracorporale perfusie als preservatie techniek 
voor extremiteiten. De resultaten uit dierexperimenteel onderzoek zijn veelbelovend, 
met succesvolle preservatie tot 24 uur.8, 9 Mogelijk zullen hierdoor de resultaten na hand-
onderarm transplantaties in de toekomst verder verbeteren.
Leerpunten/kernpunten
• Er zijn wereldwijd meer dan 100 hand transplantaties verricht
• De eerste (bilaterale) handtransplantatie in Nederland vond in 2019 plaats in het 
Radboudumc
• Om tot goede resultaten na een hand-onderarm transplantatie te komen zijn een strikte 
patiënt selectie, gedetailleerde multidisciplinaire voorbereiding en goede nazorg van 
belang
• Acute rejectie uit zich als (di¡use) roodheid van het transplantaat en kan worden 
behandeld door ophogen van de immunosuppressiva en toevoegen van topicale 
therapie
• De functie na een handtransplantatie neemt na 1 jaar nog steeds toe door vorderende 
zenuw ingroei, leidend tot sensorisch en motorisch herstel 
• Een langdurige ischemie hee® invloed op de weefselkwaliteit en daarmee functie na 
transplantatie
• Met behulp van nieuwe technieken, zoals extracorporale perfusie, wordt gehoopt in de 
toekomst de ischemieschade te kunnen beperken.
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 181
181
Eén jaar na de eerste dubbelzijdige handtransplantatie in Nederland 
9
Dankwoord
De auteurs willen graag alle medewerkers bedanken voor hun betrokkenheid bij het tot 
stand brengen of uitvoeren van de procedure. In het Radboudumc: afdeling plastische 
en reconstructieve chirurgie, afdeling interne geneeskunde-nefrologie en transplantatie 
coördinatoren, laboratorium medische immunologie, operatiekamers, revalidatie afdeling, 
Juridische dienst, medische psychologie, medische ethiek, PR en voorlichting, snijzaal en 
Raad van Bestuur. Buiten het Radboudumc: Revalidatiecentrum Rijndam, meewerkende 
Intensive Care Units in Nederland, Nederlandse Transplantatie Stichting en Ministerie van 
VWS.
563998-L-bw-vRaay




1. Dubernard JM, Owen E, Lefrancois N, et al. First human hand transplantation. Case report. 
Transpl Int. 2000;13 Suppl 1:S521-524.
2. Shores JT, Brandacher G, Lee WP. Hand and upper extremity transplantation: an update of 
outcomes in the worldwide experience. Plast Reconstr Surg. Feb 2015;135(2):351e-360e.
3. Ninkovic M, Weissenbacher A, Gabl M, et al. Functional outcome a®er hand and forearm 
transplantation: what can be achieved? Hand Clin. Nov 2011;27(4):455-465, viii-ix.
4. Hautz T, Messner F, Weissenbacher A, et al. Long-term outcome a®er hand and forearm 
transplantation - a retrospective study. Transpl Int. Sep 24 2020.
5. Kruit AS, Ulrich DJO, Abdo WF, Hovius SER. Is the rst bilateral hand transplantation feasible in 
the Netherlands? Neth J Crit Care. Mar 2019;27(2):74-80.
6. RiÓin WJ, Manjunath AK, Kantar RS, et al. A Comparison of Immunosuppression Regimens in 
Hand, Face, and Kidney Transplantation. J Surg Res. Sep 22 2020;258:17-22.
7. Elliott RM, Tintle SM, Levin LS. Upper extremity transplantation: current concepts and challenges 
in an emerging eld. Curr Rev Musculoskelet Med. Mar 2014;7(1):83-88.
8. Krezdorn N, Macleod F, Tasigiorgos S, et al. Twenty-Four-Hour Ex Vivo Perfusion with Acellular 
Solution Enables Successful Replantation of Porcine Forelimbs. Plast Reconstr Surg. Oct 
2019;144(4):608e-618e.
9. Kruit AS, Smits L, Pouwels A, Schreinemachers MJM, Hummelink SLM, Ulrich DJO. Ex-vivo 
perfusion as a successful strategy for reduction of ischemia-reperfusion injury in prolonged 
muscle ap preservation - A gene expression study. Gene. Jun 15 2019;701:89-97.
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 183
183
Eén jaar na de eerste dubbelzijdige handtransplantatie in Nederland 
9
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 184
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 185
Chapter 10
General discussion and future prospects
563998-L-bw-vRaay
Processed on: 29-7-2021 PDF page: 186
186
Chapter 10
General discussion and future prospects
Despite of tremendous advances in the eld of reconstructive surgery, the current standard 
of care for preservation of composite tissue or limbs is still static cold storage (SCS). The 
maximum preservation time using SCS is limited to six hours, particularly in tissues 
containing large volumes of muscle.1, 2 This results in a large time pressure during complex 
procedures and negatively a¡ects outcomes of procedures such as VCA, replantation or 
free ap surgery in the case of di°cult anastomoses or revisions. This thesis explored the 
application of extracorporeal perfusion (ECP) in order to extend ischemia time beyond 
the current maximum of six hours. The future goal is to safely preserve composite tissues 
far beyond this maximum by using a miniaturised machine that also is suitable for 
transportation. This would allow preservation of VCAs and amputated parts during tissue 
transportation and would extend the donor pool in VCA past country borders to increase 
matching opportunities.3 Furthermore, the machine could be applied during surgery, 
providing continuous tissue preservation until the moment of revascularisation. This which 
will increase tissue vitality and improve surgical outcomes such as muscle function and 
nerve outgrowth. This would however require adaptations of the current technique, most 
importantly reducing the machine’s size to make it suitable for transportation and adapting 
the cooling device.
This thesis performed a multi-step evaluation of ECP for prolonged preservation of 
free muscle aps and limbs. The systematic review in chapter 2 revealed that many 
uncertainties remained with regard to ECP. The large heterogeneity in outcome measures, 
perfusion settings and length of preservation periods between experiments made it hard 
to compare results and draw adequate conclusions. One conclusion of this review was 
that the benecial e¡ects of ECP seemed to be more pronounced when it was applied for 
six hours or more. This thesis further evaluated long-term ECP, aiming to preserve tissues 
well beyond this maximum of 6 hours. The rst evaluation phase was divided into three 
chapters (chapters 3, 4 and 5), which explored the degree and onset of muscle damage 
during long-term ECP compared to SCS. Di¡erent evaluation methods were used with the 
goal to gain more insight into the process of ischemia-reperfusion injury (IRI) in skeletal 
muscle. Electron microscopy, ICG angiography and gene expression outcomes all showed to 
be more favourable during preservation with ECP compared to SCS. These ndings, together 
with available evidence on skeletal muscle ischemic tolerance 2, 4-7, formed the base for the 
decision to treat the intervention group with 18 hours of ECP and the control group in the 
replantation experiments with a maximum of 4 hours SCS. In this way, the total ischemia 
time was kept below the critical boundary of six hours in the SCS group, including the 
additional time for ush and microsurgical replantation. The chosen control group therefore 
provided a ‘negative control’, in the sense that it embodied the best achievable result that 
can be reached in a replantation or VCA setting. Chapters 6 and 7 described the outcomes 
a®er replantation of composite tissues preserved by ECP. These experiments took a rst step 
towards clinical translation of the model. We were able to successfully replant porcine free 
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musculocutaneous aps and forelimbs a®er 18 hours of ECP, without the occurrence of any 
systemic reaction. The so achieved 12-hour extension of maximum allowable ischemia time 
brought our future goal of ‘safely extending ischemia time far beyond the current maximum 
of six hours’ within closer reach. 
Possibilities and restrictions in animal research
A porcine model was used in all experiments. This specic animal model provides optimal 
results since porcine tissues have a comparable-to-lower ischemic tolerance compared to 
human tissues, the anatomy and DNA of pigs is highly comparable and blood vessels have 
a similar size.8, 9 Therefore, results are thought to adequately translate to a clinical setting 
and the set-up as tested in porcine tissues is likely to be e¡ective on human tissues as well. 
One of the principles in animal research is to reduce the number of animals to a minimum, 
which resulted in small intervention groups in the experiments, possibly introducing a type 
II error.10 Additionally, the limited amount of evidence supporting ECP initially reduced 
our possibilities in animal experiments. A multiple-step approval process was therefore 
designed for the experiments in this thesis, where each experiment needed to be passed 
successfully in order to continue with the next experiment. The replantation experiments 
were restricted to a non-survival setup which did not allow a long follow-up. As a result, the 
obtained information in these experiments was restricted to the early phase of reperfusion 
injury. The observation period of twelve hour was partly chosen pragmatically, reducing 
total anaesthesia time to a feasible period, and partly based on the fact that this time 
frame that is relatively sensitive to detect free ap failure. As a general rule, 80% of ap 
compromise occurs within 24 hours a®er surgery of which again 80% presents within 
the rst 12 hours.11 Due to the successful completion of both replantation experiments, 
our research group has now been granted permission to perform experiments with an 
observation period of one week, enabling longer and more precise evaluation of the rate of 
tissue damage and recovery a®er ECP.
Outcome measures
A certain degree of muscle damage during ECP is inevitable. This is reected in literature 
by the widely described increase in serum markers for muscle damage 12-15, expression 
of hypoxia- or apoptosis related markers9, 16 or decreased muscle contraction17-19 during 
ECP in di¡erent preservation setups. However, the question that remains to be answered 
is: how do these outcomes relate to tissue survival probability? To answer this question, 
tissue viability a®er ECP needs to be related to outcomes during perfusion. When assessing 
tissue viability, a combination of damage and function is generally used. For instance, in 
kidney transplantation plasma creatinine levels are used as a marker for damage and urine 
production can be used as a marker for function.20 Both creatinine and urine production are 
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frequently used outcomes in a clinical setting and have well established reference values. 
Unfortunately this is more di°cult for skeletal muscle. There are no available validated 
outcome measures for muscle damage or function, which has led to the development of 
numerous methods and introduced a large heterogeneity into literature on this subject. Most 
of these methods are complex, expensive and time-consuming and deliver retrospective 
results.9, 21-23
In absence of a validated method to evaluate muscle damage, several methods were tested in 
this thesis in order to nd a reliable set of outcomes. Electron microscopy is highly sensitive 
to detect muscle damage, but is an elaborate and expensive technique and therefore not 
suitable for use on a large scale. RT-qPCR for evaluation of gene expression can provide 
insight into cellular processes, but has similar drawbacks to electron microscopy and 
assesses a cellular process rather than actual damage. A simple and reproducible method 
to estimate muscle injury might be measuring the level of CK or myoglobin in blood. CK is 
an important enzyme in energy metabolism and is present in cells that rapidly consume 
ATP. There are di¡erent isoforms corresponding to the producing organ, for instance CK-MM 
for skeletal muscle, CK MB for heart or CK-BB for brain. In a response to damage, CK will 
leak from the cells into blood, leading to increased serum levels.24 Our experiments showed 
increased CK levels during ECP and a®er replantation in all groups, but unfortunately 
did not seem to corelate well to muscle contraction or histological outcomes. A similar 
discrepancy between CK and muscle contraction was presented by Duraes et al. and 
Fahradyan et al. in their porcine limb perfusion experiments.13, 18 Thus, the reliability of 
serum CK as a marker for damage during ECP remains unclear.  
Histology seems to be a reliable method for evaluation of muscle damage at rst sight, but 
should be interpreted with some caution. Firstly, a standardized method for histological 
scoring of ischemia-reperfusion injury in skeletal muscle is not yet available. Since most 
histological changes to ischemia are non-specic, it is hard to determine exactly which are 
attributable to true muscle damage. Secondly, ischemia-reperfusion injury presents as a 
heterogenous phenomenon in skeletal muscle and evaluation of single muscle biopsies will 
therefore introduce sampling error.2 Taking these limitations into account, we suggested a 
new system for microscopical scoring of ischemia-reperfusion injury. To correct for sampling 
error, cross sections of free aps and whole muscles were analysed at ten randomly selected 
elds. This resulted in the collection of specimens solely at the end of the experiment, rather 
than collecting biopsies at several time points during the experiment. Histologic alterations 
were scored on a 3-point scale where a score of 0 corresponded to ‘no damage’ and a score 
of 3 to ‘severe damage’ (see chapters 6 and 7). This scale represents a simplied version of 
the HISS score as proposed in 2013 by Muller et al. which elaborately scores nerve, muscle 
and blood vessels.22 The histological score for muscle damage in our system is categorized 
into di¡erent sub-scores, enabling a separate analysis of each category. This provides the 
possibility of future assessment of the combination of categories that is most predictive for 
muscle viability. The experiments in this thesis had a short follow-up and were not able to 
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answer the question how the di¡erent outcomes related to muscle survival. However, the 
combination of serum markers, histology and muscle contraction did provide insight into 
the degree of damage during the early reperfusion phase. To further assess outcomes and 
improve the histological score, muscle viability needs to be assessed in experiments with 
a long-term follow-up. In such experiments, multiple outcomes could be measured and 
compared to muscle function or to a sensitive evaluation method for muscle damage such 
as electron microscopy.
Perfusion settings
Following the growing interest in ECP for VCA preservation, a variety of machine setups has 
been proposed.3 However, the most important variation results from the diversity in machine 
settings and not from di¡erences in machine construction. There are no standard settings 
and small changes in settings like perfusion mode (pressure regulated vs ow regulated) and 
oxygenation can make the di¡erence between the success or failure of a setup. 
The perfusion pressure was the only setting that was changed over the course of our 
experiments. It appeared to have large consequences for the quality of tissue preservation.25 
Of critical concern is to nd the right balance between adequate tissue penetration 
(which will be compromised when the perfusion pressure is too low) and the onset of 
endothelial damage (when the perfusion pressure is too high). This concept was extensively 
researched on liver perfusion by ‘t Hart et al. They found a perfusion pressure of 25% of 
the physiological pressure (25mmHg) to be optimal and result in less endothelial damage 
compared to a pressure of 50% of the physiological pressure (50mmHg).26 Conversely, 
a further reduction to 12.5% of the physiological pressure resulted in incomplete tissue 
perfusion and increased liver damage.27 Similar results were found in kidney perfusion, 
were Doorschodt et al. showed that even a 5mmHg reduction of the perfusion pressure can 
make a di¡erence. They found a pressure of 25mmHg to be superior to 30mmHg.28 These 
results have led to an increasing awareness towards perfusion pressure during ECP. In limb 
perfusion, Kueckelhaus et al. described an increased structural tissue integrity of muscle 
when a perfusion pressure of 30mmHg was used compared to a pressure of 60mmHg. Gok 
et al. assessed uid kinetics and emphasized the use of large cannula to reduce shear stress 
to vessel walls.29, 30 Our electron microscopy analysis revealed capillary thinning in aps 
preserved by ECP at a pressure of 50mmHg, which presumably resulted from mechanical 
stress during perfusion (chapter 3). In line with the above ndings, we performed a 
pilot experiment to evaluate how far the perfusion pressure could be reduced while still 
remaining complete tissue penetration. Three muscle aps were injected with a uorescent 
dye (indocyanine green; ICG) that can be visualized by a near-infrared emitting camera. 
The perfusion ow was gradually increased until a homogenous pattern of ap perfusion 
was reached. The optimal perfusion pressure was found to be around 30mmHg, which we 
have used in every experiment since.
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Another important perfusion setting is oxygenation. Oxygenated perfusion is necessary to 
prevent hypoxia during ECP.3 Even though tissue metabolism can be signicantly reduced 
during hypothermia, the residual metabolism is enough to force cells to enter anaerobic 
pathways leading to the accumulation of toxic waste products and disturbances in 
electrolyte gradients, eventually resulting in cell death.31, 32 To prove the clinical benets of 
oxygenation during ECP, the COPE-COMPARE trial was designed.33 This randomized clinical 
trial compared oxygenated ECP to non-oxygenated ECP in kidney transplantation and 
favoured the oxygenated group in the preliminary analysis. Taeger et al. were the only to 
directly compare ECP with and without oxygen in muscle aps and conrmed the benecial 
e¡ects of oxygenated perfusion.34 The optimal level of oxygenation during ECP remains a 
subject of debate due to the fear of increased production of radical oxygen species when 
high oxygen levels are being used. However, due to the lack of oxygen carriers in acellular 
preservation solutions, oxygen needs to be dissolved into the solution.35 Since gas solubility 
in a liquid is enhanced by increasing the partial pressure, high oxygen levels seem to be 
inevitable during ECP with acellular solutions. Studies on hypothermic ECP in composite 
gra®s have showed positive results when using oxygen levels varying from 21% to 100%, 
but where never designed to compare di¡erent levels of oxygenation.18, 19, 36, 37 In organ 
preservation, several studies favoured the use of high oxygen levels during hypothermic 
perfusion and could not conrm the production of radical oxygen species.38-40 Therefore, a 
gas mixture containing 95% O2 was used for infusion into the preservation solutions in our 
experiments. The addition of 5% CO2 to the gas mixture is traditionally intended to increase 
a solution’s bu¡ering capacity through bicarbonate formation.32 Even though acellular 
preservation solutions already contain bu¡ers, there is some evidence that still encourages 
the addition of carbon dioxide to these uids.41-43
Type of preservation solution
Similarly to perfusion settings, the type of preservation solution is imperative for success. 
This thesis evaluated ECP with acellular preservation solutions. While whole blood 
perfusion has the advantage to mimic physiological circumstances, it is prone to thrombosis, 
expensive and labour intensive due to the frequent need for replenishments.21, 44 Acellular 
preservation solutions provide a simpler alternative because they are readily available in 
large quantities and there is no need for frequent correction of acid-base balance or for uid 
replenishments due to their optimal bu¡er capacities.36 These characteristics make acellular 
solutions suitable for use during transportation. UW-MPS and HTK both are commercially 
available and have a xed composition, increasing the reproducibility of results. 
When comparing the muscle preservation qualities of HTK and UW-MPS, HTK seemed to be 
slightly better (chapter 4-6). This could result from its capacity to bu¡er large amounts of 
lactate in combination to its lower viscosity, theoretically leading to a better tissue perfusion 
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capacity. During pressure regulated perfusion, the lower viscosity of HTK resulted in a 
higher ow and consequently in a lower ap temperature compared to UW-MPS. Superior 
preservation qualities of HTK were also described in the skeletal muscle immersion studies 
on rats by van der Heijden et al.45, 46 and in cardiac tissue immersion experiments.47, 48 
However, the high oedema rate during perfusion with HTK warrants further investigation 
and prevented its use in our limb preservation experiment due to concerns of compartment 
syndrome. 
Clinical application of extracorporeal perfusion 
A platform for VCA was established in the Radboudumc in 2018, followed by the rst 
bilateral hand-arm transplantation a year later. Together with limb replantation procedures, 
VCA forms the best indication for ECP preservation in composite tissues. In the Netherlands, 
donor tissue needs to be transported to the recipient a®er procurement, resulting in 
additional ischemia time. In the case of the Dutch hand-arm transplantation, ischemia 
times were 6 hours and 46 minutes for the right arm and 9 hours and 28 minutes for the le® 
arm. This included a transplant relocation time of 1 hour, which is the time to transport the 
donor tissues to the operating room of the recipient hospital. In the ideal future, ECP could 
be started directly following transplant procurement and ush, and could be continued 
until microsurgical revascularisation of the transplant. Similarly, amputated extremities 
could be connected to the perfusion machine at the emergency department or even in an 
ambulance for optimal tissue preservation. This would release the time pressure during 
surgery and is presumed to improve outcomes. In order to fully deploy the ECP technique 
during transportation and surgical procedure, the perfusion machine needs to be adjusted 
and further miniaturized to improve its mobility. Since this thesis mainly focused on the 
evaluation of tissue preservation during ECP and not on optimisation of the machine, this 
remains a future goal. Our machine in its current form is not yet suitable for transportation. 
This is mainly caused by its size and the heater-cooler element that needs to be connected 
to a water tap. However, small and transportable machines are already available for organ 
transplantation. These machine have overcome this problem by cooling the preservation 
solution with ice.25 A transportable perfusion machine for composite tissue preservation 
therefore seems a realistic possibility too.
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This thesis has showed that replantation of composite tissues a®er 18-hour ECP is possible 
and that muscle function is retained during short follow-up. However, more steps need to be 
taken before this technique can be clinically introduced. Therefore, this experimental line 
will be continued to further assess the e¡ects of prolonged ECP. The next step is to conrm 
the results found in the replantation experiments by conducting porcine experiments with 
the follow-up of one week. This will provide insight into the long-term clinical, histological 
and biochemical responses to ECP and replantation. Another goal is to further optimise and 
adjust the preservation uids to better t skeletal muscle needs. In a further future, the 
machine should be adapted to a transportable version and the rst trials on (discarded) 
human tissues could be commenced. Ultimately, with the goal to li® ECP research to a 
higher level, forces should be merged by initiation of an international collaborations, 
aiming to set guidelines, collaborate in experiments and unify test results.
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Skeletal muscle is the main component of most free aps and vascularized composite 
allogra®s (VCAs), accounts for volume and function and is a highly ischemia sensitive 
tissue. To date, static cold storage (SCS) still is the golden standard for preservation of 
these tissues. However, the maximum tolerable ischemia time of muscle tissue can only be 
prolonged from four to approximately six hours when cooled to a temperature of 4°C. This 
results in a battle against time during complex or time-consuming procedures, such as VCA 
(e.g. hand transplantation), composite tissue replantation (e.g. hand replantation) or free 
ap surgery (di°cult anastomoses or revision). 
This thesis evaluated extracorporeal perfusion (ECP) as a technique to decrease ischemia-
reperfusion injury during ex-vivo preservation of porcine free musculocutaneous aps and 
limbs. The ultimate goal was to safely prolong preservation of these tissues beyond the 
maximum ischemia time. Further information on the subject is provided in chapter 1, the 
general introduction.
Summary of chapters 
Chapter 2: systematic review
This review systematically appraised the available literature on extracorporeal perfusion 
in free aps and VCA. A total of 18 articles that compared tissue vitality a®er ECP to a 
nonperfused control group was included in the review. Articles that evaluated the e¡ect 
of a single ush were not selected. The quality of included studies was generally low and 
there was a large heterogeneity in study population (rats, dogs, pigs, human waste tissue), 
tissue type (adipofascial aps, musculocutaneous aps, limbs) and outcome measures, 
that impeded an objective comparison of results. Still, histology outcomes were superior 
a®er ECP compared to control, especially when muscle tissue was preserved beyond the 
critical ischemia time of 6 hours. The serum markers lactate and creatine kinase (CK) 
generally increased during ECP, indicating some degree of anaerobic metabolism or muscle 
damage, but showed a partial recovery or complete restoration to normal values a®er tissue 
replantation. Oedema was broadly describes as a side e¡ect of perfusion, with weight 
increases varying from 8% to 100% of initial tissue weight. Therefore, the prevention of 
oedema was appointed as one of the major focus areas for further research in this eld. 
Other focus areas would be the optimization of perfusion settings, validation of outcome 
measures and maximum time of ECP. 
Chapter 3: electron microscopy
Muscle tissue is composed of several important structures that need to be preserved during 
ECP. Mitochondria are important for energy delivery, myobrils for muscle contraction and 
capillary endothelium for preventing vascular leaking or thrombosis. Since ECP might 
also have side e¡ects that a¡ect these structures, it is important to evaluate the integrity 
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of these structures during ECP. This descriptive study was the rst to assess the timing 
of onset and degree of damage to skeletal muscle tissue during ECP with transmission 
electron microscopy. Six free rectus abdominis muscle aps were raised from three pigs and 
were preserved for 36 hours on ice slurry (SCS) or by continuous ECP with oxygenated UW 
solution. The solution was cooled to 8-10°C. Muscle biopsies were evaluated for damage 
to mitochondria, myobrils and capillaries. Results showed a two-fold decrease of damage 
and also a later onset of this damage in aps preserved by ECP compared to SCS. These 
positive results encouraged further investigation of EPC as muscle preservation technique. 
Capillaries were only moderately damaged during ECP, but were a¡ected di¡erently. 
Interestingly, the capillary endothelium showed focal thinning during ECP, as opposed 
to endothelial projections that evolved into capillary luminal obstruction during SCS 
preservation. It is hypothesized that the capillary thinning is caused by the continuous 
articial ow that leads to mechanical stress on the vessel walls. Therefore, the perfusion 
pressure of 50mmHg that was used during this experiment needed to be revised.
Chapter 4: feasibility of long-term extracorporeal perfusion
Prior to this experiment, a pilot experiment was conducted to determine optimal perfusion 
pressure, which was set at 30mmHg and used in all following experiments. 
The experiment in chapter four focused on the feasibility of long-term ECP and used 
two commercially available preservation uids: UW-MPS and HTK solution. Ten rectus 
abdominis aps were retrieved from ve pigs and preserved for 36 hours by SCS (n=4), 
ECP with UW-MPS (n=3) or ECP with HTK (n=3). The preservation solutions were cooled 
to 8-10°C and oxygenated with a carbogen mixture (95% O2 + 5% CO2). There was a stable 
ow in all perfused aps during the experiment, with rates of 6-8ml/min. Flaps developed 
an abnormal appearance a®er ≥6 hours of SCS (dull, purple discoloration), whereas ECP 
preserved aps appeared normal up to ≥18 hours. The aps’ perfusion patterns were 
evaluated with ICG uorescence angiography at 24 hours of preservation and revealed 
homogenous patterns in all aps preserved by ECP, compared to inhomogeneous patterns 
during SCS. Additionally, the expression of genes related to apoptosis (TNFRS10A and 
CASP3) and inammation (IL1B, NFKBIZ) was lower in ECP preserved aps. The serum 
marker for muscle breakdown, CK, steadily accumulated in the perfusate during ECP. Final 
levels were comparable between ECP with UW-MPS (44 404 IU/L) and HTK (43 144 IU/L). 
The lactate increase was signicantly higher during ECP with UW (+ 6.6 mmol/L) compared 
to ECP with HTK (+1.1mmol/L). The larger bu¡er capacity of HTK and its quality  to decrease 
cell metabolism might explain the lower lactate increase in this group. However, the 
increase of serum markers in both ECP groups indicate that there is some degree of muscle 
breakdown and anaerobic metabolism during ECP. Since literature on CK and lactate levels 
during ECP is limited, it remains di°cult to relate these levels to tissue viability. Another 
di¡erence between UW-MPS and HTK was seen in the total weight increase, which was 
lower a®er ECP with UW-MPS solution (+22%) compared to HTK solution (+78%). To 
conclude, long-term ECP was found to be feasible. Superiority of one of the preservation 
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solutions could not be established from these results. 
Chapter 5: gene expression
In this chapter, gene expression was assessed during preservation and a®er replantation 
of porcine rectus abdominis aps. In order to select genes of interest, a microarray analysis 
was rst performed on seven aps. Out of 27,558 porcine genes, eight were selected, 
based on fold change between control and intervention samples and global function. 
The second part of the experiment assessed gene expression patterns with RT-qPCR with 
regular intervals until 12 hours a®er ap replantation. Flaps preserved by 18-hour ECP 
with UW-MP (n=5) or HTK (n=5) were compared to aps preserved by 4-hour SCS (n=4) as 
a control group. As expected, there was an up-regulated expression of pro-inammatory 
genes (IL1B, NFKBIZ) a®er ap replantation in all groups, which gradually decreased over 
time. Hypoxia, cellular stress (HIF1A, DDIT4) and apoptosis (TNFRS10A, CASP3) related 
gene expression increased a®er ap replantation and remained high until the end of the 
experiment. Since there were no di¡erences in overall gene expression patterns between 
the ECP groups compared to SCS, results suggest that muscle condition a®er 18-hour ECP 
is grossly equal to 4-hour SCS. However, all preservation techniques led to activation of 
processes related to cellular ischemia and cell death, of which some were still active at 12 
hours a®er replantation. 
Chapter 6: free 
ap preservation and replantation
In this chapter, the outcomes a®er prolonged preservation of porcine rectus abdominis aps 
with ECP were compared to that of aps preserved by short SCS. Unilateral aps were raised 
from ®een pigs. Five aps were preserved for four hours by SCS, ve were preserved for 
18 hours with oxygenated ECP using UW-MPS solution and ve with oxygenated ECP using 
HTK solution. Flaps were replanted a®er preservation and observed for another 12 hours. 
Two aps su¡ered arterial thrombosis a®er replantation (1 HTK ap, 1 UW ap), for which 
successful revision surgery was undertaken. Porcine arterial blood samples were collected 
every 6 hours. CK levels increased over time in all groups, but were signicantly higher 
in aps preserved with ECP compared to SCS. There were no di¡erences in potassium or 
lactate levels between the groups a®er ap replantation. On histological review at 12 hours 
a®er replantation, there was a trend towards more ischemia-reperfusion injury in aps 
preserved by UW perfusion (HISS 4.4) compared to aps preserved by HTK perfusion (HISS 
2.6) or SCS (HISS 3). This di¡erence especially manifested in the sub-scores for inammation 
and interstitial oedema but not in the sub-score for muscle bre damage. When comparing 
the two preservation solutions, ap weight increased with 53% a®er HTK perfusion versus 
no increase a®er UW perfusion. Final weight increase was 39% in HTK perfused aps 
versus 24% in UW perfused aps and 17% in SCS preserved aps. The higher viscosity of 
UW-MPS solution compared to HTK solution resulted in a lower ow in this group and 
a¡ected ap temperature. Although the solutions were both cooled to 10-15°C, mean ap 
core temperature was 19°C during UW perfusion versus 17°C during HTK perfusion. Overall, 
the di¡erences in histology and biochemical parameters between ECP and SCS groups were 
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small, and a prolongation of free muscle ap preservation with 13.5 hours was successfully 
achieved. Although HTK solution seemed to be slightly superior to UW-MPS solution when 
looking at histological outcomes, there was a concern of considerable oedema leading to 
compartment syndrome when using this solution in limbs. UW-MPS solution was therefore 
used in the experiment in chapter 7.
Chapter 7: limb preservation and replantation
Muscle function is an important outcome a®er VCA, since good functional outcomes can 
only be achieved when skeletal muscle is kept in optimal condition during the procedure. 
The nal experiment of this thesis therefore evaluated the e¡ect of prolonged porcine limb 
preservation on functional outcomes a®er replantation. These results were compared to 
histology scores with the goal to better predict muscle damage. The right forelimbs of 12 
pigs were amputated, preserved by 4-hour SCS (n=6) or 18-hour ECP with oxygenated UW-
MPS (n=6), and were replanted with a follow-up of 12 hours. Sham surgery was performed 
on the le® forelimb and served as internal control. ECP was uneventful in all limbs, with 
a mean ow of 16ml/min and limb temperature of 16°C. Mean limb weight was stable 
during ECP and SCS and increased with 19% respectively 12% a®er replantation. As a 
functional outcome for the entire neuromuscular unit, the muscle contraction threshold 
was measured by determining the lowest voltage of median nerve stimulation that was 
needed to obtain visible limb movement. Since nerve stimulation was performed within 
the window of maximum 3 days a®er nerve transection, it remained una¡ected by 
Wallerian degeneration. In this experiment, the contraction thresholds in ECP preserved 
limbs showed a transient increase at two hours a®er replantation but returned to baseline 
values at 8 hours a®er replantation. The stimulation thresholds for contraction at the end 
of the experiment were comparable between ECP and SCS limbs and also between ECP and 
sham limbs. On histologic review, limbs preserved by ECP showed minimal to intermediate 
muscle damage. However, the total degree of ischemia-reperfusion injury appeared to be 
higher in these limbs compared to SCS and sham limbs. Histology ndings therefore did 
not seem to correlate well to muscle function at 12 hours a®er replantation. This leads to the 
question whether histology or muscle function (or a combination) is the best predictor for 
transplant success.
Chapter 8: preparations for the rst bilateral hand transplantation in the 
Netherlands
This chapter describes the history of upper limb transplantation and the ethical and 
medical aspects of initiating a VCA programme in the Netherlands. The surgical 
procedure of hand-arm transplantation is portrayed and postoperative protocols including 
immunosuppressive therapy and rehabilitation are presented. Although more evidence 
supporting ECP is needed before it can be clinically implemented, this chapter provides a 
look into the future. 
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Chapter 9: the rst Dutch hand transplantation, results aer 1 year
This chapter presents the case of the rst bilateral hand-arm transplantation in the 
Netherlands, performed by our team in July 2019 in the Radboudumc, Nijmegen. One year 
results are presented as photographs, functional outcomes (Michigan hand questionnaire, 
active range of motion) and physiological outcomes (EQ-5D). An upper limb transplantation 
is one of the procedures that will benet from increased tissue preservation. In the ideal 
future, ECP can be the tool that can be used globally to increase the preservation time 
during these procedures.
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Nederlandse samenvatting
Extracorporale perfusie voor de langdurige 








Introductie van het onderwerp
De reconstructie van grote defecten in het menselijk lichaam behoort tot een van de 
belangrijkste gebieden binnen de plastische chirurgie. Grote defecten kunnen worden 
gereconstrueerd met lichaamseigen weefsel door dit weefsel naar het te defect te verplaatsen, 
zoals bijvoorbeeld bij een borstreconstructie. Een andere optie bestaat uit het terugplaatsen 
van geamputeerde weefsels (replantatie), bijvoorbeeld na een handletsel. Soms is het echter 
niet mogelijk een dergelijk weefsel terug te plaatsen en is het nodig weefsel van een donor 
te gebruiken. Deze procedures worden afgekort met VCA; gevasculariseerde samengestelde 
allotransplantatie. Sinds de eerste succesvolle handtransplantatie in 1998 1 zijn ook 
gezichts-, buikwand-, baarmoeder- en penis-transplantaties mogelijk geworden.2-5 De eerste 
handtransplantatie in Nederland werd in 2019 werd uitgevoerd door de afdeling plastische 
chirurgie van het Radboudumc. De vooruitgang op het gebied van weefselreplantatie en 
VCA wordt echter niet bijgehouden door de ontwikkelingen in technieken om weefsels 
buiten het lichaam te bewaren. Tot op heden is de gouden standaard voor het bewaren 
van samengestelde weefsels nog steeds koude opslag op smeltend ijs. Met behulp van deze 
methode kan het te transplanteren maximaal 6 uur worden bewaard.6, 7 
Het is echter niet bij elke procedure mogelijk om onder dit maximum van 6 uur te blijven, 
bijvoorbeeld gedurende complexe en tijdrovende reconstructieve procedures of wanneer er 
tijd nodig is het weefsel van donor naar ontvanger te transporteren. Dit resulteert in een 
‘strijd tegen de tijd’ en kan het uiteindelijke resultaat nadelig beïnvloeden. Wanneer deze 
weefsels langer buiten het lichaam te bewaren zijn, zullen niet alleen de resultaten na de 
ingreep doen verbeteren, maar zal ook het risico op afstoting na VCA afnemen.6, 8
Extracorporale perfusie (ECP) is een veelbelovende techniek voor het langdurig bewaren 
van samengestelde weefsels buiten het lichaam.9 ECP betekent letterlijk ‘het buiten het 
lichaam doen doorstromen met een vloeistof’ (extra= buiten, corpus= lichaam, perfusie= 
doorstroming [met bloed of een andere vloeistof]). De voorloper op de ECP-machine is de 
hart-longmachine, welke sinds 1953 al wordt toegepast tijdens openhartoperaties.10 Starlz 
et al. waren de eerste die ECP beschreven als veelbelovende techniek voor het bewaren 
van organen.11 Gedreven door het oplopende tekort aan donororganen, werd de techniek 
verder verbeterd en aangepast voor klinisch gebruik. Vandaag de dag is het een van de 
belangrijkste technieken voor het bewaren van organen.12, 13 Ondanks het feit dat er sinds 
de jaren ’80 een groeiende interesse is voor ECP als toepassing voor het bewaren van 
samengestelde weefsels, is er nog maar beperkt onderzoek naar verricht.14 
Spierweefsel wordt in twee typen onderscheiden; glad spierweefsel en skeletspierweefsel. 
Glad spierweefsel bekleedt de binnenkant van bloedvaten en organen en is veelal 
betrokken bij onwillekeurige processen. Skeletspierweefsel bevindt zich tussen botten 
en kan worden aangestuurd om samen te trekken, waardoor beweging ontstaat. 
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Vergeleken met andere weefsels in samengestelde weefsels, gebruikt skeletspierweefsel 
veel voedingssto¡en en zuurstof en zal daarom het snelst schade oplopen bij een tekort 
hieraan. De maximale bewaartijd van skeletspierweefsel is 4 uur bij bewaring op 
lichaamstemperatuur, vergeleken met 8 uur voor zenuwweefsel, 13 uur voor vet, 24 uur 
voor huid en 4 dagen voor bot.7 Skeletspierweefsel is een belangrijk weefsel om langdurig 
buiten het lichaam te bewaren, want dit vormt het hoofdbestanddeel van de meeste 
samengestelde weefsels, is verantwoordelijk voor volume en functie en is dus zeer gevoelig 
voor zuursto®ekort (ischemie). In dit proefschri® wordt dan ook vooral de mate van schade 
aan skeletspierweefsel tijdens het bewaren van weefsels onderzocht. Gezien de unieke 
eigenschappen van skeletspierweefsel kunnen de technieken die gebruikt worden in ECP 
bij organen, niet zomaar worden afgeleid naar dit type weefsel. 
Dit proefschri® evalueert extracorporale perfusie als techniek voor het langdurig bewaren 
van spierlappen en ledematen buiten het lichaam. Het doel was om deze weefsels veilig 
te bewaren, langer dan de maximale bewaartijd (ischemietijd) die we kennen van koude 
opslag, de huidige standaard. Organen worden niet beschouwd als weefsels en vallen 
buiten bestek van deze promotie. Alle experimenten vonden plaats op varkens en werden 
goedgekeurd door de lokale en nationale dier-ethische commissies. ECP is mogelijk met 
bloed of vloeisto¡en, waarbij elk zijn eigen voor- en nadelen hee®. In deze thesis werd ervoor 
gekozen de twee meest gebruikte vloeisto¡en te testen: Histidine-Tryptofaan-Ketoglutaraat 
(HTK) en University of Wisconsin (UW)-vloeistof. Meer informatie over dit onderwerp is te 
lezen in hoofdstuk 1, de algemene inleiding (Engelstalig). In de onderstaande samenvatting 
worden de belangrijkste bevindingen van dit proefschri® per hoofdstuk beschreven.
Hoofdstuk 2: systematische review
In het tweede hoofdstuk wordt een overzicht gegeven van de beschikbare literatuur over de 
toepassing en resultaten van ECP. Door middel van het systematische literatuuronderzoek 
werden 18 artikelen geïdenticeerd die ECP vergeleken met een controlegroep. Deze bleken 
veelal van lage kwaliteit en bovendien onderling moeilijk te vergelijkbaar, door de grote 
variatie die aanwezig was in studie populatie (ratten, honden, varkens, menselijk weefsel), 
weefseltype (vet-fascie-lappen, huid-spier-lappen, ledematen) en door het ontbreken van 
gevalideerde uitkomstmaten. Wanneer naar histologische uitkomsten werd gekeken, waren 
deze na ECP superieur ten opzichte van controle, vooral wanneer het weefsel werd bewaard 
na de kritieke ischemietijd van 6 uur. AÙraakproducten in het bloed, creatinine kinase (CK) 
en lactaat, namen over het algemeen toe tijdens ECP, wat duidt op een zekere mate van 
zuursto®ekort of spierbeschadiging tijdens de perfusie, maar vertoonde een gedeeltelijk 
of volledig herstel na het terugplaatsen van weefsel in het lichaam (replantatie). Oedeem 
(vochtophoping in het weefsel) was de meest beschreven bijwerking van ECP, met toenames 
in gewicht variërend van 8% tot 100% van het oorspronkelijke gewicht. De preventie van 
oedeem werd derhalve aangewezen als een van de belangrijkste aandachtsgebieden voor 
verder onderzoek op dit gebied. Andere aandachtspunten waren optimalisatie van perfusie-
instellingen, validatie van uitkomstmaten en maximale bewaarduur met behulp van ECP. 
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Op deze punten zal het onderzoek in deze thesis zich gaan richten.
Hoofdstuk 3: elektronen microscopie
Spierweefsel bestaat uit verschillende belangrijke structuren die tijdens ECP behouden 
moeten blijven. Mitochondria zijn belangrijk voor de levering van energie, myobrillen 
voor spiercontractie en capillair endotheel (bekleding van haarvaten) voor het voorkomen 
van stolselvorming en lekkage van deze vaatjes. Aangezien ECP mogelijk ook een negatief 
e¡ect op deze structuren kan hebben, is het belangrijk om de schade aan deze structuren 
tijdens ECP te evalueren. Deze beschrijvende studie was de eerste die de timing en de mate 
van beschadig van skeletspierweefsel beoordeelde met transmissie-elektronenmicroscopie 
gedurende ECP. Zes buikspierlappen werden uitgenomen uit drie varkens en werden 36 
uur lang bewaard op smeltend ijs (SCS) of middels ECP met UW-oplossing. De oplossing 
werd gekoeld tot 8-10°C. De mate van schade aan mitochondriën, myobrillen en 
capillair endotheel in de spierbiopten liet een tweevoudige afname van schade zien en 
ook een latere intrede van deze schade in de lappen die door ECP werden bewaard in 
vergelijking met SCS. Deze positieve resultaten stimuleerden verder onderzoek naar EPC als 
bewaartechniek voor spierweefsel. Capillairen waren slechts matig beschadigd tijdens ECP, 
maar lieten een andere uiting van schade zien. Interessant genoeg vertoonde de capillairen 
wandverdunning tijdens ECP, in tegenstelling tot juist een verdikking van de wand en 
obstructie van de capillairen die zich ontwikkelde tijdens SCS-conservering. Er wordt 
verondersteld dat deze wandverdunning wordt veroorzaakt door de continue kunstmatige 
stroming tijdens ECP die leidt tot mechanische belasting van de vaatwanden. We besloten 
daarom om de perfusiedruk te herzien (gedurende dit experiment 50mmHg). 
Hoofdstuk 4: haalbaarheid van langdurige extracorporale perfusie
Voorafgaand aan dit experiment werd een pilot-experiment uitgevoerd om de optimale 
perfusiedruk te bepalen. Deze werd op 30 mmHg gezet en werd bij alle volgende experimenten 
gebruikt.
Het experiment in hoofdstuk vier richtte zich op de haalbaarheid van langdurige ECP en 
gebruikte hiervoor twee commercieel verkrijgbare vloeisto¡en: UW-MPS en HTK-vloeistof. 
Tien buikspierlappen werden uitgenomen uit vijf varkens en 36 uur bewaard middels SCS 
(controlegroep, n = 4), ECP met UW-MPS (n = 3) of ECP met HTK (n = 3). De vloeisto¡en 
werden gekoeld tot 8-10 ° C en geïnfundeerd met medisch carbogeen (95% O2 + 5% CO2). 
Er was sprake van een stabiele perfusie in alle lappen met continue stroomsnelheiden 
van 6-8 ml/min. De controle lappen ontwikkelden een abnormaal uiterlijk na ≥6 uur SCS 
(do¡e, paarse verkleuring), terwijl de lappen die met ECP werden bewaard een normaal 
uiterlijk behielden tot ≥18 uur. Op 24 uur werd de mate van perfusie (doorstroming) van 
de lappen onderzocht met ICG-uorescentieangiograe. Alle lappen aan de ECP machine 
bleken een homogene perfusiepatroon te hebben, in tegenstelling tot de inhomogene 
en incomplete perfusiepatronen tijdens SCS. Ook werd de expressie van bepaalde 
genen onderzocht en bleken de genen gerelateerd aan celdood (TNFRS10A en CASP3) 
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en ontsteking (IL1B, NFKBIZ) lager te zijn in de lappen die werden bewaard met ECP. De 
marker voor spieraÙraak, CK, stapelde zich op in de perfusievloeisto¡en tijdens ECP. De 
eindconcentraties CK waren vergelijkbaar in beide ECP groepen en was 44.404 IE/L na 36 
uur perfusie met UW en 43.144 IE/L na 36 uur perfusie met HTK. De stijging van lactaat 
(aÙraak product van cellen in zuurstofnood) in de vloeistof was signicant hoger tijdens 
ECP met UW (+ 6,6 mmol/L) vergeleken met ECP met HTK (+ 1,1 mmol/L). Dit zou kunnen 
worden verklaard door de grotere bu¡ercapaciteit van HTK en de kwaliteit van deze 
vloeistof om de energiehuishouding van cellen te verlagen. De toename van CK en lactaat 
gedurende ECP gee® echter aan dat er tijdens deze manier van bewaren toch een zekere 
mate van spieraÙraak en zuursto®ekort is. Aangezien de informatie over CK- en lactaat 
gedurende ECP in de huidige literatuur zeer beperkt is, blij® het lastig om de hoogte van 
deze markers in verband te brengen met de vitaliteit van weefsels. Een laatste verschil 
tussen UW en HTK was de totale gewichtstoename, die lager was na ECP met UW-vloeistof 
(+ 22%) in vergelijking met HTK-vloeistof (+ 78%). Concluderend bleek langdurige ECP 
haalbaar te zijn. Uit onze resultaten kon de superioriteit van een van de vloeisto¡en echter 
niet goed worden vastgesteld.
Hoofdstuk 5: genexpressie
In dit hoofdstuk werd de expressie van genen tijdens het bewaren en na terugplaatsen 
van buikspierlappen onderzocht. Om genen van interesse te selecteren, werd eerst 
een microarray-analyse uitgevoerd op zeven lappen. Van de totaal 27.558 beschikbare 
varkensgenen werden er acht geselecteerd op basis van fold-change (expressieverschil) en 
hun globale functie. Het tweede deel van het experiment beoordeelde de expressie van deze 
genen met RT-qPCR op meerdere tijdstippen na terugplaatsing van de lap in het varken tot 
totaal 12 uur daarna. De lappen die werden bewaard met 18 uur ECP met UW vloeistof (n = 
5) of HTK vloeistof (n = 5) werden vergeleken met lappen die waren bewaard met 4 uur SCS 
(n = 4). Zoals verwacht was er een toename in expressie van genen die positief gerelateerd 
zijn aan ontsteking (IL1B, NFKBIZ) in alle groepen, waarbij deze expressie in de tijd weer 
geleidelijk afnam. De expressie van genen gerelateerd aan zuurstofgebrek, cellulaire stress 
(HIF1A, DDIT4) en celdood (TNFRS10A, CASP3) nam toe na terugplaatsing van de lappen 
en bleef hoog tot het einde van het experiment. Aangezien er geen grote verschillen waren 
tussen de gen expressie patronen in de ECP-groepen in vergelijking met de SCS groep, kan 
worden geconcludeerd dat de spierconditie na 18 uur ECP grofweg gelijk is aan 4 uur SCS. 
Alle bewaarmethoden leidden echter tot activering van processen die verband houden met 
zuursto®ekort en celdood, waarvan sommigen aan het einde van het experiment nog actief 
waren.
Hoofdstuk 6: Perfusie en replantatie van buikspier lappen
In dit experiment werden de resultaten na bewaring en terugplaatsing van buikspier 
lappen vergeleken tussen langdurige ECP en korte SCS. Er werden 15 lappen uit 15 varkens 
gehaald. Vijf lappen werden 4 uur bewaard met SCS, 5 lappen werden 18 uur bewaard met 
ECP met UW-vloeistof en 5 lappen met ECP met HTK-vloeistof. De lappen werden na deze 
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bewaarduur gereplanteerd (teruggeplaatst) op hun oorspronkelijke locatie en gedurende 
12 uur geobserveerd. Twee appen ontwikkelden een acute vaatafsluiting na replantatie 
(1 HTK-lap, 1 UW-lap), waarvoor een revisieoperatie moest worden uitgevoerd. Elke 6 uur 
werden bloedmonsters van de varkens verzameld. Het hierin gemeten CK steeg gedurende 
de tijd in alle groepen, maar was signicant hoger in lappen die waren bewaard met ECP 
ten opzichte van SCS. Er waren geen verschillen in de hoogte van het gemeten kalium of 
lactaat tussen de groepen. Aan het eind van het experiment werden alle lappen uitgenomen 
voor histologische beoordeling. De totale spierschade in lappen die werden bewaard met 
UW-perfusie (HISS 4.4) leek hoger te zijn dan in de lappen die werden bewaard met HTK-
perfusie (HISS 2.6) of SCS (HISS 3), echter was dit resultaat niet statisch signicant. Dit 
verschil kwam vooral tot uiting in de sub scores voor ontsteking en oedeem, maar niet in de 
sub score voor schade aan spiervezels. De gewichtstoename van lappen gedurende ECP was 
hoger ni de HTK groep (+53%) dan in de UW groep (0%). De uiteindelijke gewichtstoename 
aan het eind van het experiment was 39% in de HTK groep, 24% in de UW groep en 17% 
in de SCS groep. De hogere viscositeit van UW vloeistof in vergelijking met HTK vloeistof 
resulteerde in een lagere stroomsnelheid tijdens perfusie beïnvloedde de temperatuur 
van de lap. Hoewel de oplossingen beide waren gekoeld tot 10-15°C, was de gemiddelde 
kerntemperatuur van de lappen 19°C tijdens UW-perfusie versus 17°C tijdens HTK-perfusie. 
Concluderend waren de verschillen in histologie en bloedmarkers tussen ECP- en SCS-
groepen klein en werd een succesvolle verlenging van bewaring van vrije spierappen 
met 13,5 uur bereikt. Hoewel de HTK vloeistof enigszins beter leek te zijn dan UW, zou 
de oedeemvorming mogelijk kunnen leiden tot compartimentsyndroom wanneer deze 
vloeistof wordt gebruikt voor het bewaren van ledematen. Daarom werd toch UW gekozen 
als vloeistof in experiment 7. 
Hoofdstuk 7: perfusie en replantatie van ledematen
Spierfunctie is een belangrijke uitkomstmaat na VCA, aangezien goede functionele 
resultaten alleen kunnen worden behaald als het skeletspierweefsel tijdens de procedure in 
optimale conditie wordt behouden. Het laatste experiment van dit proefschri® evalueerde 
daarom het e¡ect van langdurige ECP van ledematen op de functionele uitkomsten na 
replantatie. Deze functionele resultaten werden vergeleken met histologie scores met 
als doel spierschade beter te kunnen voorspellen. De rechter voorpoten van 12 varkens 
werden geamputeerd, 4 uur bewaard met SCS (n = 6) of 18 uur bewaard met ECP met UW 
(n = 6), en vervolgens gereplanteerd met een follow-up van 12 uur. Een sham procedure 
(schijnoperatie) werd uitgevoerd op de linker voorpoot, waarbij alle structuren behalve de 
bloedvaten werden doorgenomen. Deze poot diende vervolgens als interne controle. De ECP 
verliep in alle 6 poten zonder problemen, met een gemiddelde stroomsnelheid van 16 ml/
min en poot temperatuur van 16°C. Het gewicht van de poten was stabiel tijdens ECP en 
SCS, maar nam na replantatie toe met gemiddeld 19% (ECP) en 12% (SCS). Als functionele 
uitkomst voor de gehele neuromusculaire eenheid werd de spiercontractie drempel 
gemeten. Hiertoe werd de laagst benodigde spanning gemeten die nodig was tijdens 
stimulatie van de nervus medianus om zichtbare beweging van de poot te verkrijgen. De 
563998-L-bw-vRaay




spiercontractie drempels toonden een kortdurende stijging in de eerste 4 uur na replantatie 
van de poot, maar keerden daarna terug naar de uitgangswaarde. Aan het einde van het 
experiment waren de spiercontractie drempels vergelijkbaar tussen niet alleen ECP- en 
SCS-bewaarde poten, maar ook tussen de ECP-poten en hun sham poten. De totale mate 
van spierschade bij histologische beoordeling was echter hoger in de met ECP bewaarde 
poten ten opzichte van de SCS en sham poten. De histologische bevindingen leken derhalve 
niet goed te correleren met de spierfunctie. Dit leidt tot de vraag of histologie of spierfunctie 
(of een combinatie ) de beste voorspeller is voor transplantatiesucces.
Hoofdstuk 8: voorbereidingen voor de eerste dubbelzijdige handtransplantatie 
in Nederland
Dit hoofdstuk beschrij® de geschiedenis van hand-armtransplantatie en de ethische en 
medische aspecten van het initiëren van een VCA-programma in Nederland. De chirurgische 
procedure wordt beschreven en protocollen worden toegelicht, waaronder het protocol 
voor immuun-onderdrukkende behandeling en revalidatie. Hoewel er meer bewijs nodig 
is voordat ECP klinisch kan worden gebruikt als bewaartechniek tijdens VCA, werpt dit 
hoofdstuk alvast een blik in de toekomst..
Hoofdstuk 9: de eerste dubbelzijdige handtransplantatie in Nederland, resultaten 
na 1 jaar
Dit hoofdstuk beschrij® de casus van de eerste dubbelzijdige hand-armtransplantatie 
in Nederland, uitgevoerd in juli 2019 in het Radboudumc te Nijmegen. De resultaten na 
1 jaar worden gepresenteerd, deze bestaan uit foto’s, functionele uitkomsten (Michigan 
hand questionnaire, actieve range of motion) en psychologische uitkomsten (EQ-5D). 
Een hand-armtransplantatie is één van de procedures die zal proteren van verbeterde 
weefselpreservatie. En in een ideale toekomst zal ECP hét hulpmiddel zijn dat ons helpt de 
weefsels tijdens deze procedures beter te bewaren.
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All animal experiments in this thesis (Chapters 3 to 7) were performed on pigs and were 
approved by the Central Animal Laboratory and the Animal Ethics Board (project number: 
2016-0043) and performed in accordance to local and National guidelines for animal care. 
All experiments including the welfare evaluation were registered in the digital animal 
welfare system ‘iVentionLES’.
All data obtained during this PhD at the Radboud university medical centre have been 
stored on the department server (H:) PLCHIRdata$ (\\UMCFS044). Additionally, the 
outcomes of the gene expression experiments in Chapter 4 and 5 were collected and stored 
in Labguru. Labguru is a digital laboratory which is centrally stored and backed-up on the 
local Radboudumc server and is accessible to authorized members only. 
The raw research data obtained for this thesis will be saved for 15 years a®er publication 
(until 2035). The datasets analysed during the experiments in this thesis are available upon 
reasonable request. 
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Daar is het dan, het dankwoord. Voor veel mensen het enige en zeker leukste deel van dit 
boekje om te lezen. Voor mij dé kans om iedereen te bedanken maar ook iets vreselijks om 
te schrijven, want stel je toch voor dat ik iemand vergeet!? Ik hoop van niet! Ik heb enorm 
genoten en ontzettend veel geleerd van het hele traject dat hoorde bij de totstandkoming 
van dit boekje en deel deze mooie dag dan ook graag met jullie allemaal. 
Allereerst Prof. Dr. Ulrich, beste Dietmar, je hebt mij eind 2015 aangenomen als ANIOS 
en onderzoeker op het project dat je als ‘jouw kindje’ beschouwt. Desondanks kreeg ik al 
snel het vertrouwen en ook de vrijheid het onderzoek een eigen draai en richting te geven, 
wat ik geweldig vond. Het moment van de eerste lapreplantatie zal ik nooit vergeten; dit 
ging mis en de moed zonk mij direct in de schoenen. Dat ook jij het na een lange nacht 
tevergeefs opereren even niet zag zitten, heb je me gelukkig pas veel later verteld, toen de 
experimenten inmiddels gesmeerd liepen en ons vertrouwen weer helemaal terug was. 
Andere heugelijke momenten zijn de afdelingswintersport, leuke congressen, het Coldplay 
concert en de anekdotes ‘kikker spring’. Mijn dank voor alle steun en jouw vertrouwen in 
mij is bijzonder groot, waarbij vooral de vele (nachtelijke) uren hulp tijdens de proeven op 
het dierenlab niet ongenoemd mogen blijven!
Dr. Hummelink, beste Stefan, vanaf het eerste moment was jij bij dit project betrokken. 
Eerst nog vanaf de zijlijn, maar al snel was jij niet meer weg te denken als cruciaal 
onderdeel van het promotieteam. Van samen het eerste model perfusiebox in elkaar kitten 
tot het zetten van de puntjes op de i betre¡ende de uitvoering van mijn laatste experiment. 
Met mijn vragen kon ik altijd bij jou terecht. Met een cafeïneboost erbij, bracht jij me binnen 
no-time weer terug tot de kern van het verhaal en kon ik vol inspiratie verder. Ik wil je 
bedanken voor al jouw hulp, voor alle lachbuien die we samen hebben gehad en voor de 
waardevolle kluslessen.😉 Ik hoop dat we nog lang samenwerken!
Dr. Schreinemachers, beste Marie-Claire, als ervaringsdeskundige op het gebied van 
nierperfusie had jij een kritische blik en scherpe opmerkingen. Bedankt voor jouw rake 
aanvullingen of commentaren op mijn manuscripten. Ook hebben we heel wat tot in de 
late uurtjes samen staan opereren, met als toppunt onze 2 uur durende ‘overnachting’ in de 
achterkamers van afdeling C2N tijdens een dienst in de zomerreductieperiode. Extra leuk, 
dat we nu weer even collega’s zijn voor 3 maanden.
Leden van de manuscriptcommissie, Prof. Dr. Morshuis, Prof. Dr. van der Lei en Dr. van 
der Geest, bedankt voor jullie deelname in deze commissie en voor de kritische beoordeling 
van mijn proefschri®. Daarnaast wil ik ook graag de andere leden van de promotiecommissie 
bedanken.
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Her, Erik, Alex, Maikel en Francien. Jullie waren onmisbare krachten tijdens de uitvoering 
van mijn experimenten in het dierenlab. Zonder jullie was mijn onderzoek niet mogelijk 
geweest, nee echt niet! Ik heb meer genoten van mijn tijd tussen de varkens, dan ik me 
vooraf ooit had kunnen voorstellen. Mede dankzij jullie: de tomeloze inzet, het meedenken, 
mee-opereren (zelfs onder de microscoop!), de humor, nachtelijke Lucifer-marathons, 
goede gesprekken en gezelligheid. Bedankt!
Van de afdeling pathologie wil ik met name Dominique van Midden, Benno Kusters, 
Lilian Eshuis, Floor Vos en Yordy Welling bedanken, maar ook alle anderen die hebben 
geholpen bij de verwerking en analyse van mijn histologische samples. Ik zocht jullie meer 
dan eens op met een grote hoeveelheid weefsel op formaldehyde, of een rekje vol coupes 
die moesten worden geanalyseerd. Mijn dank is groot! Van de klinische neurofysiologie 
wil ik in het bijzonder Nens van Alfen en Sander Pagen bedanken voor de prettige 
samenwerking en voor het afstaan van meetapparatuur aan het dierenlab, waarmee ik 
zenuwstudies kon verrichten. Bedankt voor alle hulp van de onderzoekers in het urologie 
lab in de onderzoektoren en in het bijzonder aan Mirjam de Weijert en Frank Smits voor 
de hulp met mijn proeven en bij het begeleiden van stagiaires in het lab. Hans Peters en 
Jasper Lok wil ik bedanken voor hun hulp met uitvoerig onderzoek naar uorescentie 
kleuringen, die prachtige plaatjes opleverden maar helaas geen bruikbare resultaten. Bram 
van Cranenbroek bedankt voor de uitvoering van de cytokinemetingen. En tot slot Judith 
van Luijk van SYRCLE voor de hulp tijdens het schrijven van de systematische review. 
Angèle, Laura, Harm, Joep, Saskia en Lisa; mijn groep onderzoek studenten. Bedankt 
voor jullie hulp tijdens het uitvoeren van de experimenten. Jullie hulp varieerde van het 
uitvoeren van metingen en proeven in het lab, ondersteuning tijdens experimenten of het 
minutieus bestuderen van de literatuur. 
Ik dank alle betrokkenen voor hun medewerking aan de eerste dubbelzijdige 
handtransplantatie van Nederland. Daarnaast bovenal onze geweldige en eindeloos 
optimistische patiënte en de moedige donorfamilie die de unanieme toestemming gaf die 
nodig was om deze procedure als eerste in ons land uit te kunnen voeren.
Lieve (oud-)collega’s van het Radboudumc. Allereerst Steven, Till en Pieter bedankt 
voor jullie hulp tijdens de uitvoering van het technische en microchirgische deel van 
replantaties. Tevens dank ik Steven en Till ook voor het onder hun hoede nemen van 
mij op het gebied van congenitale handchirurgie. Een zeer waardevolle, leerzame en 
ook gezellige samenwerking! Bij de staeden horen verder nog: Erik, Hanneke, Franz, 
Tim en Tim, Brigitte, Mariëlle, alle assistenten Marijn, Marjolijn, Claire, Nicholas, 
Tycho, Femke, Lennart, Bo, Laura, Harm, Saskia en overige collega’s Erik de Laat, 
Nienke en Yasmille: bedankt voor alle steun, grappen, borrels en gezelligheid. Wat 
hebben we toch een bijzondere groep. Zonder jullie was het een stuk minder leuk geweest. 
Ik hoop met het overgrote deel van jullie nog lang samen te werken! Last but not least; 
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Kaj. Zet ‘m op met het inmiddels alweer afrondende gedeelte van jouw vervolg op mijn 
studies.
Lieve afdeling C2N, OK-personeel (Francien en Aly), poli-medewerkers, secretaresses 
en onderzoekers van de plastische chirurgie; bedankt voor jullie gezelligheid, het jne 
samenwerken en dat ik de kasten mocht komen plunderen voor spullen die ik weer eens 
nodig had op het lab. Stephan bedankt voor alle hulp bij het vormgeven van guren en 
met name voor jouw grote rol in het ontwerp en de opmaak van mijn boekje. Mét hierbij een 
goede dosis humor, met jouw geweldige fotoshopacties weet je me nog altijd te neppen. En 
wat een resultaat; het boekje is prachtig geworden!
Lieve Vera, paranimfe, ik was net verhuisd naar Nijmegen en kende daar nog niemand. 
Het duurde echter niet lang, of ik vond jou als gezellige collega op mijn werk en we 
werden al snel het praatgrage en (ietsjes maar) luidruchtige duo van de afdeling. Je kent 
de grillen van mijn promotie en experimenten van dichtbij en ik heb je dan ook graag 
aan mijn zijde op deze belangrijke dag. Ik vind je een prachtig persoon met een tomeloos 
doorzettingsvermogen (óók als het om onderzoek gaat). Hopelijk werken we nog lang 
samen!
Lieve Bente, paranimfe, eerste deelden wij vooral de roeisport, maar vooral in onze laatste 
studiejaren zijn we verder naar elkaar toe gegroeid. Als singles gingen we samen stappen 
in de Hofman, waar de mannen eerlijk werden verdeeld. Inmiddels beiden gesetteld, geniet 
ik net zo veel van onze ‘Wineclub’-weekenden met de mannen. Je altijd positieve instelling, 
geduld en doorzettingsvermogen maken je niet alleen een lieve vriendin, maar ook een 
geweldige dierenarts.
Lieve Damesch ‘10; Anouk L, Anouk D, Arina, Bente, Jojanneke, Katja, Krista, Loes en 
Monica. Mijn wedstrijdroei-jaar zie ik nog altijd als de basis van mijn doorzettingsvermogen 
en discipline en ik kijk hier dan ook op terug als een erg bijzondere tijd. Zonder 
bovenstaande eigenschappen was dit boekje nooit zo goed tot stand gekomen. Ook nu we 
allemaal onze eigen weg op zijn gegaan, blijven we samen een bijzondere groep waarin het 
altijd direct weer vertrouwd voelt. De momenten van aeiding tijdens het schrijven van dit 
boekje waren meer dan welkom; bedankt daarvoor!
Lieve Esra, onze reis naar Australië vormde de basis voor onze vriendschap, waarin we 
elkaar inmiddels zo goed kennen, dat we aan een half woord vaak genoeg hebben. Ik ben 
trots op jou als professionele en kundige militair arts! Dank voor alle gezellige momenten, 
op naar meer!
Lieve Caimin. Met jou in de buurt is Nijmegen een stuk gezelliger. Bedankt voor alle 
gezellige avondjes van aeiding!!
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Lieve, lieve A Mares; Anne, Anouk, Ellen, Laurien en Nienke; mijn onvoorstelbaar, 
schittermagisch mooi groepje vriendinnen. Allemaal anders en allemaal zo goed bezig. 
Wie had gedacht, toen we in 2008 als groentjes samen in een roeibootje stapten, dat we 
nu hier zouden staan!? Bedankt voor alle mooie momenten die we de afgelopen jaren 
hebben meegemaakt met elkaar. Om er zo maar een paar te noemen: onvergetelijke Triton 
verkleedfeestjes, Texel- of boerderijweekendjes, raceetsen in de Ardennen, Jordanië-reis, 
prachtige bruilo®en, alweer 3 kindjes en dan nu de derde promotie. Ik ben stuk voor stuk 
ongelofelijk trots op jullie! Bedankt voor alle heerlijke momenten tot nu, op naar nog veel 
meer!
En dan mijn lieve family! Opa, jij bent de liefste en lee® altijd met al mijn avonturen mee. 
Ik ben er zó trots dat ik jou op je 95e nog een exemplaar van dit boekje kan overhandigen! 
Kruite
uitjes; Roos, Piet en Jas - bedankt voor alle jne momenten van aeiding en 
ontspanning tijdens het samenzijn met de familie. Jullie zijn geweldig, een lievere zus, 
broer en zwagert kan ik me niet wensen! Pap en mam; wat kan ik mijzelf gelukkig prijzen 
met zulke lieve ouders en zo’n jne jeugd. Aan de basis van dit alles staan jullie en daarom 
draag ik dit boekje graag aan jullie op. Het boekje van pap was mijn eerste voorbeeld van 
een proefschri®, dat had ik al sinds jonge geneeskundestudente in mijn bezit. En kijk nu 
eens wat hier ligt! Roos en mam bedankt voor het deelnemen aan mijn ‘proefpanel’ voor de 
ka® en voor ieder geldt: bedankt voor het proeezen van de Nederlandse samenvatting en. 
Jullie liefde en steun betekent de wereld voor me!
Lieve Pieter, dankzij mijn baan in Nijmegen, en dus mede dankzij deze promotie, zijn wij 
elkaar op de werk-BBQ in 2017 tegengekomen. Sindsdien kan ik niet meer zonder je. Je vult 
mijn zwakheden perfect aan. Bedankt voor je oneindige geduld, steun en begrip. Op naar 
een promotieloze tijd, waarin we samen volop gaan genieten van reizen, klussen, sporten, 
niksen en lekker eten!
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